data_2dcq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dcq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.576 ' NE2' ' HZ2' ' A' ' 46' ' ' LYS . 26.2 mm-40 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HZ2' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 61' ' ' PHE . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' NE2' ' HZ2' ' A' ' 46' ' ' LYS . 36.5 mm-40 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HZ2' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.591 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.501 HH11 ' HB2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.406 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.477 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 48' ' ' ALA . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' H ' ' HD2' ' A' ' 47' ' ' LYS . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HE2' HD11 ' A' ' 89' ' ' LEU . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' HE2' ' A' ' 58' ' ' LYS . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HE2' HD13 ' A' ' 89' ' ' LEU . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 58' ' ' LYS . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 50' ' ' SER . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.5 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 28' ' ' ARG . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.195 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.46 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.511 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.495 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.495 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.53 109.27 20.67 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -72.01 82.86 0.96 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 0.0 108.884 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.83 0.93 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.169 0.89 . . . . 0.0 111.697 -170.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -95.13 -166.78 1.51 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.457 1.128 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -13.0 90.54 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.271 3.429 . . . . 0.0 114.02 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.67 27.4 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.576 ' NE2' ' HZ2' ' A' ' 46' ' ' LYS . 26.2 mm-40 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HZ2' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.428 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.97 -162.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -74.11 161.41 30.04 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 119.91 -1.744 . . . . 0.0 109.756 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -60.84 139.64 57.9 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m -147.86 179.99 7.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.589 1.956 . . . . 0.0 106.816 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -140.89 97.32 3.16 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.608 -1.307 . . . . 0.0 111.182 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.82 78.68 0.04 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.798 -1.001 . . . . 0.0 111.409 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -41.93 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 119.845 1.823 . . . . 0.0 111.425 -171.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.9 p -67.47 -13.27 61.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.454 1.025 . . . . 0.0 112.502 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t -72.57 -14.5 61.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.679 0.672 . . . . 0.0 111.847 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -177.85 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -69.49 174.16 5.2 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 173.87 3.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 158.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.9 -94.5 0.75 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.205 -2.758 . . . . 0.0 106.205 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -133.03 -173.68 3.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.33 1.052 . . . . 0.0 111.955 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 57.33 62.09 2.29 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.778 2.031 . . . . 0.0 111.633 163.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.38 172.47 34.72 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 61' ' ' PHE . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 59' ' ' PRO . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -66.36 -171.95 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -66.78 177.48 1.63 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.096 0.958 . . . . 0.0 109.425 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.74 117.79 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.4 m -140.67 139.94 34.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -104.39 176.96 4.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.653 0.781 . . . . 0.0 109.893 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.1 61.24 7.36 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.48 1.038 . . . . 0.0 112.436 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.59 127.22 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.422 2.081 . . . . 0.0 109.802 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m 59.58 22.22 10.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.043 0.937 . . . . 0.0 112.674 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.6 t -61.77 -12.93 19.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.527 1.531 . . . . 0.0 114.678 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -166.231 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -147.75 -167.07 2.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.653 1.581 . . . . 0.0 107.518 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -69.54 170.59 10.35 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 153.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.77 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.826 0.727 . . . . 0.0 113.467 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 p -146.18 170.8 16.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.492 1.117 . . . . 0.0 109.14 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 p -60.02 133.01 55.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.11 177.51 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 169.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -78.27 177.73 8.41 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.81 18.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.787 -1.196 . . . . 0.0 112.695 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -23.81 17.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 116.642 -1.647 . . . . 0.0 112.813 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.5 t 36.64 46.35 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.659 1.983 . . . . 0.0 112.501 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 m -70.41 -5.2 26.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -164.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 145.39 176.58 19.46 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.457 1.98 . . . . 0.0 108.154 -162.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.95 -8.53 15.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.254 3.302 . . . . 0.0 114.322 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.7 t -126.18 -49.54 1.57 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.61 1.095 . . . . 0.0 108.291 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.5 p 60.52 -36.82 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 129.819 3.248 . . . . 0.0 116.33 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 107.884 -2.086 . . . . 0.0 107.884 166.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -69.87 11.68 0.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.489 1.916 . . . . 0.0 113.236 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -144.59 163.49 33.76 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 120.508 -1.37 . . . . 0.0 112.452 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -93.42 0.1 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -62.8 -7.94 5.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.635 0.774 . . . . 0.0 112.572 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.82 155.42 7.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.211 1.404 . . . . 0.0 111.736 172.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.78 170.53 35.12 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.81 -163.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -119.84 18.96 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.384 -1.448 . . . . 0.0 112.842 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -139.34 78.58 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.404 1.482 . . . . 0.0 109.498 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.4 p -65.02 98.19 0.28 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -160.51 5.56 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 69.51 0.92 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.165 1.348 . . . . 0.0 113.961 169.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.02 74.75 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.436 3.424 . . . . 0.0 110.361 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m 55.03 47.98 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.022 0.929 . . . . 0.0 110.211 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.6 t -160.49 175.86 12.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 109.768 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -174.154 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -153.15 -173.8 4.71 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.945 0.898 . . . . 0.0 110.156 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -138.91 119.41 13.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.569 2.348 . . . . 0.0 105.829 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.49 -154.67 14.97 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -60.55 -16.75 40.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.944 0.872 . . . . 0.0 112.787 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.8 m -91.89 89.48 7.05 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 162.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.99 -176.35 43.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' NE2' ' HZ2' ' A' ' 46' ' ' LYS . 36.5 mm-40 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.434 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HZ2' ' NE2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.24 -172.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -108.44 18.72 20.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.42 1.488 . . . . 0.0 112.277 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 -169.01 1.73 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.709 1.604 . . . . 0.0 109.77 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.9 p -131.74 136.52 47.66 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.033 1.733 . . . . 0.0 106.764 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -170.78 -169.54 0.79 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.949 0.9 . . . . 0.0 110.547 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.32 48.28 53.0 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.24 -3.13 11.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 CA-C-N 121.268 2.534 . . . . 0.0 113.71 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.1 t -135.69 -67.46 0.53 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -75.58 114.33 14.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.288 0.495 . . . . 0.0 110.955 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 C-N-CA 130.102 3.715 . . . . 0.0 104.666 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -144.47 -41.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.677 1.191 . . . . 0.0 108.841 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -59.78 132.25 53.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 159.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.44 154.24 7.49 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 m -135.66 41.07 2.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.82 1.248 . . . . 0.0 111.144 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 m -60.07 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.932 0.872 . . . . 0.0 112.518 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.62 167.74 13.46 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.168 2.318 . . . . 0.0 111.063 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 32' ' ' ASP . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.72 -169.96 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -60.3 136.91 58.18 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.35 -1.468 . . . . 0.0 110.708 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -61.98 136.11 57.83 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -136.58 165.23 26.35 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.7 t -80.31 -70.46 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.17 84.65 0.21 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.26 -46.98 13.21 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.513 1.657 . . . . 0.0 109.652 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.58 35.28 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.679 2.791 . . . . 0.0 112.564 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -147.61 95.12 2.47 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 119.498 -2.001 . . . . 0.0 108.89 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.902 0 N-CA-C 105.332 -3.107 . . . . 0.0 105.332 -161.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.327 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -69.34 174.72 4.52 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -121.09 -78.82 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.068 0.947 . . . . 0.0 108.918 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.89 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -126.23 -2.45 6.96 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.573 1.549 . . . . 0.0 112.803 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -79.29 163.31 25.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.9 0.857 . . . . 0.0 109.538 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.83 173.6 40.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 167.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.31 -177.0 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.49 171.26 6.32 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.498 -0.751 . . . . 0.0 109.095 168.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -46.79 121.59 3.69 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.26 1.024 . . . . 0.0 110.776 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -146.0 164.28 32.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.368 1.867 . . . . 0.0 107.391 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -112.04 129.42 56.21 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.71 72.19 0.26 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.534 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.35 1.07 5.18 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.782 2.988 . . . . 0.0 113.143 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.61 4.89 9.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.798 1.239 . . . . 0.0 111.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -60.24 151.6 26.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.059 0.845 . . . . 0.0 110.246 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -173.446 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 75.38 -28.39 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.023 2.529 . . . . 0.0 114.005 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -54.72 130.84 42.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.788 1.176 . . . . 0.0 108.267 165.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.87 5.02 55.42 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.525 1.06 . . . . 0.0 112.769 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 58.84 29.75 19.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.729 1.265 . . . . 0.0 110.673 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -142.29 122.4 13.76 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.991 1.317 . . . . 0.0 109.564 -160.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.91 -165.71 37.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.435 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -75.47 -177.23 3.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -110.68 20.61 17.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.3 1.04 . . . . 0.0 111.621 -167.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.08 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.586 1.955 . . . . 0.0 109.537 170.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -131.68 1.32 4.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 0.0 111.572 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -84.81 98.31 10.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.14 48.44 0.53 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.959 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.18 7.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.838 2.358 . . . . 0.0 113.879 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 p -142.56 12.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.69 1.596 . . . . 0.0 111.987 -171.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -50.27 74.62 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.824 0.738 . . . . 0.0 110.977 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.391 -1.783 . . . . 0.0 110.739 -172.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 t -163.39 -178.27 5.8 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.005 0.907 . . . . 0.0 109.451 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -117.2 -6.9 11.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.798 2.439 . . . . 0.0 111.03 163.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.97 88.71 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -145.53 168.55 20.33 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.038 0.935 . . . . 0.0 108.818 166.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 p -55.8 161.97 1.97 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.85 1.66 . . . . 0.0 112.713 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.11 159.8 17.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -70.35 -173.54 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.263 0.1 OUTLIER -113.06 10.39 18.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.35 1.46 . . . . 0.0 112.472 -169.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -126.66 167.5 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.701 1.6 . . . . 0.0 108.51 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -140.55 128.64 22.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.77 160.89 36.82 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.46 -0.775 . . . . 0.0 110.366 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 34.71 65.8 0.36 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.506 2.479 . . . . 0.0 114.178 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.44 -0.66 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.63 2.887 . . . . 0.0 115.732 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -146.67 33.97 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.469 1.108 . . . . 0.0 109.681 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.3 m -118.93 4.76 11.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.227 1.011 . . . . 0.0 112.751 -166.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-N 119.672 1.123 . . . . 0.0 110.338 177.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -162.36 -168.68 1.92 Allowed 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 -171.84 3.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.785 1.234 . . . . 0.0 108.05 162.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.4 -51.62 0.7 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.852 1.215 . . . . 0.0 111.432 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -131.06 -3.02 3.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.409 ' HG ' ' HB3' ' A' ' 104' ' ' ALA . 36.1 m -82.12 94.58 7.26 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.942 -1.099 . . . . 0.0 112.369 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.09 -176.59 46.37 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.591 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 6' ' ' SER . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.16 -161.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -104.48 19.05 21.01 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.299 -1.501 . . . . 0.0 112.257 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -144.19 94.57 2.59 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.367 0.667 . . . . 0.0 109.475 173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.49 105.9 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.859 1.664 . . . . 0.0 108.243 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m -98.98 -165.67 1.26 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.031 1.332 . . . . 0.0 109.648 -174.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.39 81.41 0.09 OUTLIER Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.08 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -81.14 86.53 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.642 3.561 . . . . 0.0 109.867 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m 46.43 40.34 7.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.91 0.884 . . . . 0.0 111.711 -172.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -71.96 157.61 37.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.367 -0.833 . . . . 0.0 110.784 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -177.557 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -59.33 157.96 10.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.892 1.277 . . . . 0.0 111.761 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -126.15 1.62 7.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.839 1.655 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.63 -168.32 46.45 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.953 1.263 . . . . 0.0 114.42 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 -46.74 1.04 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.739 1.615 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.6 p -60.68 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.838 2.055 . . . . 0.0 110.898 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.5 171.93 12.67 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 126.954 2.216 . . . . 0.0 108.62 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.406 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.501 HH11 ' HB2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.406 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.477 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.77 -172.43 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 15.73 11.8 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.439 1.896 . . . . 0.0 112.371 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -149.22 158.68 44.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.996 2.918 . . . . 0.0 106.826 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -67.37 -42.38 83.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.9 m 60.83 -3.27 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 89.38 0.6 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.006 1.288 . . . . 0.0 110.633 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.56 -10.76 29.05 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.375 2.717 . . . . 0.0 114.575 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 p -146.2 7.57 1.03 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.572 1.149 . . . . 0.0 112.177 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.2 m -63.67 127.4 31.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 -174.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -74.33 73.29 1.84 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.759 2.024 . . . . 0.0 111.509 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -122.96 -95.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.098 1.759 . . . . 0.0 106.864 164.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.05 40.73 0.46 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.306 0.957 . . . . 0.0 111.479 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -128.55 146.33 50.87 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.235 1.014 . . . . 0.0 109.982 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -61.47 168.74 2.62 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.223 1.409 . . . . 0.0 113.252 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.88 176.82 30.07 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.531 2.015 . . . . 0.0 108.849 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' HD2' ' H ' ' A' ' 48' ' ' ALA . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' H ' ' HD2' ' A' ' 47' ' ' LYS . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HE2' HD11 ' A' ' 89' ' ' LEU . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 HD11 ' HE2' ' A' ' 58' ' ' LYS . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -73.44 -174.14 1.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 23.61 10.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.249 1.02 . . . . 0.0 112.369 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -68.86 78.04 0.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.3 t -72.09 58.28 0.36 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.964 1.706 . . . . 0.0 108.987 168.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 p -155.47 161.33 40.97 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.004 -1.685 . . . . 0.0 111.497 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.61 171.07 12.91 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.59 2.043 . . . . 0.0 110.547 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -61.86 -25.76 78.55 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.461 2.108 . . . . 0.0 112.607 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -103.26 19.72 19.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.671 1.188 . . . . 0.0 111.81 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -53.52 -52.47 59.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.654 1.115 . . . . 0.0 109.831 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 117.393 -1.781 . . . . 0.0 109.15 -154.724 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -66.97 172.53 4.38 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.287 1.035 . . . . 0.0 112.291 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t -145.96 150.5 36.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.098 1.359 . . . . 0.0 108.291 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.32 -87.96 2.0 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 126.34 1.924 . . . . 0.0 108.322 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -117.25 10.53 13.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.465 . . . . 0.0 114.664 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -106.68 178.44 4.56 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.727 1.149 . . . . 0.0 112.644 -169.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.14 -179.96 48.3 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.497 1.046 . . . . 0.0 110.51 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.405 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.52 -77.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.91 164.29 30.07 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.72 2.008 . . . . 0.0 108.092 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -80.17 21.17 0.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.443 1.097 . . . . 0.0 112.5 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.1 m -60.25 131.81 51.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.744 1.218 . . . . 0.0 108.901 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -64.52 105.4 0.94 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.88 1.272 . . . . 0.0 109.887 173.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.44 76.47 0.31 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.641 1.591 . . . . 0.0 109.847 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.89 -19.26 20.95 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.748 2.966 . . . . 0.0 113.903 -171.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 m -119.07 -63.77 1.36 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 87.11 -11.59 0.55 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.165 2.986 . . . . 0.0 112.723 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 162.542 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -142.0 140.95 32.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 158.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.44 -16.28 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.215 1.006 . . . . 0.0 113.005 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.97 -145.82 8.55 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.764 1.166 . . . . 0.0 112.67 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 m -107.9 6.7 27.54 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.95 1.3 . . . . 0.0 111.637 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -72.28 -172.9 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.547 1.539 . . . . 0.0 110.606 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.81 -179.49 41.54 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 120.976 -1.078 . . . . 0.0 111.168 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.441 ' HE2' HD13 ' A' ' 89' ' ' LEU . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 58' ' ' LYS . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.615 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.65 -161.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -119.99 26.61 9.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.105 1.362 . . . . 0.0 111.49 166.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -136.31 146.25 46.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.036 1.334 . . . . 0.0 109.016 -170.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.2 m -132.89 71.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -157.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.59 100.24 2.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.141 0.976 . . . . 0.0 108.935 -156.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.36 71.39 1.29 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.84 -0.978 . . . . 0.0 110.766 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -69.21 -40.96 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.831 2.354 . . . . 0.0 112.212 -165.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 m -79.79 -67.2 0.78 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.469 0.652 . . . . 0.0 109.46 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 m -88.2 -0.62 57.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -150.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.344 -1.254 . . . . 0.0 112.392 -171.438 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.19 -9.49 36.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.91 0.855 . . . . 0.0 110.989 168.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 161.89 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.14 -169.62 21.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.376 0.988 . . . . 0.0 112.812 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -78.99 -11.25 60.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.842 2.057 . . . . 0.0 114.178 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 p -65.19 172.51 3.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.579 0.752 . . . . 0.0 110.715 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.96 174.18 46.87 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.64 -1.287 . . . . 0.0 111.156 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.411 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.428 ' C ' ' HG1' ' A' ' 51' ' ' THR . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 50' ' ' SER . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.45 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.411 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -72.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -148.81 152.02 35.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.861 2.864 . . . . 0.0 104.839 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -65.02 138.18 58.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.527 0.603 . . . . 0.0 110.85 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -120.24 -168.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.404 1.482 . . . . 0.0 108.616 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -140.59 179.27 6.78 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.525 1.53 . . . . 0.0 107.128 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.15 61.11 0.39 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-O 118.139 -1.367 . . . . 0.0 112.685 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -70.92 9.34 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.589 2.859 . . . . 0.0 113.178 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 m -142.05 23.33 2.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.914 1.286 . . . . 0.0 110.027 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.4 p -73.21 121.57 20.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 170.442 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -120.46 164.18 16.8 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 109.987 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -132.22 142.65 49.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.173 2.189 . . . . 0.0 105.446 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.82 -81.51 1.14 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -68.63 169.06 11.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.96 0.88 . . . . 0.0 112.43 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.41 37.71 16.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.127 2.171 . . . . 0.0 115.545 161.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.82 177.05 28.06 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.5 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 28' ' ' ARG . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.74 -170.88 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 169.33 13.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.249 -0.907 . . . . 0.0 108.829 165.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -69.4 100.26 1.34 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.851 0.86 . . . . 0.0 111.742 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.7 -163.24 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.802 2.441 . . . . 0.0 104.964 163.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.61 151.13 37.6 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.528 -1.358 . . . . 0.0 108.134 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.59 164.98 26.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 164.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.78 109.93 2.43 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.321 2.681 . . . . 0.0 108.931 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 p 50.88 0.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.73 2.812 . . . . 0.0 117.178 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -6.45 21.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.543 1.519 . . . . 0.0 113.299 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.129 -3.588 . . . . 0.0 104.129 176.626 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.58 -167.63 0.47 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.9 1.28 . . . . 0.0 109.73 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.37 138.05 41.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.137 0.975 . . . . 0.0 108.7 165.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.37 -90.98 0.16 Allowed Glycine 0 C--N 1.33 0.208 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 m -59.01 -30.18 67.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.656 1.182 . . . . 0.0 112.98 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -126.41 172.43 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.248 0.931 . . . . 0.0 110.043 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.14 175.04 28.55 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 125.235 1.398 . . . . 0.0 109.882 166.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 82' ' ' LYS . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.475 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 -172.34 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -69.87 159.53 33.5 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.212 -1.555 . . . . 0.0 107.516 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -64.26 109.51 1.91 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 p -123.05 171.21 9.44 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.938 1.295 . . . . 0.0 110.449 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -76.05 74.94 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.973 1.709 . . . . 0.0 109.333 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 171.38 63.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-O 118.218 -1.323 . . . . 0.0 111.531 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 -6.2 16.57 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.612 2.208 . . . . 0.0 113.203 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -68.74 -16.32 63.77 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.712 -1.243 . . . . 0.0 112.261 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -96.81 -17.93 19.91 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.387 0.994 . . . . 0.0 113.398 -164.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -169.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -63.39 151.1 41.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -121.69 13.85 10.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.094 0.958 . . . . 0.0 110.213 167.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.06 131.37 10.3 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.2 m -135.77 -62.71 0.68 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.649 1.58 . . . . 0.0 107.159 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.18 141.12 11.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.052 2.941 . . . . 0.0 110.765 172.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.86 167.09 18.35 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 -172.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.402 ' HA ' ' CE3' ' A' ' 122' ' ' TRP . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.498 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' H ' HD21 ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' A' ' 39' ' ' PRO . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 -170.06 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -72.19 166.89 21.46 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.782 -1.199 . . . . 0.0 108.51 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.21 16.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.498 2.319 . . . . 0.0 115.22 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.54 92.19 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.3 m -139.9 -178.97 5.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.563 1.545 . . . . 0.0 110.326 -169.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.19 69.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.34 116.71 4.04 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.672 2.248 . . . . 0.0 109.237 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t 59.95 29.34 18.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.983 0.913 . . . . 0.0 112.235 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -36.35 32.84 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.392 1.077 . . . . 0.0 113.744 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 177.371 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.414 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 t -135.69 178.11 7.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -134.29 165.34 25.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.662 0.785 . . . . 0.0 111.817 -160.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.82 -178.21 29.6 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -166.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -81.05 74.15 8.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.904 0.882 . . . . 0.0 109.911 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -146.29 170.64 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 109.123 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.36 172.83 37.68 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.46 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.511 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.444 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.511 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -70.98 -175.49 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -133.99 133.1 40.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.008 1.723 . . . . 0.0 107.072 165.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 42.94 31.64 0.34 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.153 2.181 . . . . 0.0 114.052 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.2 p -145.64 44.77 1.29 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.524 1.53 . . . . 0.0 110.811 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m -48.64 -46.88 40.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 112.426 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.34 -161.95 18.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.228 -1.318 . . . . 0.0 111.134 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.78 75.39 1.23 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.06 3.84 . . . . 0.0 112.168 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 m 53.93 17.96 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.141 1.776 . . . . 0.0 112.712 -174.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.5 1.92 . . . . 0.0 112.344 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 169.053 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.515 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 m -74.9 123.71 25.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t -155.17 -5.18 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 117.826 -1.083 . . . . 0.0 113.457 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.99 178.6 47.6 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 121.269 1.85 . . . . 0.0 110.96 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -110.26 60.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -165.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 p -68.7 -171.73 0.31 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.332 1.063 . . . . 0.0 110.728 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.62 178.92 39.63 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 165.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.495 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.495 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -75.64 -177.54 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -104.07 20.66 17.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 111.797 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.75 157.27 17.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.018 1.327 . . . . 0.0 110.402 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -121.0 17.1 11.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.487 1.915 . . . . 0.0 109.487 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -128.49 139.35 52.37 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.99 69.36 0.41 Allowed Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.181 -1.344 . . . . 0.0 112.809 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.97 10.43 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.149 3.232 . . . . 0.0 112.863 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 p -150.96 50.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.358 2.263 . . . . 0.0 106.36 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -15.99 56.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.397 -0.814 . . . . 0.0 111.46 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 178.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 120' ' ' LEU . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CG ' HD22 ' A' ' 120' ' ' LEU . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.573 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 24' ' ' LEU . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 10' ' ' LYS . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 45.4 Cg_endo . . . . . 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HD3' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 44' ' ' LEU . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 29' ' ' ALA . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 13' ' ' TYR . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD21 ' HD3' ' A' ' 10' ' ' LYS . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 44' ' ' LEU . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 13' ' ' TYR . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.57 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' A' ' 18' ' ' THR . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.558 HD22 HD23 ' A' ' 24' ' ' LEU . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 35' ' ' GLN . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 13' ' ' TYR . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.408 ' CE ' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 115' ' ' TRP . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 120' ' ' LEU . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 89' ' ' LEU . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 53' ' ' TYR . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 13' ' ' TYR . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' CG ' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 24' ' ' LEU . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 HD22 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' A' ' 10' ' ' LYS . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' HD22 ' A' ' 120' ' ' LEU . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.538 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' A' ' 120' ' ' LEU . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 115' ' ' TRP . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 32.3 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' HD21 ' A' ' 120' ' ' LEU . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.518 ' CE1' HD11 ' A' ' 44' ' ' LEU . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD23 ' A' ' 24' ' ' LEU . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 13' ' ' TYR . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' ARG . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 115' ' ' TRP . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CE1' HD11 ' A' ' 44' ' ' LEU . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' LEU . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 13' ' ' TYR . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CZ ' ' HA2' ' A' ' 55' ' ' GLY . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 53' ' ' TYR . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.467 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 87' ' ' SER . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 13' ' ' TYR . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 47' ' ' LYS . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE3' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 44' ' ' LEU . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 13' ' ' TYR . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 115' ' ' TRP . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.401 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 74.4 Cg_endo . . . . . 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' CG ' HD22 ' A' ' 120' ' ' LEU . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 44' ' ' LEU . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 16' ' ' LEU . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HB2' HH11 ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 13' ' ' TYR . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.41 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.489 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HA ' HG22 ' A' ' 18' ' ' THR . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB3' HD13 ' A' ' 44' ' ' LEU . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.424 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 16' ' ' LEU . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' HD12 ' A' ' 123' ' ' ILE . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 79' ' ' ILE . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.415 HD22 ' CG ' ' A' ' 13' ' ' TYR . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.451 HD12 ' HE2' ' A' ' 47' ' ' LYS . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CD2' HD22 ' A' ' 120' ' ' LEU . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 44' ' ' LEU . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.459 HH11 ' HB3' ' A' ' 109' ' ' ALA . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 16' ' ' LEU . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 68' ' ' LYS . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.641 ' HA ' HD13 ' A' ' 65' ' ' LEU . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 62' ' ' LEU . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.457 ' HG2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 25' ' ' LEU . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 13' ' ' TYR . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HE3' HD21 ' A' ' 120' ' ' LEU . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 120' ' ' LEU . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 71' ' ' ASP . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.49 HD22 ' CD2' ' A' ' 13' ' ' TYR . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.474 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 18.3 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD21 ' A' ' 120' ' ' LEU . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.536 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' O ' ' HE3' ' A' ' 46' ' ' LYS . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 96' ' ' LEU . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 10' ' ' LYS . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.9 Cg_endo . . . . . 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CD2' HD22 ' A' ' 120' ' ' LEU . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.912 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' ASP . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.448 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 71' ' ' ASP . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 13' ' ' TYR . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.42 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 61.8 Cg_endo . . . . . 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CD2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.406 HG21 HH22 ' A' ' 28' ' ' ARG . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 52' ' ' VAL . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 96' ' ' LEU . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.542 HD22 ' CD2' ' A' ' 13' ' ' TYR . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 47' ' ' LYS . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 51.9 Cg_endo . . . . . 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 120' ' ' LEU . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.431 ' HB ' HD23 ' A' ' 44' ' ' LEU . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 13' ' ' TYR . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.416 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 122' ' ' TRP 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.195 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HE2' ' OH ' ' A' ' 53' ' ' TYR . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.559 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' HD21 ' A' ' 120' ' ' LEU . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.461 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.461 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.565 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 10' ' ' LYS . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.53 109.27 20.67 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -72.01 82.86 0.96 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 0.0 108.884 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.83 0.93 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.169 0.89 . . . . 0.0 111.697 -170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -95.13 -166.78 1.51 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.457 1.128 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -13.0 90.54 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.271 3.429 . . . . 0.0 114.02 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.67 27.4 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 120' ' ' LEU . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CG ' HD22 ' A' ' 120' ' ' LEU . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.573 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 24' ' ' LEU . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.485 HD21 ' HG2' ' A' ' 10' ' ' LYS . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 45.4 Cg_endo -66.97 -162.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -74.11 161.41 30.04 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 119.91 -1.744 . . . . 0.0 109.756 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -60.84 139.64 57.9 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m -147.86 179.99 7.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.589 1.956 . . . . 0.0 106.816 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -140.89 97.32 3.16 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.608 -1.307 . . . . 0.0 111.182 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.82 78.68 0.04 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.798 -1.001 . . . . 0.0 111.409 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -41.93 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 119.845 1.823 . . . . 0.0 111.425 -171.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.9 p -67.47 -13.27 61.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.454 1.025 . . . . 0.0 112.502 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t -72.57 -14.5 61.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.679 0.672 . . . . 0.0 111.847 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -177.85 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -69.49 174.16 5.2 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 173.87 3.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 158.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.9 -94.5 0.75 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.205 -2.758 . . . . 0.0 106.205 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -133.03 -173.68 3.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.33 1.052 . . . . 0.0 111.955 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 57.33 62.09 2.29 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.778 2.031 . . . . 0.0 111.633 163.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.38 172.47 34.72 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HD3' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 44' ' ' LEU . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 29' ' ' ALA . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 13' ' ' TYR . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD21 ' HD3' ' A' ' 10' ' ' LYS . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -66.36 -171.95 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -66.78 177.48 1.63 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.096 0.958 . . . . 0.0 109.425 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.74 117.79 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.4 m -140.67 139.94 34.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -104.39 176.96 4.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.653 0.781 . . . . 0.0 109.893 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.1 61.24 7.36 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.48 1.038 . . . . 0.0 112.436 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.59 127.22 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.422 2.081 . . . . 0.0 109.802 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m 59.58 22.22 10.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.043 0.937 . . . . 0.0 112.674 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.6 t -61.77 -12.93 19.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.527 1.531 . . . . 0.0 114.678 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -166.231 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -147.75 -167.07 2.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.653 1.581 . . . . 0.0 107.518 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -69.54 170.59 10.35 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 153.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.77 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.826 0.727 . . . . 0.0 113.467 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 p -146.18 170.8 16.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.492 1.117 . . . . 0.0 109.14 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 p -60.02 133.01 55.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.11 177.51 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 169.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 44' ' ' LEU . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 13' ' ' TYR . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -78.27 177.73 8.41 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.81 18.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.787 -1.196 . . . . 0.0 112.695 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -23.81 17.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 116.642 -1.647 . . . . 0.0 112.813 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.5 t 36.64 46.35 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.659 1.983 . . . . 0.0 112.501 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 m -70.41 -5.2 26.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -164.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 145.39 176.58 19.46 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.457 1.98 . . . . 0.0 108.154 -162.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.95 -8.53 15.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.254 3.302 . . . . 0.0 114.322 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.7 t -126.18 -49.54 1.57 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.61 1.095 . . . . 0.0 108.291 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.5 p 60.52 -36.82 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 129.819 3.248 . . . . 0.0 116.33 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 107.884 -2.086 . . . . 0.0 107.884 166.903 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -69.87 11.68 0.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.489 1.916 . . . . 0.0 113.236 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -144.59 163.49 33.76 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 120.508 -1.37 . . . . 0.0 112.452 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -93.42 0.1 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -62.8 -7.94 5.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.635 0.774 . . . . 0.0 112.572 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.82 155.42 7.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.211 1.404 . . . . 0.0 111.736 172.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.78 170.53 35.12 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.57 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' A' ' 18' ' ' THR . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.558 HD22 HD23 ' A' ' 24' ' ' LEU . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 35' ' ' GLN . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 13' ' ' TYR . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.408 ' CE ' ' HA ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 115' ' ' TRP . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.81 -163.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -119.84 18.96 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.384 -1.448 . . . . 0.0 112.842 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -139.34 78.58 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.404 1.482 . . . . 0.0 109.498 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.4 p -65.02 98.19 0.28 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -160.51 5.56 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 69.51 0.92 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.165 1.348 . . . . 0.0 113.961 169.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.02 74.75 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.436 3.424 . . . . 0.0 110.361 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m 55.03 47.98 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.022 0.929 . . . . 0.0 110.211 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.6 t -160.49 175.86 12.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 109.768 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -174.154 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -153.15 -173.8 4.71 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.945 0.898 . . . . 0.0 110.156 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -138.91 119.41 13.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.569 2.348 . . . . 0.0 105.829 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.49 -154.67 14.97 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -60.55 -16.75 40.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.944 0.872 . . . . 0.0 112.787 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.8 m -91.89 89.48 7.05 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 162.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.99 -176.35 43.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 120' ' ' LEU . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 89' ' ' LEU . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 53' ' ' TYR . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 13' ' ' TYR . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.24 -172.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -108.44 18.72 20.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.42 1.488 . . . . 0.0 112.277 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 -169.01 1.73 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.709 1.604 . . . . 0.0 109.77 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.9 p -131.74 136.52 47.66 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.033 1.733 . . . . 0.0 106.764 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -170.78 -169.54 0.79 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.949 0.9 . . . . 0.0 110.547 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.32 48.28 53.0 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.24 -3.13 11.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 CA-C-N 121.268 2.534 . . . . 0.0 113.71 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.1 t -135.69 -67.46 0.53 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -75.58 114.33 14.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.288 0.495 . . . . 0.0 110.955 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 C-N-CA 130.102 3.715 . . . . 0.0 104.666 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -144.47 -41.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.677 1.191 . . . . 0.0 108.841 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -59.78 132.25 53.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 159.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.44 154.24 7.49 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 m -135.66 41.07 2.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.82 1.248 . . . . 0.0 111.144 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 m -60.07 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.932 0.872 . . . . 0.0 112.518 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.62 167.74 13.46 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.168 2.318 . . . . 0.0 111.063 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' CG ' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 24' ' ' LEU . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 HD22 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' A' ' 10' ' ' LYS . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.72 -169.96 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -60.3 136.91 58.18 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.35 -1.468 . . . . 0.0 110.708 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -61.98 136.11 57.83 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -136.58 165.23 26.35 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.7 t -80.31 -70.46 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.17 84.65 0.21 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.26 -46.98 13.21 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.513 1.657 . . . . 0.0 109.652 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.58 35.28 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.679 2.791 . . . . 0.0 112.564 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -147.61 95.12 2.47 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 119.498 -2.001 . . . . 0.0 108.89 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.902 0 N-CA-C 105.332 -3.107 . . . . 0.0 105.332 -161.401 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.327 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -69.34 174.72 4.52 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -121.09 -78.82 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.068 0.947 . . . . 0.0 108.918 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.89 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -126.23 -2.45 6.96 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.573 1.549 . . . . 0.0 112.803 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -79.29 163.31 25.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.9 0.857 . . . . 0.0 109.538 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.83 173.6 40.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 167.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' HD22 ' A' ' 120' ' ' LEU . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.538 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.508 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' A' ' 120' ' ' LEU . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 115' ' ' TRP . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 32.3 Cg_endo -73.31 -177.0 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.49 171.26 6.32 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.498 -0.751 . . . . 0.0 109.095 168.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -46.79 121.59 3.69 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.26 1.024 . . . . 0.0 110.776 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -146.0 164.28 32.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.368 1.867 . . . . 0.0 107.391 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -112.04 129.42 56.21 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.71 72.19 0.26 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.534 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.35 1.07 5.18 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.782 2.988 . . . . 0.0 113.143 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.61 4.89 9.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.798 1.239 . . . . 0.0 111.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -60.24 151.6 26.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.059 0.845 . . . . 0.0 110.246 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -173.446 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 75.38 -28.39 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.023 2.529 . . . . 0.0 114.005 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -54.72 130.84 42.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.788 1.176 . . . . 0.0 108.267 165.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.87 5.02 55.42 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.525 1.06 . . . . 0.0 112.769 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 58.84 29.75 19.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.729 1.265 . . . . 0.0 110.673 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -142.29 122.4 13.76 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.991 1.317 . . . . 0.0 109.564 -160.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.91 -165.71 37.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' HD21 ' A' ' 120' ' ' LEU . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.518 ' CE1' HD11 ' A' ' 44' ' ' LEU . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD23 ' A' ' 24' ' ' LEU . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 13' ' ' TYR . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' ARG . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 115' ' ' TRP . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -75.47 -177.23 3.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -110.68 20.61 17.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.3 1.04 . . . . 0.0 111.621 -167.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.08 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.586 1.955 . . . . 0.0 109.537 170.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -131.68 1.32 4.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 0.0 111.572 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -84.81 98.31 10.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.14 48.44 0.53 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.959 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.18 7.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.838 2.358 . . . . 0.0 113.879 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 p -142.56 12.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.69 1.596 . . . . 0.0 111.987 -171.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -50.27 74.62 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.824 0.738 . . . . 0.0 110.977 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.391 -1.783 . . . . 0.0 110.739 -172.487 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 t -163.39 -178.27 5.8 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.005 0.907 . . . . 0.0 109.451 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -117.2 -6.9 11.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.798 2.439 . . . . 0.0 111.03 163.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.97 88.71 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -145.53 168.55 20.33 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.038 0.935 . . . . 0.0 108.818 166.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 p -55.8 161.97 1.97 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.85 1.66 . . . . 0.0 112.713 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.11 159.8 17.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CE1' HD11 ' A' ' 44' ' ' LEU . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' LEU . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 13' ' ' TYR . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CZ ' ' HA2' ' A' ' 55' ' ' GLY . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 53' ' ' TYR . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.467 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 87' ' ' SER . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 13' ' ' TYR . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 47' ' ' LYS . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -70.35 -173.54 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.263 0.1 OUTLIER -113.06 10.39 18.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.35 1.46 . . . . 0.0 112.472 -169.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -126.66 167.5 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.701 1.6 . . . . 0.0 108.51 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -140.55 128.64 22.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.77 160.89 36.82 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.46 -0.775 . . . . 0.0 110.366 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 34.71 65.8 0.36 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.506 2.479 . . . . 0.0 114.178 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.44 -0.66 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.63 2.887 . . . . 0.0 115.732 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -146.67 33.97 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.469 1.108 . . . . 0.0 109.681 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.3 m -118.93 4.76 11.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.227 1.011 . . . . 0.0 112.751 -166.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-N 119.672 1.123 . . . . 0.0 110.338 177.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -162.36 -168.68 1.92 Allowed 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 -171.84 3.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.785 1.234 . . . . 0.0 108.05 162.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.4 -51.62 0.7 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.852 1.215 . . . . 0.0 111.432 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -131.06 -3.02 3.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 m -82.12 94.58 7.26 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.942 -1.099 . . . . 0.0 112.369 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.09 -176.59 46.37 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE3' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 44' ' ' LEU . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 13' ' ' TYR . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 115' ' ' TRP . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.401 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 74.4 Cg_endo -66.16 -161.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -104.48 19.05 21.01 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.299 -1.501 . . . . 0.0 112.257 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -144.19 94.57 2.59 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.367 0.667 . . . . 0.0 109.475 173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.49 105.9 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.859 1.664 . . . . 0.0 108.243 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m -98.98 -165.67 1.26 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.031 1.332 . . . . 0.0 109.648 -174.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.39 81.41 0.09 OUTLIER Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.08 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -81.14 86.53 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.642 3.561 . . . . 0.0 109.867 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m 46.43 40.34 7.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.91 0.884 . . . . 0.0 111.711 -172.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -71.96 157.61 37.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.367 -0.833 . . . . 0.0 110.784 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -177.557 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -59.33 157.96 10.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.892 1.277 . . . . 0.0 111.761 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -126.15 1.62 7.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.839 1.655 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.63 -168.32 46.45 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.953 1.263 . . . . 0.0 114.42 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 -46.74 1.04 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.739 1.615 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 1.6 p -60.68 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.838 2.055 . . . . 0.0 110.898 172.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.5 171.93 12.67 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 126.954 2.216 . . . . 0.0 108.62 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' CG ' HD22 ' A' ' 120' ' ' LEU . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 44' ' ' LEU . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 16' ' ' LEU . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HB2' HH11 ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 13' ' ' TYR . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.41 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.489 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.8 Cg_endo -68.77 -172.43 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 15.73 11.8 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.439 1.896 . . . . 0.0 112.371 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -149.22 158.68 44.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.996 2.918 . . . . 0.0 106.826 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -67.37 -42.38 83.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.9 m 60.83 -3.27 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 89.38 0.6 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.006 1.288 . . . . 0.0 110.633 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.56 -10.76 29.05 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.375 2.717 . . . . 0.0 114.575 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 p -146.2 7.57 1.03 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.572 1.149 . . . . 0.0 112.177 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.2 m -63.67 127.4 31.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 -174.822 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -74.33 73.29 1.84 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.759 2.024 . . . . 0.0 111.509 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -122.96 -95.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.098 1.759 . . . . 0.0 106.864 164.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.05 40.73 0.46 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.306 0.957 . . . . 0.0 111.479 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -128.55 146.33 50.87 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.235 1.014 . . . . 0.0 109.982 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -61.47 168.74 2.62 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.223 1.409 . . . . 0.0 113.252 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.88 176.82 30.07 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.531 2.015 . . . . 0.0 108.849 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HA ' HG22 ' A' ' 18' ' ' THR . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB3' HD13 ' A' ' 44' ' ' LEU . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 16' ' ' LEU . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' HD12 ' A' ' 123' ' ' ILE . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.443 HD12 ' H ' ' A' ' 79' ' ' ILE . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.415 HD22 ' CG ' ' A' ' 13' ' ' TYR . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.451 HD12 ' HE2' ' A' ' 47' ' ' LYS . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -73.44 -174.14 1.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 23.61 10.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.249 1.02 . . . . 0.0 112.369 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -68.86 78.04 0.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 128' ' ' THR . 5.3 t -72.09 58.28 0.36 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.964 1.706 . . . . 0.0 108.987 168.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 p -155.47 161.33 40.97 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.004 -1.685 . . . . 0.0 111.497 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.61 171.07 12.91 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.59 2.043 . . . . 0.0 110.547 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -61.86 -25.76 78.55 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.461 2.108 . . . . 0.0 112.607 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -103.26 19.72 19.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.671 1.188 . . . . 0.0 111.81 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -53.52 -52.47 59.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.654 1.115 . . . . 0.0 109.831 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 117.393 -1.781 . . . . 0.0 109.15 -154.724 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -66.97 172.53 4.38 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.287 1.035 . . . . 0.0 112.291 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t -145.96 150.5 36.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.098 1.359 . . . . 0.0 108.291 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.32 -87.96 2.0 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 126.34 1.924 . . . . 0.0 108.322 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -117.25 10.53 13.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.465 . . . . 0.0 114.664 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -106.68 178.44 4.56 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.727 1.149 . . . . 0.0 112.644 -169.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.14 -179.96 48.3 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.497 1.046 . . . . 0.0 110.51 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CD2' HD22 ' A' ' 120' ' ' LEU . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 44' ' ' LEU . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.459 HH11 ' HB3' ' A' ' 109' ' ' ALA . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 16' ' ' LEU . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 68' ' ' LYS . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.641 ' HA ' HD13 ' A' ' 65' ' ' LEU . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 62' ' ' LEU . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.457 ' HG2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 25' ' ' LEU . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 13' ' ' TYR . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.52 -77.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.91 164.29 30.07 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.72 2.008 . . . . 0.0 108.092 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -80.17 21.17 0.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.443 1.097 . . . . 0.0 112.5 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.1 m -60.25 131.81 51.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.744 1.218 . . . . 0.0 108.901 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -64.52 105.4 0.94 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.88 1.272 . . . . 0.0 109.887 173.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.44 76.47 0.31 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.641 1.591 . . . . 0.0 109.847 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.89 -19.26 20.95 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.748 2.966 . . . . 0.0 113.903 -171.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 m -119.07 -63.77 1.36 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 87.11 -11.59 0.55 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.165 2.986 . . . . 0.0 112.723 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 162.542 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -142.0 140.95 32.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 158.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.44 -16.28 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.215 1.006 . . . . 0.0 113.005 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.97 -145.82 8.55 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.764 1.166 . . . . 0.0 112.67 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 m -107.9 6.7 27.54 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.95 1.3 . . . . 0.0 111.637 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -72.28 -172.9 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.547 1.539 . . . . 0.0 110.606 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.81 -179.49 41.54 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 120.976 -1.078 . . . . 0.0 111.168 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HE3' HD21 ' A' ' 120' ' ' LEU . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 120' ' ' LEU . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 71' ' ' ASP . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.49 HD22 ' CD2' ' A' ' 13' ' ' TYR . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.474 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 18.3 Cg_endo -70.65 -161.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -119.99 26.61 9.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.105 1.362 . . . . 0.0 111.49 166.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -136.31 146.25 46.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.036 1.334 . . . . 0.0 109.016 -170.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.2 m -132.89 71.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -157.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.59 100.24 2.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.141 0.976 . . . . 0.0 108.935 -156.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.36 71.39 1.29 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.84 -0.978 . . . . 0.0 110.766 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -69.21 -40.96 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.831 2.354 . . . . 0.0 112.212 -165.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 m -79.79 -67.2 0.78 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.469 0.652 . . . . 0.0 109.46 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 m -88.2 -0.62 57.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -150.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.344 -1.254 . . . . 0.0 112.392 -171.438 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.19 -9.49 36.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.91 0.855 . . . . 0.0 110.989 168.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 161.89 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.14 -169.62 21.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.376 0.988 . . . . 0.0 112.812 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -78.99 -11.25 60.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.842 2.057 . . . . 0.0 114.178 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 p -65.19 172.51 3.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.579 0.752 . . . . 0.0 110.715 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.96 174.18 46.87 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.64 -1.287 . . . . 0.0 111.156 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD21 ' A' ' 120' ' ' LEU . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.536 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' O ' ' HE3' ' A' ' 46' ' ' LYS . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 96' ' ' LEU . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 10' ' ' LYS . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.9 Cg_endo -67.04 -72.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -148.81 152.02 35.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.861 2.864 . . . . 0.0 104.839 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -65.02 138.18 58.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.527 0.603 . . . . 0.0 110.85 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -120.24 -168.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.404 1.482 . . . . 0.0 108.616 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -140.59 179.27 6.78 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.525 1.53 . . . . 0.0 107.128 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.15 61.11 0.39 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-O 118.139 -1.367 . . . . 0.0 112.685 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -70.92 9.34 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.589 2.859 . . . . 0.0 113.178 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 m -142.05 23.33 2.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.914 1.286 . . . . 0.0 110.027 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.4 p -73.21 121.57 20.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 170.442 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -120.46 164.18 16.8 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 109.987 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -132.22 142.65 49.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.173 2.189 . . . . 0.0 105.446 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.82 -81.51 1.14 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -68.63 169.06 11.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.96 0.88 . . . . 0.0 112.43 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.41 37.71 16.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.127 2.171 . . . . 0.0 115.545 161.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.82 177.05 28.06 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CD2' HD22 ' A' ' 120' ' ' LEU . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.912 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' ASP . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.448 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 71' ' ' ASP . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 13' ' ' TYR . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.42 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 61.8 Cg_endo -70.74 -170.88 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 169.33 13.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.249 -0.907 . . . . 0.0 108.829 165.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -69.4 100.26 1.34 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.851 0.86 . . . . 0.0 111.742 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.7 -163.24 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.802 2.441 . . . . 0.0 104.964 163.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.61 151.13 37.6 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.528 -1.358 . . . . 0.0 108.134 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.59 164.98 26.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 164.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.78 109.93 2.43 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.321 2.681 . . . . 0.0 108.931 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 p 50.88 0.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.73 2.812 . . . . 0.0 117.178 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -6.45 21.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.543 1.519 . . . . 0.0 113.299 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.129 -3.588 . . . . 0.0 104.129 176.626 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.58 -167.63 0.47 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.9 1.28 . . . . 0.0 109.73 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.37 138.05 41.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.137 0.975 . . . . 0.0 108.7 165.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.37 -90.98 0.16 Allowed Glycine 0 C--N 1.33 0.208 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 m -59.01 -30.18 67.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.656 1.182 . . . . 0.0 112.98 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -126.41 172.43 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.248 0.931 . . . . 0.0 110.043 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.14 175.04 28.55 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 125.235 1.398 . . . . 0.0 109.882 166.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CD2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.406 HG21 HH22 ' A' ' 28' ' ' ARG . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 52' ' ' VAL . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.538 HD12 ' H ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 96' ' ' LEU . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.542 HD22 ' CD2' ' A' ' 13' ' ' TYR . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 47' ' ' LYS . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 51.9 Cg_endo -69.54 -172.34 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -69.87 159.53 33.5 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.212 -1.555 . . . . 0.0 107.516 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -64.26 109.51 1.91 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 p -123.05 171.21 9.44 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.938 1.295 . . . . 0.0 110.449 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -76.05 74.94 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.973 1.709 . . . . 0.0 109.333 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 171.38 63.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-O 118.218 -1.323 . . . . 0.0 111.531 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 -6.2 16.57 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.612 2.208 . . . . 0.0 113.203 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -68.74 -16.32 63.77 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.712 -1.243 . . . . 0.0 112.261 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -96.81 -17.93 19.91 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.387 0.994 . . . . 0.0 113.398 -164.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -169.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -63.39 151.1 41.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -121.69 13.85 10.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.094 0.958 . . . . 0.0 110.213 167.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.06 131.37 10.3 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.2 m -135.77 -62.71 0.68 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.649 1.58 . . . . 0.0 107.159 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.18 141.12 11.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.052 2.941 . . . . 0.0 110.765 172.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.86 167.09 18.35 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 -172.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 120' ' ' LEU . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.431 ' HB ' HD23 ' A' ' 44' ' ' LEU . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 13' ' ' TYR . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.416 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 122' ' ' TRP 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 -170.06 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -72.19 166.89 21.46 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.782 -1.199 . . . . 0.0 108.51 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.21 16.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.498 2.319 . . . . 0.0 115.22 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.54 92.19 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.3 m -139.9 -178.97 5.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.563 1.545 . . . . 0.0 110.326 -169.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.19 69.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.34 116.71 4.04 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.672 2.248 . . . . 0.0 109.237 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t 59.95 29.34 18.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.983 0.913 . . . . 0.0 112.235 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -36.35 32.84 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.392 1.077 . . . . 0.0 113.744 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 177.371 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.414 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 t -135.69 178.11 7.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -134.29 165.34 25.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.662 0.785 . . . . 0.0 111.817 -160.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.82 -178.21 29.6 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -166.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -81.05 74.15 8.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.904 0.882 . . . . 0.0 109.911 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -146.29 170.64 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 109.123 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.36 172.83 37.68 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HE2' ' OH ' ' A' ' 53' ' ' TYR . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.559 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -70.98 -175.49 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -133.99 133.1 40.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.008 1.723 . . . . 0.0 107.072 165.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 42.94 31.64 0.34 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.153 2.181 . . . . 0.0 114.052 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.2 p -145.64 44.77 1.29 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.524 1.53 . . . . 0.0 110.811 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m -48.64 -46.88 40.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 112.426 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.34 -161.95 18.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.228 -1.318 . . . . 0.0 111.134 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.78 75.39 1.23 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.06 3.84 . . . . 0.0 112.168 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 m 53.93 17.96 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.141 1.776 . . . . 0.0 112.712 -174.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.5 1.92 . . . . 0.0 112.344 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 169.053 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.515 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 m -74.9 123.71 25.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t -155.17 -5.18 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 117.826 -1.083 . . . . 0.0 113.457 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.99 178.6 47.6 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 121.269 1.85 . . . . 0.0 110.96 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -110.26 60.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -165.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 p -68.7 -171.73 0.31 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.332 1.063 . . . . 0.0 110.728 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.62 178.92 39.63 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 165.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' HD21 ' A' ' 120' ' ' LEU . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.461 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.461 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.565 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 10' ' ' LYS . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -75.64 -177.54 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -104.07 20.66 17.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 111.797 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.75 157.27 17.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.018 1.327 . . . . 0.0 110.402 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -121.0 17.1 11.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.487 1.915 . . . . 0.0 109.487 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -128.49 139.35 52.37 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.99 69.36 0.41 Allowed Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.181 -1.344 . . . . 0.0 112.809 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.97 10.43 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.149 3.232 . . . . 0.0 112.863 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 p -150.96 50.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.358 2.263 . . . . 0.0 106.36 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -15.99 56.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.397 -0.814 . . . . 0.0 111.46 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 178.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 120' ' ' LEU . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CG ' HD22 ' A' ' 120' ' ' LEU . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.573 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 24' ' ' LEU . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 13' ' ' TYR . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 45.4 Cg_endo . . . . . 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HD3' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 44' ' ' LEU . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 29' ' ' ALA . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 13' ' ' TYR . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD21 ' HD3' ' A' ' 10' ' ' LYS . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 44' ' ' LEU . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 13' ' ' TYR . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.57 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' A' ' 18' ' ' THR . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.558 HD22 HD23 ' A' ' 24' ' ' LEU . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 35' ' ' GLN . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 13' ' ' TYR . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 115' ' ' TRP . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo . . . . . 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 120' ' ' LEU . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.401 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 89' ' ' LEU . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 53' ' ' TYR . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 13' ' ' TYR . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.421 ' CG ' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 24' ' ' LEU . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.41 HE21 ' HE2' ' A' ' 46' ' ' LYS . 1.1 mm-40 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 HD22 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HE2' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' A' ' 10' ' ' LYS . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' HD22 ' A' ' 120' ' ' LEU . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.538 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' A' ' 120' ' ' LEU . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 115' ' ' TRP . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 32.3 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' HD21 ' A' ' 120' ' ' LEU . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.518 ' CE1' HD11 ' A' ' 44' ' ' LEU . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD23 ' A' ' 24' ' ' LEU . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 13' ' ' TYR . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' ARG . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 115' ' ' TRP . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CE1' HD11 ' A' ' 44' ' ' LEU . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' LEU . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 13' ' ' TYR . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CZ ' ' HA2' ' A' ' 55' ' ' GLY . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 53' ' ' TYR . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.467 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 87' ' ' SER . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 13' ' ' TYR . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 47' ' ' LYS . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE3' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 44' ' ' LEU . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 13' ' ' TYR . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 115' ' ' TRP . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.401 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 74.4 Cg_endo . . . . . 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' CG ' HD22 ' A' ' 120' ' ' LEU . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 44' ' ' LEU . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 16' ' ' LEU . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 13' ' ' TYR . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.41 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.489 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.8 Cg_endo . . . . . 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HA ' HG22 ' A' ' 18' ' ' THR . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB3' HD13 ' A' ' 44' ' ' LEU . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.424 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 16' ' ' LEU . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' HD12 ' A' ' 123' ' ' ILE . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.415 HD22 ' CG ' ' A' ' 13' ' ' TYR . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.451 HD12 ' HE2' ' A' ' 47' ' ' LYS . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.784 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CD2' HD22 ' A' ' 120' ' ' LEU . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 44' ' ' LEU . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.459 HH11 ' HB3' ' A' ' 109' ' ' ALA . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 16' ' ' LEU . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 68' ' ' LYS . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.641 ' HA ' HD13 ' A' ' 65' ' ' LEU . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 62' ' ' LEU . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.457 ' HG2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 25' ' ' LEU . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 13' ' ' TYR . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HE3' HD21 ' A' ' 120' ' ' LEU . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 120' ' ' LEU . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 71' ' ' ASP . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.688 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.49 HD22 ' CD2' ' A' ' 13' ' ' TYR . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.474 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 18.3 Cg_endo . . . . . 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD21 ' A' ' 120' ' ' LEU . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.536 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' O ' ' HE3' ' A' ' 46' ' ' LYS . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 96' ' ' LEU . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 10' ' ' LYS . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.9 Cg_endo . . . . . 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CD2' HD22 ' A' ' 120' ' ' LEU . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.912 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' ASP . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.448 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.511 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 71' ' ' ASP . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 13' ' ' TYR . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.42 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 61.8 Cg_endo . . . . . 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CD2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.406 HG21 HH22 ' A' ' 28' ' ' ARG . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 52' ' ' VAL . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 96' ' ' LEU . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.542 HD22 ' CD2' ' A' ' 13' ' ' TYR . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 47' ' ' LYS . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 51.9 Cg_endo . . . . . 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 120' ' ' LEU . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.431 ' HB ' HD23 ' A' ' 44' ' ' LEU . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 13' ' ' TYR . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.416 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 122' ' ' TRP 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.195 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HE2' ' OH ' ' A' ' 53' ' ' TYR . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.559 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' HD21 ' A' ' 120' ' ' LEU . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.461 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.461 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.565 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 10' ' ' LYS . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.53 109.27 20.67 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 173.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -72.01 82.86 0.96 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.953 0.901 . . . . 0.0 108.884 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.6 -30.83 0.93 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.169 0.89 . . . . 0.0 111.697 -170.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 t -95.13 -166.78 1.51 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 118.457 1.128 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -13.0 90.54 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 130.271 3.429 . . . . 0.0 114.02 -176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.06 179.67 27.4 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 169.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.39 161.45 1.38 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.127 1.371 . . . . 0.0 109.343 173.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.66 -53.26 49.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.646 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.485 ' HG2' HD21 ' A' ' 120' ' ' LEU . 18.7 mtpp -58.41 -24.52 60.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.069 1.304 . . . . 0.0 113.825 175.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -32.59 63.86 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.786 1.63 . . . . 0.0 111.002 -172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.89 -63.75 1.24 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.483 -0.77 . . . . 0.0 110.484 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CG ' HD22 ' A' ' 120' ' ' LEU . 86.6 t80 -49.73 -44.39 48.35 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.616 1.166 . . . . 0.0 113.542 -175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -49.28 -60.01 3.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -69.69 -19.4 63.58 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 124.462 1.105 . . . . 0.0 113.846 -176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -51.79 68.55 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 126.754 2.022 . . . . 0.0 110.426 169.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.76 -42.78 20.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -72.69 -23.36 60.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.738 0.769 . . . . 0.0 112.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 21' ' ' ASN . 39.1 t70 -81.24 -23.2 38.21 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.006 -1.059 . . . . 0.0 113.305 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 58.08 -16.17 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.176 2.99 . . . . 0.0 114.057 -174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 19' ' ' ASP . 61.9 m-80 -104.45 -13.51 16.04 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.902 2.081 . . . . 0.0 111.619 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 165.0 16.59 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.724 0.809 . . . . 0.0 111.554 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -145.06 173.94 11.47 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.916 1.287 . . . . 0.0 111.642 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -128.8 129.94 46.32 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.897 1.279 . . . . 0.0 108.948 177.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.573 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -114.02 93.32 4.31 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.636 1.574 . . . . 0.0 107.292 173.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 97.03 2.34 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.987 -1.071 . . . . 0.0 108.868 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 pt -76.71 -4.49 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.991 0.917 . . . . 0.0 112.936 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mtm-85 -59.46 149.26 30.08 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.49 154.03 14.82 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.517 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.6 m -62.55 -26.31 68.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.895 -0.503 . . . . 0.0 111.873 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.49 -29.67 70.71 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.399 1.08 . . . . 0.0 112.682 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.18 -27.9 62.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 118.526 0.603 . . . . 0.0 110.029 -173.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -71.15 -8.4 53.25 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.595 -1.316 . . . . 0.0 113.395 167.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -93.76 -34.84 13.05 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.105 0.962 . . . . 0.0 111.03 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -111.96 -14.09 13.53 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.187 0.929 . . . . 0.0 112.897 -161.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.96 -45.13 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 126.786 2.034 . . . . 0.0 110.409 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 119.85 -159.45 14.93 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 119.802 -1.811 . . . . 0.0 112.043 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.41 159.31 73.06 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 117.693 0.746 . . . . 0.0 110.499 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -73.47 129.08 13.36 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.65 2.9 . . . . 0.0 111.624 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -89.44 79.05 7.03 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.277 -0.89 . . . . 0.0 110.037 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.55 9.13 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -35.05 74.1 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.141 0.882 . . . . 0.0 111.429 -169.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.37 -22.5 67.52 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.657 1.117 . . . . 0.0 113.42 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -73.79 -30.0 62.5 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.33 1.565 . . . . 0.0 110.147 172.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.2 -25.19 0.25 Allowed Glycine 0 C--N 1.335 0.488 0 O-C-N 121.9 -0.5 . . . . 0.0 114.338 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -163.14 168.69 20.46 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 118.562 1.181 . . . . 0.0 111.454 -165.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.12 167.35 15.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 109.449 174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.08 157.86 26.58 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.701 0.8 . . . . 0.0 110.179 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.14 103.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.4 p -77.38 116.57 18.09 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.0 m -148.93 111.65 4.8 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.86 125.5 19.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -71.42 146.21 48.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 -142.08 109.23 5.52 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.265 -2.494 . . . . 0.0 104.265 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.69 -14.03 8.99 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.001 0.819 . . . . 0.0 113.093 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -36.16 -67.45 0.17 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.994 2.517 . . . . 0.0 112.93 162.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -142.3 84.4 1.87 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -153.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -50.75 -56.94 15.39 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.147 1.379 . . . . 0.0 112.178 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.13 -39.9 17.13 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.135 1.89 . . . . 0.0 112.144 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -69.6 8.75 2.95 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.916 1.722 . . . . 0.0 113.375 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -118.88 -53.22 2.29 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.988 1.715 . . . . 0.0 108.145 173.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -57.63 -18.19 18.77 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.069 0.947 . . . . 0.0 113.186 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.68 -18.5 21.01 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 119.669 1.122 . . . . 0.0 112.685 172.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -86.19 -30.35 22.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 119.125 0.875 . . . . 0.0 111.218 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -75.11 -43.17 54.33 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.2 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -57.59 -25.1 59.55 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -166.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.37 -9.94 28.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.157 0.983 . . . . 0.0 113.205 -179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -97.67 -16.63 19.88 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.244 1.018 . . . . 0.0 112.827 -167.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 50.7 m-85 -127.63 125.87 40.96 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -171.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -60.36 -61.74 2.38 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.874 0.869 . . . . 0.0 110.048 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -120.72 65.78 12.83 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.617 1.198 . . . . 0.0 108.104 -164.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.05 -32.57 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.331 2.02 . . . . 0.0 109.972 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -54.71 -14.55 1.41 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.871 2.469 . . . . 0.0 113.983 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -142.86 -10.14 0.79 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 121.792 2.087 . . . . 0.0 114.365 170.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.1 m -56.13 130.09 42.73 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.085 1.354 . . . . 0.0 108.401 170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -91.99 102.53 15.09 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.96 157.55 28.15 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.133 -1.604 . . . . 0.0 109.923 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -135.24 115.55 13.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mp -69.1 162.45 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 O-C-N 121.652 -0.655 . . . . 0.0 109.238 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB2' HD11 ' A' ' 24' ' ' LEU . 1.1 tt -143.85 107.89 4.73 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.043 0.937 . . . . 0.0 108.54 171.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -89.49 170.88 10.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.095 0.958 . . . . 0.0 111.574 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -62.4 -49.11 76.79 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 127.828 2.451 . . . . 0.0 109.304 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.38 -81.68 0.32 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -111.67 -62.77 1.51 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.8 -119.74 18.13 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -136.46 31.4 2.86 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 109.42 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.5 p -47.2 -56.05 7.41 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.587 1.155 . . . . 0.0 112.164 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.81 -15.73 63.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.135 1.374 . . . . 0.0 112.452 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.02 -52.46 8.75 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.0 t -58.44 -35.1 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.37 -12.73 32.57 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.119 1.368 . . . . 0.0 112.512 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.27 9.47 11.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.005 1.322 . . . . 0.0 112.84 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.0 tp -99.63 -52.71 3.39 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 120.672 -1.268 . . . . 0.0 111.652 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.1 m -56.28 -45.29 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.148 0.885 . . . . 0.0 112.622 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.19 -26.94 68.63 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.936 1.294 . . . . 0.0 110.642 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -92.77 -6.01 49.94 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.229 1.411 . . . . 0.0 110.902 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -118.19 18.6 13.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.442 1.897 . . . . 0.0 110.55 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.37 0.12 25.02 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 118.754 -1.026 . . . . 0.0 115.014 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -87.07 175.49 8.07 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.819 1.31 . . . . 0.0 109.835 164.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.52 -75.05 0.34 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 m -148.02 130.4 15.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.25 158.86 39.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.45 1.119 . . . . 0.0 111.149 -170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -142.08 158.87 43.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 128.41 2.684 . . . . 0.0 108.798 -165.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -123.96 175.91 6.65 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.073 1.749 . . . . 0.0 109.642 169.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.05 129.63 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 C-N-CA 125.804 1.642 . . . . 0.0 106.995 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -68.74 152.2 45.64 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.79 5.46 2.29 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.76 1.624 . . . . 0.0 111.784 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.74 -130.37 35.2 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 124.554 1.073 . . . . 0.0 112.241 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.94 -52.64 3.8 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.353 1.061 . . . . 0.0 110.213 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -95.63 -2.76 47.55 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.737 1.273 . . . . 0.0 112.911 -167.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.87 166.3 28.02 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 121.338 -0.851 . . . . 0.0 112.269 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.4 -18.36 62.81 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.536 2.157 . . . . 0.0 113.336 -170.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -136.99 21.57 3.03 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.295 1.438 . . . . 0.0 110.483 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.88 -170.01 20.6 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -47.32 -52.66 15.75 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.635 1.574 . . . . 0.0 111.912 -174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.49 -45.56 88.47 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -84.47 33.77 0.51 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.325 1.85 . . . . 0.0 111.285 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.1 t -140.57 14.75 2.35 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.958 -1.089 . . . . 0.0 113.113 -172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.4 t 68.3 8.6 6.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.742 1.156 . . . . 0.0 112.277 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.485 HD22 ' CG ' ' A' ' 13' ' ' TYR . 57.8 mt -80.63 155.61 73.47 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.788 1.235 . . . . 0.0 110.524 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.44 150.59 25.24 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.841 2.361 . . . . 0.0 111.593 -172.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -135.35 164.92 26.66 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.61 0.764 . . . . 0.0 111.137 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -107.81 -47.83 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 CA-C-O 117.317 -1.325 . . . . 0.0 109.433 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HA ' ' HA3' ' A' ' 37' ' ' GLY 0.285 0.1 OUTLIER 66.82 164.92 0.12 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.812 1.645 . . . . 0.0 112.081 -176.296 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 45.4 Cg_endo -66.97 -162.07 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.04 2.493 . . . . 0.0 111.49 165.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -74.11 161.41 30.04 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 119.91 -1.744 . . . . 0.0 109.756 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -60.84 139.64 57.9 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.2 m -147.86 179.99 7.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.589 1.956 . . . . 0.0 106.816 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.7 p -140.89 97.32 3.16 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.608 -1.307 . . . . 0.0 111.182 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.82 78.68 0.04 OUTLIER Glycine 0 CA--C 1.527 0.81 0 CA-C-O 118.798 -1.001 . . . . 0.0 111.409 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 -41.93 6.15 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 119.845 1.823 . . . . 0.0 111.425 -171.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 87.9 p -67.47 -13.27 61.89 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.454 1.025 . . . . 0.0 112.502 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.4 t -72.57 -14.5 61.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.679 0.672 . . . . 0.0 111.847 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -177.85 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.3 p -69.49 174.16 5.2 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 167.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 173.87 3.29 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 158.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.9 -94.5 0.75 Allowed Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 106.205 -2.758 . . . . 0.0 106.205 -168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -133.03 -173.68 3.26 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.33 1.052 . . . . 0.0 111.955 -173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m 57.33 62.09 2.29 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.778 2.031 . . . . 0.0 111.633 163.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.38 172.47 34.72 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-O 122.828 1.238 . . . . 0.0 112.994 -173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.2 m -63.31 161.0 14.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 159.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.51 -66.31 0.41 Allowed 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 119.537 1.062 . . . . 0.0 112.283 -174.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HD3' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -58.99 -24.12 62.43 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.07 -1.443 . . . . 0.0 112.992 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -54.13 -39.53 66.56 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.841 1.655 . . . . 0.0 110.982 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.67 -65.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.624 1.17 . . . . 0.0 111.364 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CE2' HD11 ' A' ' 44' ' ' LEU . 64.3 t80 -47.14 -39.77 14.22 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.434 1.494 . . . . 0.0 112.609 177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -53.68 -41.0 66.42 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.8 mmpt? -70.24 -43.42 70.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.456 -176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 mp -50.19 -46.43 54.36 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 123.763 0.825 . . . . 0.0 110.965 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.62 44.33 1.52 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -157.45 -23.75 0.09 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.451 0.7 . . . . 0.0 110.483 171.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.32 -32.64 26.2 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 120.342 -1.474 . . . . 0.0 112.166 168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.9 t70 67.17 -43.7 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.24 3.416 . . . . 0.0 113.891 -169.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -76.59 -19.18 58.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.595 1.089 . . . . 0.0 112.813 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.22 159.82 3.29 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.955 2.102 . . . . 0.0 111.123 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.7 176.7 8.47 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.093 -1.005 . . . . 0.0 113.416 -176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.23 129.04 44.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.036 1.735 . . . . 0.0 110.44 176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.51 95.81 5.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.205 1.402 . . . . 0.0 109.182 173.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -73.26 104.91 4.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.6 pt -90.74 3.48 6.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.675 1.19 . . . . 0.0 111.615 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm-85 -67.63 160.06 28.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.669 1.122 . . . . 0.0 110.181 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . . . -63.26 155.08 29.5 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.129 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -56.53 -41.75 77.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.325 1.05 . . . . 0.0 110.962 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.54 -23.8 61.04 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 122.433 0.293 . . . . 0.0 111.56 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' ' HB3' ' A' ' 29' ' ' ALA . 15.6 m-20 -69.87 -22.23 63.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.863 -0.589 . . . . 0.0 109.97 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.2 -0.47 16.92 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.202 -1.562 . . . . 0.0 112.964 169.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -111.33 -24.09 10.42 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.441 1.496 . . . . 0.0 111.192 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -121.09 -20.37 6.82 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.54 -43.12 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 126.416 1.886 . . . . 0.0 110.078 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 -157.92 14.62 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 119.5 -2.0 . . . . 0.0 110.156 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.51 156.04 75.11 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.77 1.228 . . . . 0.0 111.539 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -74.58 132.65 16.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.691 2.927 . . . . 0.0 111.369 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -89.93 112.51 23.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.98 13.21 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.769 0.668 . . . . 0.0 111.584 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -47.09 78.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.005 -170.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.76 -10.92 80.69 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 119.275 0.943 . . . . 0.0 112.8 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CE2' ' A' ' 13' ' ' TYR . 12.9 mt -74.76 -20.25 59.89 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.534 1.167 . . . . 0.0 109.364 166.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.31 -29.21 0.45 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 126.477 1.989 . . . . 0.0 113.283 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 169.42 6.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.423 1.611 . . . . 0.0 109.651 -164.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.38 156.27 24.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.766 0.827 . . . . 0.0 109.532 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.88 153.15 29.84 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.124 0.57 . . . . 0.0 110.328 170.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.2 t -83.93 154.47 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 161.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.2 p -127.35 122.78 34.64 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.756 1.222 . . . . 0.0 108.227 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.8 m -155.86 107.29 2.53 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 t -56.19 122.46 5.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.7 147.68 52.57 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.242 1.02 . . . . 0.0 108.296 170.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -148.05 115.3 6.21 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 167.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.18 -14.54 59.51 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 119.222 -0.766 . . . . 0.0 113.27 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.68 -58.49 8.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.737 1.615 . . . . 0.0 111.715 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -115.76 92.29 3.86 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.914 0.864 . . . . 0.0 108.848 -171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -56.49 -57.16 25.07 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.64 1.176 . . . . 0.0 112.812 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.25 -38.71 52.89 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.833 1.689 . . . . 0.0 110.535 173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.0 27.04 0.19 Allowed Glycine 0 C--N 1.339 0.73 0 C-N-CA 127.126 2.298 . . . . 0.0 114.942 174.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -138.13 -48.8 0.55 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.781 1.232 . . . . 0.0 108.959 170.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.44 -21.62 26.6 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.243 0.617 . . . . 0.0 111.827 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -64.15 -10.8 25.06 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.475 1.51 . . . . 0.0 112.899 176.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -97.44 -28.66 13.9 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.338 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.19 -38.13 60.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.288 0.949 . . . . 0.0 109.382 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -60.29 -11.81 7.42 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.6 pt? -124.6 11.06 8.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.587 1.155 . . . . 0.0 112.31 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -111.03 -13.99 13.99 Favored 'General case' 0 N--CA 1.458 -0.058 0 C-N-CA 124.868 1.267 . . . . 0.0 113.835 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -126.38 163.87 22.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.676 1.58 . . . . 0.0 110.648 -173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -94.33 -64.8 1.04 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 121.42 -0.8 . . . . 0.0 109.97 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -115.25 68.07 2.41 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.042 1.737 . . . . 0.0 109.457 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -68.52 -35.23 17.97 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.324 2.016 . . . . 0.0 111.607 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.97 -15.06 4.2 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.811 1.644 . . . . 0.0 113.536 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -129.06 -17.37 3.9 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.68 1.127 . . . . 0.0 113.204 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -71.75 121.45 18.93 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.162 0.985 . . . . 0.0 109.833 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 93.0 m -78.38 109.71 12.77 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.26 157.91 22.46 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.932 -1.105 . . . . 0.0 110.901 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -134.35 102.77 5.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.899 2.079 . . . . 0.0 106.877 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -63.66 165.68 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 O-C-N 121.039 -1.038 . . . . 0.0 110.094 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.36 124.52 11.47 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.52 1.528 . . . . 0.0 108.262 170.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.64 -177.84 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.693 1.597 . . . . 0.0 112.032 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -62.03 -61.24 2.62 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.846 2.058 . . . . 0.0 110.547 172.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -153.71 -47.04 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.09 1.314 . . . . 0.0 112.217 -163.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -136.85 -55.56 0.73 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.9 -116.41 3.31 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 126.505 2.002 . . . . 0.0 110.602 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -147.97 24.87 1.04 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.878 0.871 . . . . 0.0 109.215 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.75 -46.46 20.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.448 1.499 . . . . 0.0 111.966 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -64.73 -45.73 85.27 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.734 0.814 . . . . 0.0 109.92 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.25 -46.52 79.58 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.881 1.672 . . . . 0.0 110.508 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.3 -31.94 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 118.574 -0.727 . . . . 0.0 109.688 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -60.27 -38.74 84.46 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.09 34.0 1.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.23 -0.919 . . . . 0.0 111.045 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.6 tp -122.88 -58.34 1.66 Allowed 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.166 0.987 . . . . 0.0 109.539 173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 m -61.85 -37.48 78.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 122.877 0.471 . . . . 0.0 111.129 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 -14.1 51.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.93 1.292 . . . . 0.0 113.106 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.1 -7.85 14.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.501 1.52 . . . . 0.0 110.885 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -106.07 -5.51 19.4 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.011 1.324 . . . . 0.0 111.71 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 140.62 -3.3 2.33 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.369 -1.24 . . . . 0.0 115.058 169.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.26 172.52 12.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.373 1.587 . . . . 0.0 110.356 167.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 1.0 OUTLIER -71.35 -80.95 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.459 1.104 . . . . 0.0 112.008 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.4 m -150.24 140.51 22.23 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 128.919 2.888 . . . . 0.0 107.013 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -130.16 146.68 51.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.192 0.996 . . . . 0.0 110.789 -171.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -109.31 163.31 13.5 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.959 2.104 . . . . 0.0 109.171 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.23 160.84 32.65 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 108.948 166.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.9 124.61 68.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 172.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.59 152.75 45.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.105 170.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 73.27 7.84 5.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.021 1.728 . . . . 0.0 111.266 172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.3 -117.12 0.69 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.909 2.195 . . . . 0.0 112.978 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.85 -47.41 3.59 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.905 1.282 . . . . 0.0 110.481 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.93 -17.46 40.59 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.758 1.223 . . . . 0.0 112.288 -166.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.32 161.19 38.61 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.808 0.718 . . . . 0.0 112.055 -173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.81 -13.43 36.99 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.364 2.709 . . . . 0.0 114.21 -169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -141.18 25.27 2.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.849 1.659 . . . . 0.0 111.341 170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.1 -166.92 8.98 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 172.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -46.79 -55.67 7.5 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.242 1.417 . . . . 0.0 111.834 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.81 -50.63 72.62 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.25 43.12 0.52 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.496 1.518 . . . . 0.0 111.529 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.19 18.5 1.74 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.267 1.027 . . . . 0.0 112.885 176.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 67.71 13.85 9.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.27 0.941 . . . . 0.0 111.9 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD21 ' HD3' ' A' ' 10' ' ' LYS . 71.6 mt -76.98 150.91 81.61 Favored Pre-proline 0 C--O 1.234 0.251 0 O-C-N 120.795 -1.191 . . . . 0.0 110.527 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.38 164.3 20.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.106 1.871 . . . . 0.0 110.466 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 5.1 t-105 -139.95 172.32 12.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.97 0.908 . . . . 0.0 108.729 172.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 53.5 mt -102.46 -31.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.555 1.142 . . . . 0.0 109.621 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 62.79 166.59 0.1 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.146 1.379 . . . . 0.0 111.75 -168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -66.36 -171.95 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.001 1.8 . . . . 0.0 109.929 166.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -66.78 177.48 1.63 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.096 0.958 . . . . 0.0 109.425 178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -47.74 117.79 2.01 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.4 m -140.67 139.94 34.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -104.39 176.96 4.98 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.653 0.781 . . . . 0.0 109.893 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.1 61.24 7.36 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.48 1.038 . . . . 0.0 112.436 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -65.59 127.22 17.57 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.422 2.081 . . . . 0.0 109.802 -172.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m 59.58 22.22 10.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.043 0.937 . . . . 0.0 112.674 172.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.6 t -61.77 -12.93 19.3 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.527 1.531 . . . . 0.0 114.678 -169.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -166.231 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.772 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.8 t -147.75 -167.07 2.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.653 1.581 . . . . 0.0 107.518 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.5 t -69.54 170.59 10.35 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 153.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.77 23.36 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.826 0.727 . . . . 0.0 113.467 168.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 p -146.18 170.8 16.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.492 1.117 . . . . 0.0 109.14 170.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 p -60.02 133.01 55.69 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.11 177.51 42.91 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 169.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 m -74.72 -173.47 1.85 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.52 -0.988 . . . . 0.0 111.547 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.35 -78.56 0.05 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.361 1.065 . . . . 0.0 112.369 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.73 -33.18 9.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.189 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -46.61 -49.88 18.35 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.408 1.083 . . . . 0.0 111.981 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.45 9.68 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.383 0.673 . . . . 0.0 111.811 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 44' ' ' LEU . 62.5 t80 -54.17 -38.19 65.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.464 1.105 . . . . 0.0 112.164 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.3 m -51.57 -48.16 63.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -63.54 -50.13 70.74 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 110.391 -175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.0 mp -48.54 -33.82 10.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.003 0.819 . . . . 0.0 112.098 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 5.67 83.75 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 118.033 -1.426 . . . . 0.0 115.519 -177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -126.14 -16.86 5.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.383 1.592 . . . . 0.0 111.064 172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -114.66 90.78 3.42 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 127.248 2.219 . . . . 0.0 106.855 -172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -63.92 -16.58 61.79 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.77 0.828 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -90.0 -16.66 29.37 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.759 1.624 . . . . 0.0 112.336 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.34 168.45 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.871 1.214 . . . . 0.0 109.956 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -146.44 175.23 10.71 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.96 0.904 . . . . 0.0 112.839 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.39 125.31 38.36 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.422 1.489 . . . . 0.0 109.179 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.67 97.73 6.77 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.862 1.265 . . . . 0.0 108.209 175.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -76.99 104.46 7.49 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 pt -93.82 6.1 6.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 123.247 0.619 . . . . 0.0 111.85 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 50.8 mtm-85 -66.24 155.78 36.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.308 1.051 . . . . 0.0 109.566 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.1 154.83 7.18 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 126.717 2.007 . . . . 0.0 110.609 -171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -60.78 -35.54 76.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.059 -1.025 . . . . 0.0 110.714 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.88 -18.93 62.67 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 111.948 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.02 -33.55 76.05 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.623 0.647 . . . . 0.0 109.992 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -71.91 2.85 4.92 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.098 -1.001 . . . . 0.0 113.243 172.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -121.17 -22.18 6.16 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.704 1.601 . . . . 0.0 112.74 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -109.1 -34.16 6.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.427 1.091 . . . . 0.0 111.799 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.9 t -102.8 -74.14 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.29 -146.37 17.74 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 161.22 34.08 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.108 1.954 . . . . 0.0 110.873 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.77 131.68 18.87 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 124.129 3.219 . . . . 0.0 111.429 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.99 82.76 3.55 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 121.707 0.765 . . . . 0.0 111.799 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -91.28 6.48 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.333 1.053 . . . . 0.0 112.761 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -38.94 79.25 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.755 1.162 . . . . 0.0 111.679 -170.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.05 -17.6 61.35 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.884 0.766 . . . . 0.0 113.333 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD11 ' CE1' ' A' ' 13' ' ' TYR . 20.4 mt -79.99 -13.07 59.62 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.522 1.161 . . . . 0.0 110.692 175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.49 -24.78 1.84 Allowed Glycine 0 C--N 1.342 0.87 0 C-N-CA 124.828 1.204 . . . . 0.0 115.078 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.96 164.68 7.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 118.753 1.276 . . . . 0.0 111.525 -172.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.9 158.84 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.68 162.48 13.12 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.086 0.555 . . . . 0.0 110.538 167.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.85 134.6 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 168.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -102.48 124.2 47.6 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 119.148 0.885 . . . . 0.0 110.005 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.0 m -153.51 101.71 2.52 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.837 1.255 . . . . 0.0 107.733 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.04 128.02 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 118.554 0.615 . . . . 0.0 110.476 174.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.31 157.65 29.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.359 1.064 . . . . 0.0 110.842 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.14 -75.51 0.43 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.479 0.712 . . . . 0.0 109.528 165.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.74 -19.53 25.75 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 124.356 0.979 . . . . 0.0 113.016 -176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -47.87 -40.48 21.71 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.591 1.195 . . . . 0.0 109.512 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -131.72 97.5 4.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -52.96 -62.03 3.98 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.641 1.576 . . . . 0.0 112.434 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.88 -31.14 48.23 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.302 2.002 . . . . 0.0 111.789 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.59 0.89 8.29 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.544 1.068 . . . . 0.0 114.643 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -109.34 -47.44 3.4 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.958 1.703 . . . . 0.0 109.635 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.6 mt -60.36 -7.08 1.8 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.765 1.226 . . . . 0.0 112.89 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -13.1 59.35 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 119.661 1.119 . . . . 0.0 112.397 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -83.22 -45.73 13.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.703 0.801 . . . . 0.0 111.278 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.82 -38.98 83.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.105 -164.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -4.63 0.99 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.59 0.1 3.59 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.675 1.125 . . . . 0.0 113.175 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -101.65 -13.5 17.78 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 117.233 -1.365 . . . . 0.0 112.194 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.449 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 24.5 m-85 -121.36 148.5 44.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 120.189 1.359 . . . . 0.0 109.768 -171.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -65.07 0.85 Allowed 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.158 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.08 67.8 80.15 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 -162.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.84 -30.05 34.12 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.759 2.306 . . . . 0.0 111.444 -168.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -54.84 -26.92 38.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.395 1.878 . . . . 0.0 113.715 -171.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.91 25.24 2.34 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.741 2.417 . . . . 0.0 110.708 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.58 143.97 30.67 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.5 m -92.15 119.93 32.26 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 165.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.49 154.94 19.95 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 118.908 0.776 . . . . 0.0 110.496 171.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -131.59 110.68 11.12 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 104.6 -2.371 . . . . 0.0 104.6 168.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -67.52 164.89 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.49 124.71 16.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 164.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -118.83 -178.74 3.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.185 1.394 . . . . 0.0 109.43 176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -77.69 0.05 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.183 1.356 . . . . 0.0 110.262 -178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -122.48 -58.03 1.71 Allowed 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -116.64 -75.58 0.58 Allowed 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 173.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.4 -125.98 15.09 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.24 28.9 2.5 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.039 0.919 . . . . 0.0 111.108 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.0 p -40.7 -55.17 2.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.888 1.675 . . . . 0.0 113.109 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -64.43 -41.84 96.35 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 123.694 0.797 . . . . 0.0 110.714 -176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.44 -44.52 89.18 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.6 t -68.09 -37.11 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.331 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.82 -22.29 66.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.675 1.19 . . . . 0.0 112.811 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.8 18.73 18.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.574 1.149 . . . . 0.0 111.176 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.9 tp -113.89 -53.88 2.64 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 124.133 0.973 . . . . 0.0 110.834 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.58 -41.32 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.63 -15.19 50.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 112.636 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.3 mp -107.15 -1.11 22.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.261 1.424 . . . . 0.0 111.108 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -123.45 -3.79 8.35 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.554 1.142 . . . . 0.0 113.502 -167.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.49 26.77 0.3 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 119.195 -0.781 . . . . 0.0 113.208 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -135.61 171.58 14.25 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.814 1.646 . . . . 0.0 107.14 168.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -86.09 -50.62 6.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.0 142.8 16.43 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -166.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.22 167.52 21.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 118.978 0.808 . . . . 0.0 111.101 172.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -132.8 158.19 43.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.212 1.805 . . . . 0.0 109.213 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -115.65 160.51 19.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.53 1.132 . . . . 0.0 110.306 162.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.1 119.64 61.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 126.567 1.947 . . . . 0.0 106.218 177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.14 149.03 29.23 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 171.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 63.58 3.12 1.39 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.532 1.933 . . . . 0.0 113.147 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.04 -122.44 8.21 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.312 1.91 . . . . 0.0 112.265 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -111.45 -19.16 12.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.272 1.829 . . . . 0.0 111.938 174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -120.11 69.79 0.86 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.245 1.818 . . . . 0.0 108.901 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -152.44 177.73 30.02 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.28 -17.72 21.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.142 1.895 . . . . 0.0 113.177 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -143.01 28.37 1.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.265 1.826 . . . . 0.0 110.658 172.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.43 -169.28 10.02 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -48.15 -57.47 5.83 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.365 1.466 . . . . 0.0 111.319 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.0 mt -61.09 -46.78 89.23 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.51 0.671 . . . . 0.0 109.619 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.69 22.82 0.56 Allowed 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.037 -1.039 . . . . 0.0 112.77 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -128.81 12.08 6.21 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.569 1.547 . . . . 0.0 110.522 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 t 59.94 55.35 3.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.678 1.991 . . . . 0.0 110.414 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.1 mt -117.72 155.83 50.29 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.475 1.11 . . . . 0.0 110.958 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.42 153.33 50.15 Favored 'Trans proline' 0 C--O 1.241 0.633 0 C-N-CA 122.607 2.204 . . . . 0.0 112.839 -168.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -139.81 146.78 39.85 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.485 1.114 . . . . 0.0 110.669 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.6 mt -82.68 -32.19 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 125.193 1.397 . . . . 0.0 109.674 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 60.95 160.93 0.11 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 126.652 1.981 . . . . 0.0 113.231 -167.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -78.27 177.73 8.41 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 121.85 1.7 . . . . 0.0 111.521 163.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.81 18.72 0.75 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.787 -1.196 . . . . 0.0 112.695 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -23.81 17.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 116.642 -1.647 . . . . 0.0 112.813 175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.5 t 36.64 46.35 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.659 1.983 . . . . 0.0 112.501 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 m -70.41 -5.2 26.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -164.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 145.39 176.58 19.46 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 126.457 1.98 . . . . 0.0 108.154 -162.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.95 -8.53 15.55 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.254 3.302 . . . . 0.0 114.322 -172.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.7 t -126.18 -49.54 1.57 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.61 1.095 . . . . 0.0 108.291 175.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 83.5 p 60.52 -36.82 0.09 Allowed 'General case' 0 C--O 1.232 0.132 0 C-N-CA 129.819 3.248 . . . . 0.0 116.33 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 107.884 -2.086 . . . . 0.0 107.884 166.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -69.87 11.68 0.27 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.489 1.916 . . . . 0.0 113.236 -174.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -144.59 163.49 33.76 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 120.508 -1.37 . . . . 0.0 112.452 -159.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.24 -93.42 0.1 OUTLIER Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -62.8 -7.94 5.94 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.635 0.774 . . . . 0.0 112.572 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.82 155.42 7.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.211 1.404 . . . . 0.0 111.736 172.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.78 170.53 35.12 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.0 m -56.04 169.15 0.41 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . . . -58.22 -58.41 8.58 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -171.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -30.43 69.96 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.586 -0.696 . . . . 0.0 110.086 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -11.27 6.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.359 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.33 -39.41 6.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 121.118 1.781 . . . . 0.0 114.419 168.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.57 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.1 t80 -70.13 -42.91 71.99 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.343 1.429 . . . . 0.0 113.14 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -47.81 -37.49 13.81 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.864 0.757 . . . . 0.0 111.883 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.507 ' HA ' HG22 ' A' ' 18' ' ' THR . 63.2 mmtt -84.57 -27.85 26.99 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.617 1.167 . . . . 0.0 112.896 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.558 HD22 HD23 ' A' ' 24' ' ' LEU . 51.5 tp -64.2 -28.3 69.65 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.877 1.271 . . . . 0.0 110.462 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.81 60.83 0.55 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.507 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -156.36 -34.41 0.08 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 164.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.76 -18.05 61.54 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 112.623 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.49 -15.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.283 3.833 . . . . 0.0 117.064 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -102.36 -2.81 28.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.448 1.099 . . . . 0.0 111.753 160.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.68 149.38 43.78 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 122.655 1.217 . . . . 0.0 110.781 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -138.87 173.85 11.14 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.679 1.592 . . . . 0.0 109.104 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.558 HD23 HD22 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -134.06 129.31 35.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.404 1.082 . . . . 0.0 109.686 -172.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -119.56 90.9 3.42 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 175.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -68.48 113.16 5.78 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 pt -100.16 11.88 6.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 125.077 1.351 . . . . 0.0 111.544 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -68.85 151.35 46.71 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.466 1.03 . . . . 0.0 110.343 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.47 147.52 51.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.68 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.5 m -56.32 -21.82 26.66 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.14 -26.4 63.92 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.04 -48.6 75.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.24 -6.29 0.39 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.323 1.849 . . . . 0.0 113.554 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.3 mtt-85 -109.72 -27.38 9.37 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.389 1.476 . . . . 0.0 112.138 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -117.16 -25.64 7.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.32 1.448 . . . . 0.0 112.321 -167.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 35' ' ' GLN . 61.2 t -132.82 -47.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.31 1.444 . . . . 0.0 110.181 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.85 -135.98 8.44 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 121.097 1.771 . . . . 0.0 113.286 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.65 156.57 32.35 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 123.935 0.894 . . . . 0.0 109.495 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.26 122.27 6.06 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.582 2.854 . . . . 0.0 112.854 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -86.96 86.02 7.29 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.1 6.99 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.638 -0.664 . . . . 0.0 111.797 172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.97 -22.89 65.0 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.53 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 -25.73 72.6 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 119.625 1.102 . . . . 0.0 111.695 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 13' ' ' TYR . 68.5 mt -75.06 -13.06 60.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.45 1.125 . . . . 0.0 112.238 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.33 -50.6 0.59 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.874 1.215 . . . . 0.0 113.611 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.44 166.85 29.79 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.493 1.117 . . . . 0.0 110.408 -160.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 165.52 16.78 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 121.328 -0.857 . . . . 0.0 109.741 -175.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.49 155.97 37.41 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 165.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.7 t -86.07 145.49 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -123.75 106.68 10.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.761 1.224 . . . . 0.0 108.38 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -144.6 101.86 3.73 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.381 1.472 . . . . 0.0 107.19 -174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.22 122.22 9.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -75.05 144.09 43.18 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.152 0.501 . . . . 0.0 110.407 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -141.33 143.05 33.81 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.474 1.11 . . . . 0.0 108.85 166.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.7 -5.89 89.7 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.952 1.263 . . . . 0.0 114.102 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -74.54 -58.75 3.09 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.09 1.756 . . . . 0.0 109.813 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 -120.6 77.06 1.24 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.892 1.277 . . . . 0.0 109.415 -167.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -39.66 -59.43 1.67 Allowed Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 126.106 1.762 . . . . 0.0 113.154 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 -18.06 34.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 112.889 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.07 8.54 73.06 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 125.776 1.655 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -122.6 -51.51 1.94 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.946 1.698 . . . . 0.0 108.924 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.9 mt -58.4 -17.93 24.21 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -30.72 45.53 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.813 1.245 . . . . 0.0 111.195 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -78.42 -30.76 47.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 118.845 -1.142 . . . . 0.0 111.34 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.03 -33.83 68.33 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.723 0.692 . . . . 0.0 110.723 -169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -9.34 8.79 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -171.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.57 14.98 3.71 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.806 2.442 . . . . 0.0 111.302 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -119.99 -9.69 9.59 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.84 2.056 . . . . 0.0 114.203 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -134.34 141.27 46.84 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.548 1.139 . . . . 0.0 108.182 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -49.42 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.53 1.059 . . . . 0.0 110.024 170.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -122.12 69.26 28.72 Favored Pre-proline 0 C--N 1.33 -0.248 0 C-N-CA 124.055 0.942 . . . . 0.0 110.563 -167.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.6 -37.85 35.18 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.48 1.454 . . . . 0.0 110.556 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.69 -10.29 55.42 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.276 1.43 . . . . 0.0 114.121 -172.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -128.13 -4.33 5.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 120.404 1.457 . . . . 0.0 112.014 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -69.26 147.51 51.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.593 1.088 . . . . 0.0 110.011 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.7 m -98.38 106.35 18.62 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 160.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 143.65 33.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -120.17 106.96 12.44 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.49 138.02 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.76 121.28 35.05 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.324 1.85 . . . . 0.0 106.824 175.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.49 -176.97 3.04 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.84 0.746 . . . . 0.0 110.688 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -69.04 -50.53 47.8 Favored 'General case' 0 C--O 1.218 -0.6 0 O-C-N 120.57 -1.331 . . . . 0.0 109.676 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -158.45 -37.05 0.07 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.805 0.729 . . . . 0.0 112.492 -160.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -158.18 -61.87 0.08 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.75 2.42 . . . . 0.0 105.853 -171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.52 -89.61 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 128.226 2.822 . . . . 0.0 112.079 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -173.46 29.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.99 2.516 . . . . 0.0 108.462 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -46.06 37.1 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.248 1.019 . . . . 0.0 111.078 -172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.5 -41.67 98.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.108 1.363 . . . . 0.0 112.057 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -60.97 -50.84 71.77 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 123.601 0.761 . . . . 0.0 109.045 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.4 t -66.03 -26.18 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 O-C-N 121.581 -0.7 . . . . 0.0 110.513 -174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.83 -25.61 64.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.316 1.047 . . . . 0.0 113.135 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.29 -38.66 18.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.111 0.869 . . . . 0.0 110.467 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 40.5 tp -56.83 -52.86 63.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.4 m -65.36 -40.63 89.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.083 0.856 . . . . 0.0 111.335 -178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.46 -25.03 67.77 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.486 1.114 . . . . 0.0 111.576 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 mp -93.64 -4.39 50.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.571 1.948 . . . . 0.0 112.187 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.74 13.49 15.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.737 1.615 . . . . 0.0 112.389 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.54 -15.07 7.19 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 124.279 0.942 . . . . 0.0 113.707 171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -76.33 171.0 15.29 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.755 1.278 . . . . 0.0 109.643 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.408 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 1.2 tpmt? -71.59 -83.51 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.761 0.825 . . . . 0.0 110.684 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.3 m -138.56 159.19 42.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.981 1.712 . . . . 0.0 109.498 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.83 173.05 12.02 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.749 0.785 . . . . 0.0 112.782 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -141.97 160.85 39.39 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.147 2.179 . . . . 0.0 110.766 -162.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.69 107.04 4.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.698 1.599 . . . . 0.0 111.15 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -68.99 130.66 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.202 -0.936 . . . . 0.0 108.51 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 149.02 50.48 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 171.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 65.04 2.55 1.83 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.621 1.168 . . . . 0.0 112.057 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.63 -118.8 1.24 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.32 1.438 . . . . 0.0 112.146 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.06 -16.82 9.78 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 118.52 1.16 . . . . 0.0 113.968 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -121.58 0.91 10.01 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.206 2.202 . . . . 0.0 112.104 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.48 170.97 55.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.245 0.926 . . . . 0.0 111.928 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.54 -26.64 83.27 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.647 2.898 . . . . 0.0 114.789 -164.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -133.48 26.26 4.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.121 0.968 . . . . 0.0 109.903 175.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.88 -173.14 10.88 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.081 0.848 . . . . 0.0 111.652 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 120' ' ' LEU . 17.7 t-105 -40.58 -59.79 1.28 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.338 2.255 . . . . 0.0 111.239 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.7 mt -49.81 -62.15 1.72 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.955 0.902 . . . . 0.0 109.796 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -66.89 11.44 0.1 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.627 2.771 . . . . 0.0 112.421 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -124.75 21.49 8.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.475 1.91 . . . . 0.0 110.843 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m 64.83 19.6 11.89 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.062 1.745 . . . . 0.0 114.237 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 115' ' ' TRP . 33.6 mt -78.82 158.0 75.91 Favored Pre-proline 0 N--CA 1.449 -0.519 0 O-C-N 121.352 -0.842 . . . . 0.0 110.513 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -67.07 145.06 72.05 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.641 2.894 . . . . 0.0 112.028 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -135.21 165.07 26.27 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.676 1.59 . . . . 0.0 108.267 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.53 -35.28 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.077 1.351 . . . . 0.0 110.008 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 61.94 163.99 0.11 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 126.679 1.992 . . . . 0.0 112.496 -166.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -63.81 -163.59 0.05 OUTLIER 'Trans proline' 0 CA--C 1.55 1.292 0 C-N-CA 122.41 2.074 . . . . 0.0 110.695 157.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -119.84 18.96 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.384 -1.448 . . . . 0.0 112.842 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -139.34 78.58 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.404 1.482 . . . . 0.0 109.498 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.4 p -65.02 98.19 0.28 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.1 t -160.51 5.56 0.08 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 69.51 0.92 Allowed Glycine 0 CA--C 1.531 1.087 0 CA-C-N 120.165 1.348 . . . . 0.0 113.961 169.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -74.02 74.75 3.4 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.436 3.424 . . . . 0.0 110.361 173.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 m 55.03 47.98 20.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.022 0.929 . . . . 0.0 110.211 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.6 t -160.49 175.86 12.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.949 0.9 . . . . 0.0 109.768 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -174.154 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.2 t -153.15 -173.8 4.71 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.945 0.898 . . . . 0.0 110.156 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.5 t -138.91 119.41 13.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.569 2.348 . . . . 0.0 105.829 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.49 -154.67 14.97 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.1 m -60.55 -16.75 40.75 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 117.944 0.872 . . . . 0.0 112.787 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.8 m -91.89 89.48 7.05 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 162.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.99 -176.35 43.64 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -59.89 172.44 0.75 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.528 0.731 . . . . 0.0 110.394 167.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.78 -72.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.764 -0.585 . . . . 0.0 112.329 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -25.6 46.44 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.026 -1.464 . . . . 0.0 111.295 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -48.7 -40.77 29.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.017 1.28 . . . . 0.0 111.806 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.92 -63.12 1.12 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.242 1.017 . . . . 0.0 111.546 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 120' ' ' LEU . 65.7 t80 -52.8 -36.89 59.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.564 1.075 . . . . 0.0 112.127 -177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.5 m -55.61 -53.94 50.33 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.341 1.056 . . . . 0.0 108.801 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? -65.34 -44.7 86.93 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 123.186 0.594 . . . . 0.0 109.983 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.406 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -42.57 -45.45 4.57 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 126.594 1.957 . . . . 0.0 112.389 171.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.96 8.28 80.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 123.47 0.557 . . . . 0.0 112.705 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.03 -8.38 5.98 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.826 1.251 . . . . 0.0 110.05 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -124.6 108.25 11.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.487 1.915 . . . . 0.0 107.952 -172.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -56.29 -10.03 0.8 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.075 1.75 . . . . 0.0 113.777 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -118.59 1.5 11.68 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.845 2.458 . . . . 0.0 111.561 -169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.48 161.63 24.78 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.538 -1.351 . . . . 0.0 111.056 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -148.23 172.42 14.37 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.246 1.018 . . . . 0.0 111.709 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.72 130.28 39.82 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 125.147 1.379 . . . . 0.0 109.611 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.31 95.66 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.093 1.357 . . . . 0.0 108.364 175.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.04 92.87 3.21 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 121.235 -0.916 . . . . 0.0 108.965 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -77.39 2.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.312 1.445 . . . . 0.0 112.68 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 -59.0 147.86 32.9 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.29 158.71 13.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.631 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 m -65.02 -24.41 67.48 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.235 -0.915 . . . . 0.0 111.775 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 -25.83 63.91 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.224 -0.893 . . . . 0.0 113.069 173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -56.15 -49.94 72.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 124.567 1.147 . . . . 0.0 109.563 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -63.37 -8.26 8.46 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -97.63 -29.53 13.37 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.324 1.05 . . . . 0.0 113.066 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -116.75 -19.38 9.95 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.272 1.429 . . . . 0.0 113.609 -168.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.66 -75.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.2 -153.4 23.38 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.68 153.51 65.03 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 119.161 1.481 . . . . 0.0 111.805 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.75 125.25 10.37 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.945 3.096 . . . . 0.0 111.936 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -86.8 83.27 7.59 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.401 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -91.54 -0.13 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.293 165.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -35.91 75.85 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.93 -18.01 61.6 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 117.693 -1.615 . . . . 0.0 113.778 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -79.11 -31.29 44.16 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.211 2.005 . . . . 0.0 110.522 170.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.22 -41.91 0.21 Allowed Glycine 0 CA--C 1.522 0.501 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.625 -176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 164.8 24.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.331 1.066 . . . . 0.0 111.788 -168.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.24 166.12 24.13 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.478 0.711 . . . . 0.0 110.254 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.39 -175.82 2.05 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.118 1.767 . . . . 0.0 111.013 166.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.4 t -129.01 104.47 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.63 1.972 . . . . 0.0 107.548 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 p -78.67 116.33 18.96 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.9 m -154.4 102.02 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.2 124.79 13.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD22 ' A' ' 89' ' ' LEU . 31.7 t80 -69.34 144.78 53.39 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.11 126.99 14.45 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.279 1.432 . . . . 0.0 108.799 172.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.34 -9.99 66.38 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 118.646 -1.085 . . . . 0.0 113.097 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.58 -47.28 70.26 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.604 1.202 . . . . 0.0 109.492 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -127.51 66.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.509 1.524 . . . . 0.0 109.424 -173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -37.82 -64.15 0.46 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 125.721 1.608 . . . . 0.0 112.694 162.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.18 0.6 7.68 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.589 2.86 . . . . 0.0 114.817 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.45 8.56 55.14 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.122 1.82 . . . . 0.0 113.293 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -114.49 -45.27 3.03 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.78 1.79 . . . . 0.0 111.841 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.1 mt -61.67 -7.31 3.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.812 1.245 . . . . 0.0 112.887 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -8.48 15.89 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 129.367 3.067 . . . . 0.0 113.028 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -109.83 6.44 23.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.175 0.99 . . . . 0.0 111.488 167.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -126.35 5.84 7.0 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 120.11 1.323 . . . . 0.0 112.491 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -113.21 -4.97 13.67 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.037 -1.039 . . . . 0.0 112.957 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 pp -130.5 0.72 4.49 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.584 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -93.11 -11.53 32.69 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 125.895 1.678 . . . . 0.0 113.046 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -135.46 163.75 29.35 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.782 1.233 . . . . 0.0 107.683 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -107.19 -37.54 6.25 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.486 0.314 . . . . 0.0 111.474 -169.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -137.67 68.19 51.8 Favored Pre-proline 0 N--CA 1.449 -0.498 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -63.18 -33.9 70.58 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 121.776 1.651 . . . . 0.0 111.006 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -10.45 21.18 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 128.071 2.548 . . . . 0.0 112.64 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -138.32 -3.81 1.71 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.324 0.65 . . . . 0.0 111.797 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.7 m -74.76 149.49 39.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.608 1.563 . . . . 0.0 109.525 173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.8 m -115.07 97.7 6.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mt -72.09 155.34 40.39 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.83 -0.544 . . . . 0.0 109.577 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -138.51 102.72 4.69 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.912 1.685 . . . . 0.0 106.712 172.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mt -73.09 151.56 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 O-C-N 120.958 -1.089 . . . . 0.0 110.09 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.37 108.56 6.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.228 1.411 . . . . 0.0 108.655 -177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.2 177.51 5.55 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.735 1.614 . . . . 0.0 110.949 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.2 mtmm -67.19 -50.12 62.14 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 119.993 -1.692 . . . . 0.0 112.842 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -148.49 -45.9 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.71 1.595 . . . . 0.0 111.481 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.33 -62.95 0.56 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 123.701 0.8 . . . . 0.0 109.199 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.49 -124.47 14.88 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 172.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -144.72 37.2 1.18 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.702 2.001 . . . . 0.0 108.899 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 p -60.87 -49.34 77.87 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.328 -1.482 . . . . 0.0 110.629 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -59.46 -34.68 72.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.567 1.547 . . . . 0.0 111.46 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.525 HD22 ' CE2' ' A' ' 53' ' ' TYR . 7.7 tt -62.1 -48.64 79.29 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.701 1.601 . . . . 0.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.41 -29.75 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 118.665 -0.683 . . . . 0.0 109.659 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.89 80.1 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -93.95 11.38 29.8 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.347 0.659 . . . . 0.0 111.887 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -102.86 -53.95 2.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.308 -0.87 . . . . 0.0 109.655 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -59.92 -44.03 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.522 0.601 . . . . 0.0 111.103 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.91 -9.91 43.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.098 0.959 . . . . 0.0 112.668 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -106.28 2.17 26.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.137 1.775 . . . . 0.0 110.767 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.14 14.32 4.22 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.516 1.526 . . . . 0.0 111.755 -169.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.66 -16.25 5.11 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-O 118.86 -0.967 . . . . 0.0 113.831 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -87.93 168.78 12.58 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.906 1.353 . . . . 0.0 110.867 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -72.72 -79.88 0.07 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.512 1.125 . . . . 0.0 111.691 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.3 m -146.32 152.16 38.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.243 2.217 . . . . 0.0 105.896 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.99 160.28 43.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 110.071 -171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -134.05 165.48 24.95 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.871 1.268 . . . . 0.0 110.19 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -125.56 164.44 20.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.614 1.166 . . . . 0.0 107.881 166.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.12 118.42 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 168.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -59.16 152.65 19.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.85 7.26 5.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.143 0.977 . . . . 0.0 111.658 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.78 -127.66 7.26 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 127.994 2.711 . . . . 0.0 113.151 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.79 -52.76 4.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.612 1.165 . . . . 0.0 110.422 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.39 -11.7 59.96 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.474 1.909 . . . . 0.0 112.864 -164.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -73.13 161.2 54.3 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.063 -1.023 . . . . 0.0 112.569 -170.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 -11.77 28.93 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.799 2.999 . . . . 0.0 113.425 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -137.11 18.11 2.99 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.802 2.041 . . . . 0.0 110.582 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.74 -169.4 36.06 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -49.35 -54.43 17.26 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.023 1.729 . . . . 0.0 111.513 -174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.9 -31.44 72.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.471 0.709 . . . . 0.0 111.569 -168.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.23 3.61 54.41 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.089 0.956 . . . . 0.0 111.366 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 t -93.95 2.04 56.19 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.945 -1.097 . . . . 0.0 112.508 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.8 t 49.57 84.39 0.04 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.748 1.619 . . . . 0.0 109.73 -157.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 13' ' ' TYR . 51.4 mt -132.76 152.87 80.66 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 125.67 1.588 . . . . 0.0 108.288 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -67.57 156.99 63.83 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.612 1.541 . . . . 0.0 110.54 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -145.61 160.09 42.17 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.997 0.919 . . . . 0.0 109.049 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 66.0 mt -95.07 -32.09 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.763 1.625 . . . . 0.0 110.101 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 61.46 162.41 0.11 Allowed Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.316 1.847 . . . . 0.0 114.043 -168.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -69.24 -172.81 0.56 Allowed 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.409 2.073 . . . . 0.0 110.42 161.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -108.44 18.72 20.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.42 1.488 . . . . 0.0 112.277 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 -169.01 1.73 Allowed 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 125.709 1.604 . . . . 0.0 109.77 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.9 p -131.74 136.52 47.66 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 126.033 1.733 . . . . 0.0 106.764 -176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.0 p -170.78 -169.54 0.79 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.949 0.9 . . . . 0.0 110.547 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.32 48.28 53.0 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -69.24 -3.13 11.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 CA-C-N 121.268 2.534 . . . . 0.0 113.71 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.1 t -135.69 -67.46 0.53 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 169.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -75.58 114.33 14.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.288 0.495 . . . . 0.0 110.955 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 C-N-CA 130.102 3.715 . . . . 0.0 104.666 174.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.703 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -144.47 -41.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.677 1.191 . . . . 0.0 108.841 171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.4 m -59.78 132.25 53.38 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 159.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.44 154.24 7.49 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 m -135.66 41.07 2.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.82 1.248 . . . . 0.0 111.144 -172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.6 m -60.07 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.932 0.872 . . . . 0.0 112.518 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.62 167.74 13.46 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.168 2.318 . . . . 0.0 111.063 -169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 m -57.0 155.98 7.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.201 1.0 . . . . 0.0 110.458 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.05 75.27 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.922 -1.111 . . . . 0.0 113.183 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' CG ' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -65.88 -23.32 66.62 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 117.023 -1.465 . . . . 0.0 112.29 176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -51.36 -50.61 59.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.619 1.554 . . . . 0.0 109.746 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.23 -53.16 48.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.927 0.891 . . . . 0.0 111.514 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -57.41 -41.78 81.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.779 0.718 . . . . 0.0 111.441 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m -55.7 -39.02 70.46 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 121.685 -0.634 . . . . 0.0 111.0 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -84.22 -7.97 59.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.576 1.08 . . . . 0.0 113.74 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD22 HD23 ' A' ' 24' ' ' LEU . 39.8 tp -79.86 -20.92 44.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 120.339 1.427 . . . . 0.0 113.276 -163.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.55 29.63 2.0 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 124.727 1.156 . . . . 0.0 111.399 -175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . 0.254 0.3 OUTLIER -127.9 13.79 6.84 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.44 1.496 . . . . 0.0 108.654 -178.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -134.48 -8.71 2.52 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.092 1.357 . . . . 0.0 112.804 -168.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 57.68 -10.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 129.383 3.073 . . . . 0.0 117.286 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -106.26 -14.89 14.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.82 1.648 . . . . 0.0 112.93 170.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.24 143.12 39.17 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.424 0.556 . . . . 0.0 111.106 -163.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.41 HE21 ' HE2' ' A' ' 46' ' ' LYS . 1.1 mm-40 -136.16 173.66 11.46 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 110.556 -173.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD23 HD22 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -129.83 135.66 48.67 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.997 1.319 . . . . 0.0 110.889 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -123.09 102.27 7.88 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 122.592 1.187 . . . . 0.0 109.569 174.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -79.54 101.11 8.08 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.264 1.425 . . . . 0.0 107.952 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.5 pt -87.86 6.96 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 118.77 -0.634 . . . . 0.0 112.175 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.8 mtm-85 -66.93 150.81 48.69 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.266 0.939 . . . . 0.0 108.98 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 158.72 17.22 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.036 0.934 . . . . 0.0 111.336 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 m -64.81 -23.13 67.14 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.754 -1.217 . . . . 0.0 111.676 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.45 -24.64 66.46 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.122 1.369 . . . . 0.0 113.432 171.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.39 -45.78 91.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.455 1.102 . . . . 0.0 109.928 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -63.42 -0.03 0.8 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.217 1.407 . . . . 0.0 113.649 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -111.96 -21.93 11.32 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.846 2.058 . . . . 0.0 111.889 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -128.44 -21.42 3.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.558 1.143 . . . . 0.0 113.909 -170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.34 -56.76 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.991 2.116 . . . . 0.0 107.643 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.31 -143.1 14.14 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.01 157.91 66.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.51 134.61 24.71 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.617 2.211 . . . . 0.0 110.582 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -91.64 109.71 21.02 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.34 13.41 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 123.419 0.687 . . . . 0.0 110.955 173.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -64.02 -30.18 71.27 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.145 -0.972 . . . . 0.0 110.937 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.26 -22.73 61.26 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.503 1.049 . . . . 0.0 112.532 172.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.5 mt -82.26 -13.43 57.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.901 1.351 . . . . 0.0 111.65 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.91 -23.47 2.61 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.234 0.925 . . . . 0.0 115.18 174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HE2' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -166.91 166.17 15.63 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.499 1.149 . . . . 0.0 109.652 -166.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 175.32 10.75 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.34 0.59 . . . . 0.0 109.558 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.09 136.43 35.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 162.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.2 t -72.74 126.52 33.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 166.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 t -86.38 140.42 30.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.932 1.242 . . . . 0.0 108.386 160.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -153.08 107.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 158.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 t -54.32 132.35 17.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -98.94 132.63 44.11 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.342 1.057 . . . . 0.0 109.476 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -94.51 -69.29 0.76 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.28 -18.88 38.25 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.455 1.502 . . . . 0.0 112.963 -168.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -52.9 -65.48 0.55 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.385 1.874 . . . . 0.0 109.11 162.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -99.14 68.72 1.69 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.579 2.752 . . . . 0.0 110.389 -170.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -49.88 -58.85 8.14 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.705 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.15 -48.56 9.77 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.439 2.092 . . . . 0.0 110.398 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -70.47 25.25 0.47 Allowed Glycine 0 C--O 1.222 -0.641 0 CA-C-O 117.594 -1.67 . . . . 0.0 114.609 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -121.76 -46.42 2.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.753 2.021 . . . . 0.0 108.591 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -57.1 -14.29 3.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.458 1.903 . . . . 0.0 112.348 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -59.52 -7.69 1.55 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 128.115 2.566 . . . . 0.0 113.183 173.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -118.94 -4.23 10.65 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.586 1.154 . . . . 0.0 112.383 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -110.12 -38.74 5.21 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-O 118.309 -0.853 . . . . 0.0 109.061 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.6 -8.24 1.86 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.93 16.95 5.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.848 1.659 . . . . 0.0 112.304 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -119.81 -7.02 10.07 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 126.334 1.854 . . . . 0.0 114.834 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 14.6 m-85 -130.8 141.66 50.36 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -73.14 -61.87 1.67 Allowed 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.74 73.05 4.28 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 124.729 1.212 . . . . 0.0 107.741 -170.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 82.0 Cg_endo -65.53 -32.89 47.96 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.092 1.861 . . . . 0.0 109.408 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -44.29 -32.84 1.41 Allowed 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.247 3.419 . . . . 0.0 113.726 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -130.1 -9.69 4.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.508 1.123 . . . . 0.0 113.759 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -62.68 130.43 44.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.487 1.494 . . . . 0.0 111.604 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.5 m -80.27 113.58 18.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.894 0.878 . . . . 0.0 108.848 159.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.4 160.03 19.18 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 120.235 -1.54 . . . . 0.0 110.831 170.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -133.16 116.83 16.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 171.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.97 144.09 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 118.884 0.765 . . . . 0.0 109.341 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.3 121.62 26.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 125.955 1.702 . . . . 0.0 107.776 176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -114.43 -175.37 2.67 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.006 1.323 . . . . 0.0 111.773 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -66.91 -64.79 0.78 Allowed 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.951 1.701 . . . . 0.0 111.321 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -142.74 -68.85 0.35 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 127.029 2.132 . . . . 0.0 107.541 -170.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.89 -38.35 4.56 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.775 1.23 . . . . 0.0 110.569 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 37.8 -111.16 0.13 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 127.578 2.513 . . . . 0.0 111.542 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -153.88 17.98 0.51 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.461 1.505 . . . . 0.0 110.592 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -48.8 -45.89 40.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.004 0.921 . . . . 0.0 112.648 -163.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -76.88 -14.8 59.85 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.107 1.363 . . . . 0.0 112.656 -175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.08 -54.3 7.39 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 170.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.3 t -59.92 -29.61 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 118.684 -0.675 . . . . 0.0 109.843 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.88 -18.62 60.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.651 1.58 . . . . 0.0 114.354 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -103.81 -30.35 10.43 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.32 1.418 . . . . 0.0 112.683 169.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.2 tp -57.25 -50.78 71.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -170.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.83 -37.22 78.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -26.07 67.66 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.643 1.211 . . . . 0.0 110.827 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mp -83.06 -8.75 59.5 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.607 1.563 . . . . 0.0 112.509 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -122.75 15.44 10.17 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.501 1.12 . . . . 0.0 111.017 -170.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.4 -28.65 2.99 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.474 1.035 . . . . 0.0 114.06 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 34.0 m-85 -76.7 172.12 13.58 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.017 0.908 . . . . 0.0 111.165 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.627 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.4 OUTLIER -73.99 -75.65 0.15 Allowed 'General case' 0 C--N 1.34 0.165 0 CA-C-O 119.479 -0.296 . . . . 0.0 111.247 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.0 m -147.69 156.02 42.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.91 169.6 17.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.492 -0.755 . . . . 0.0 110.609 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -136.08 171.88 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.684 2.394 . . . . 0.0 108.404 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -131.32 169.89 15.38 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.187 1.395 . . . . 0.0 108.806 168.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.54 131.85 70.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 167.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -72.17 157.21 38.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 123.828 0.705 . . . . 0.0 109.117 177.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 67.08 6.26 4.64 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 110.713 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.98 -141.97 23.34 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 125.84 1.686 . . . . 0.0 112.712 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.34 -46.78 9.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.353 1.061 . . . . 0.0 110.577 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -84.79 -13.63 50.56 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.343 1.027 . . . . 0.0 112.985 -165.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.09 157.34 43.31 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.82 0.736 . . . . 0.0 111.873 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.2 -15.35 39.36 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.925 2.417 . . . . 0.0 114.561 -176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -132.95 16.65 4.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.459 1.904 . . . . 0.0 111.549 171.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.0 -171.1 7.0 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.302 0.953 . . . . 0.0 110.798 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -47.35 -53.33 14.03 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.515 1.526 . . . . 0.0 111.81 -173.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.9 mt -53.41 -59.17 4.92 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -79.65 33.02 0.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.775 1.63 . . . . 0.0 112.092 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -123.68 13.37 9.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.685 1.994 . . . . 0.0 111.389 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.7 m 53.46 52.05 14.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.931 1.293 . . . . 0.0 111.243 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.421 HD21 ' CG ' ' A' ' 10' ' ' LYS . 47.1 mt -112.12 156.91 41.2 Favored Pre-proline 0 C--O 1.236 0.377 0 C-N-CA 124.582 1.153 . . . . 0.0 110.886 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.16 146.77 58.65 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.314 2.009 . . . . 0.0 111.856 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -140.01 161.94 36.4 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.563 1.545 . . . . 0.0 109.161 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 79.9 mt -98.49 -32.5 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.17 1.788 . . . . 0.0 110.612 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 65.58 163.18 0.12 Allowed Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.981 2.112 . . . . 0.0 112.695 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.72 -169.96 0.25 Allowed 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.451 2.1 . . . . 0.0 110.551 163.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -60.3 136.91 58.18 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.35 -1.468 . . . . 0.0 110.708 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -61.98 136.11 57.83 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 165.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 41.0 m -136.58 165.23 26.35 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -169.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.7 t -80.31 -70.46 0.52 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.17 84.65 0.21 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -61.26 -46.98 13.21 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.513 1.657 . . . . 0.0 109.652 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.58 35.28 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.679 2.791 . . . . 0.0 112.564 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -147.61 95.12 2.47 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 119.498 -2.001 . . . . 0.0 108.89 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.902 0 N-CA-C 105.332 -3.107 . . . . 0.0 105.332 -161.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.327 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 t -69.34 174.72 4.52 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -121.09 -78.82 0.6 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.068 0.947 . . . . 0.0 108.918 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.89 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.525 0.684 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.9 m -126.23 -2.45 6.96 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.573 1.549 . . . . 0.0 112.803 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -79.29 163.31 25.02 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.9 0.857 . . . . 0.0 109.538 170.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.83 173.6 40.73 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 167.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -58.89 158.41 8.34 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 117.711 0.755 . . . . 0.0 111.723 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.01 -59.65 4.27 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -63.33 -22.14 66.69 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.029 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -45.63 63.2 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.168 1.349 . . . . 0.0 109.592 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.84 -57.43 3.88 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.302 1.441 . . . . 0.0 109.722 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' HD22 ' A' ' 120' ' ' LEU . 71.1 t80 -51.93 -47.53 64.64 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.028 0.931 . . . . 0.0 112.841 -175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.1 m -48.54 -47.98 38.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.778 0.831 . . . . 0.0 111.421 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.51 -33.89 67.23 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.356 0.663 . . . . 0.0 111.321 -174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -23.2 17.47 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.472 1.909 . . . . 0.0 113.084 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.22 25.32 8.32 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.638 1.113 . . . . 0.0 113.457 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.6 t -141.69 -31.11 0.57 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.15 0.98 . . . . 0.0 108.651 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -81.04 112.58 18.56 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 156.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.29 -30.97 70.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.683 0.674 . . . . 0.0 111.458 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -79.69 -19.41 49.04 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.029 0.932 . . . . 0.0 110.876 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.97 154.41 39.48 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.253 0.621 . . . . 0.0 109.857 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -145.36 178.26 8.23 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 111.181 -167.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.21 128.36 39.79 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.664 1.186 . . . . 0.0 110.287 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.543 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -117.95 94.61 4.58 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.372 1.469 . . . . 0.0 109.736 173.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.22 102.26 4.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.345 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -90.25 6.11 4.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 C-N-CA 124.701 1.2 . . . . 0.0 112.008 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -64.89 158.96 23.82 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.984 0.811 . . . . 0.0 109.68 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.98 148.79 10.05 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.406 1.082 . . . . 0.0 110.507 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.6 m -58.04 -36.12 72.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.329 -0.857 . . . . 0.0 111.504 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.41 66.33 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.633 0.773 . . . . 0.0 111.685 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -32.98 74.87 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.679 0.792 . . . . 0.0 109.843 -175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.64 -12.0 59.48 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.222 -0.924 . . . . 0.0 112.373 173.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.17 -40.7 7.85 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.702 1.601 . . . . 0.0 111.195 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -97.72 -27.53 14.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.37 -77.72 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.44 -162.11 26.92 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.421 1.486 . . . . 0.0 110.015 -171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.53 153.34 77.61 Favored Pre-proline 0 N--CA 1.472 0.629 0 CA-C-N 118.744 1.272 . . . . 0.0 111.747 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.48 140.87 27.56 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 124.974 3.783 . . . . 0.0 113.054 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -99.75 83.67 2.79 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.968 0.89 . . . . 0.0 109.798 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 pt -88.16 4.76 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.406 170.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -63.67 -35.77 81.64 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 121.103 -0.998 . . . . 0.0 110.964 -173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -57.12 -29.43 59.63 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 119.324 -0.709 . . . . 0.0 112.608 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.19 -25.42 63.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.379 1.089 . . . . 0.0 112.417 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.48 -32.06 0.7 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.935 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 161.7 20.36 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 119.092 1.446 . . . . 0.0 110.615 -166.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.76 159.61 28.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.17 164.55 20.19 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.997 -0.44 . . . . 0.0 110.447 166.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.66 157.81 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 160.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 p -133.14 120.52 21.33 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.036 1.334 . . . . 0.0 108.775 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -154.22 109.58 3.15 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.4 p -59.87 124.15 13.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 119.294 0.952 . . . . 0.0 109.233 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -72.4 153.17 41.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.716 0.806 . . . . 0.0 109.756 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -149.34 139.86 22.5 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.66 -19.17 77.78 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.361 -1.244 . . . . 0.0 113.97 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.03 -49.98 75.22 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.504 1.652 . . . . 0.0 109.908 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -128.62 73.08 1.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.704 1.202 . . . . 0.0 109.52 -153.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -47.94 -58.59 7.46 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.255 1.022 . . . . 0.0 111.875 170.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -66.63 -19.62 53.86 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.202 1.934 . . . . 0.0 113.571 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.538 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -79.39 0.01 82.0 Favored Glycine 0 C--O 1.222 -0.614 0 O-C-N 120.973 -1.08 . . . . 0.0 112.751 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -117.93 -51.84 2.44 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.561 1.545 . . . . 0.0 110.249 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.3 mt -59.53 -11.18 4.21 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.103 . . . . 0.0 112.681 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -65.04 -11.9 44.42 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.188 1.395 . . . . 0.0 113.2 174.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -98.66 -39.15 8.82 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.557 0.743 . . . . 0.0 110.577 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.45 10.98 4.92 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -163.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.1 t -81.5 -52.25 7.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 120.808 1.64 . . . . 0.0 109.964 154.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.18 11.83 9.12 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.477 -0.764 . . . . 0.0 112.122 -158.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -122.65 -5.48 8.65 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.625 2.37 . . . . 0.0 111.704 -170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 70.3 m-85 -128.9 175.77 8.39 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.321 1.849 . . . . 0.0 109.43 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 pttt -131.79 -24.9 2.14 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -142.41 67.87 20.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.01 -35.33 77.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.608 1.539 . . . . 0.0 111.072 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -67.05 0.38 2.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.688 1.995 . . . . 0.0 113.601 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -133.36 -11.81 2.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.478 1.035 . . . . 0.0 112.92 167.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.59 126.07 27.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.564 1.075 . . . . 0.0 110.428 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.9 m -86.57 86.27 7.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.532 1.533 . . . . 0.0 106.899 165.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.508 HD11 ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -78.53 137.84 38.11 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 120.027 -1.671 . . . . 0.0 110.544 -175.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 103' ' ' TYR . 86.4 m-85 -113.65 116.05 28.85 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -64.86 161.25 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -146.14 113.95 6.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 167.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.95 -177.92 3.5 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.911 1.285 . . . . 0.0 110.488 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -68.54 -44.36 74.72 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 119.85 -1.781 . . . . 0.0 111.266 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.79 -36.33 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -157.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -164.64 -65.97 0.04 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.451 2.3 . . . . 0.0 105.537 -174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 51.41 -127.44 29.95 Favored Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.231 1.872 . . . . 0.0 109.261 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -131.84 41.33 3.28 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.8 p -53.68 -52.33 60.34 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.24 1.416 . . . . 0.0 111.957 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -61.19 -36.26 79.38 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.625 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.99 -56.24 18.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.859 0.864 . . . . 0.0 109.499 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.7 -32.79 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.053 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.16 -11.56 15.1 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 117.338 -1.315 . . . . 0.0 113.932 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -121.88 -11.37 8.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 121.328 1.876 . . . . 0.0 113.978 171.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.45 -39.05 78.01 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.57 -0.706 . . . . 0.0 112.107 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -78.11 -38.88 24.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.899 -169.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.3 -47.7 82.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.497 1.141 . . . . 0.0 108.721 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.4 -2.96 0.55 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 127.231 2.212 . . . . 0.0 113.531 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -125.32 6.1 7.73 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.287 1.435 . . . . 0.0 112.79 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.47 -8.01 4.98 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 120.854 -1.154 . . . . 0.0 113.578 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -85.5 169.64 13.41 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.7 1.25 . . . . 0.0 110.02 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -80.38 -61.12 2.07 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.5 m -148.66 155.98 41.77 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -143.6 162.29 36.3 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 121.206 0.527 . . . . 0.0 110.29 166.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 9.5 m-85 -131.41 161.65 31.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.618 1.567 . . . . 0.0 111.074 -176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -110.22 151.35 27.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.556 1.142 . . . . 0.0 109.102 167.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -98.52 124.84 51.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 163.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -65.75 154.02 40.16 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 67.44 0.85 2.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.833 1.253 . . . . 0.0 113.133 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.0 -142.62 12.88 Favored Glycine 0 C--N 1.342 0.912 0 C-N-CA 127.404 2.431 . . . . 0.0 112.515 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.38 -55.82 4.46 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.386 1.093 . . . . 0.0 110.494 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -80.23 -7.06 58.81 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.491 1.117 . . . . 0.0 112.111 -159.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.55 165.68 13.33 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 121.634 -0.666 . . . . 0.0 113.707 -173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -65.83 -13.14 38.4 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.167 2.578 . . . . 0.0 111.343 166.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -137.87 12.02 2.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.193 2.197 . . . . 0.0 110.847 -168.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.8 -155.15 31.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 124.877 1.227 . . . . 0.0 110.252 -171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.458 ' HA ' HD12 ' A' ' 120' ' ' LEU . 21.3 t-105 -60.01 -51.5 69.37 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.168 -1.195 . . . . 0.0 109.245 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.59 175.56 6.97 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.6 t30 48.56 17.71 0.15 Allowed 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 127.562 2.345 . . . . 0.0 113.897 -170.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.5 m -143.17 30.25 1.42 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.456 2.302 . . . . 0.0 110.909 -167.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t 73.81 -3.86 2.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 127.604 2.362 . . . . 0.0 113.931 169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 115' ' ' TRP . 38.4 mt -76.8 153.41 83.14 Favored Pre-proline 0 C--O 1.235 0.297 0 O-C-N 120.982 -1.074 . . . . 0.0 111.771 -165.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.2 153.53 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.944 1.763 . . . . 0.0 110.899 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -148.3 152.18 36.66 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.359 -173.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -93.93 -44.24 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 C-N-CA 125.1 1.36 . . . . 0.0 110.073 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 4.6 pt-20 66.01 160.79 0.13 Allowed Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.662 1.985 . . . . 0.0 112.795 -178.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 32.3 Cg_endo -73.31 -177.0 2.73 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.245 2.63 . . . . 0.0 110.194 173.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -67.49 171.26 6.32 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.498 -0.751 . . . . 0.0 109.095 168.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -46.79 121.59 3.69 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.26 1.024 . . . . 0.0 110.776 172.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -146.0 164.28 32.58 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.368 1.867 . . . . 0.0 107.391 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -112.04 129.42 56.21 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 158.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -115.71 72.19 0.26 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-O 118.32 -1.266 . . . . 0.0 111.534 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -70.35 1.07 5.18 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.782 2.988 . . . . 0.0 113.143 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.61 4.89 9.54 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.798 1.239 . . . . 0.0 111.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -60.24 151.6 26.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.059 0.845 . . . . 0.0 110.246 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -173.446 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t 75.38 -28.39 0.19 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.023 2.529 . . . . 0.0 114.005 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -54.72 130.84 42.06 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.788 1.176 . . . . 0.0 108.267 165.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.87 5.02 55.42 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.525 1.06 . . . . 0.0 112.769 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.8 m 58.84 29.75 19.2 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.729 1.265 . . . . 0.0 110.673 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -142.29 122.4 13.76 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.991 1.317 . . . . 0.0 109.564 -160.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.91 -165.71 37.02 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 161.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -54.17 167.06 0.32 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 122.297 1.046 . . . . 0.0 110.739 166.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.55 -53.13 25.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.569 1.147 . . . . 0.0 112.576 170.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.405 ' HG2' HD21 ' A' ' 120' ' ' LEU . 5.5 mtpt -64.82 -23.8 67.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.684 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -65.22 -20.23 66.34 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.998 1.272 . . . . 0.0 111.804 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.61 -68.79 0.56 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 164.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.518 ' CE1' HD11 ' A' ' 44' ' ' LEU . 81.3 t80 -57.35 -44.03 83.98 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -167.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.6 m -56.0 -44.17 78.4 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -77.39 -21.63 52.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.964 0.505 . . . . 0.0 111.677 -176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.479 HD22 HD23 ' A' ' 24' ' ' LEU . 55.8 tp -66.34 -20.89 66.21 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.606 1.562 . . . . 0.0 111.428 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.87 -8.57 13.5 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.116 -0.825 . . . . 0.0 112.93 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.81 -25.78 64.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.019 1.41 . . . . 0.0 110.188 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.91 107.78 11.22 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -56.48 -32.53 65.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.587 0.63 . . . . 0.0 112.449 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -65.42 -26.6 68.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.71 1.604 . . . . 0.0 109.328 -172.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 160.56 5.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.068 1.747 . . . . 0.0 111.261 -175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -147.21 173.83 12.17 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.325 1.05 . . . . 0.0 109.8 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD23 HD22 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.69 128.01 43.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.751 1.22 . . . . 0.0 108.064 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -111.95 95.97 5.78 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 125.578 1.551 . . . . 0.0 107.351 177.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -74.96 106.14 6.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -98.4 4.09 10.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.378 1.071 . . . . 0.0 111.949 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 26.3 mtm-85 -65.25 155.42 35.19 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.92 151.31 26.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.024 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m -56.48 -33.25 65.78 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 110.534 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.52 -34.13 68.79 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 128.011 2.525 . . . . 0.0 113.684 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.93 -43.48 98.57 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.227 0.921 . . . . 0.0 108.589 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 3.7 m-85 -61.88 -13.78 27.8 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.518 -0.738 . . . . 0.0 112.925 174.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 29.4 mmm-85 -101.55 -28.05 12.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 117.296 -1.335 . . . . 0.0 111.548 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.65 -44.71 5.74 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.798 1.181 . . . . 0.0 112.093 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.41 -30.49 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.28 1.832 . . . . 0.0 112.597 -173.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.9 -153.7 19.51 Favored Glycine 0 C--N 1.337 0.619 0 O-C-N 120.773 -1.204 . . . . 0.0 110.435 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.6 m -143.53 155.5 60.45 Favored Pre-proline 0 C--O 1.233 0.236 0 O-C-N 120.169 -1.783 . . . . 0.0 110.327 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.87 156.96 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.073 2.515 . . . . 0.0 110.504 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -103.98 141.54 36.0 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 166.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 pt -140.74 10.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.257 1.023 . . . . 0.0 111.54 165.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -59.17 -45.74 90.21 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.45 -159.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.45 -12.23 63.4 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.402 -1.221 . . . . 0.0 113.396 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 13' ' ' TYR . 48.0 mt -72.37 -10.17 59.45 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.793 1.796 . . . . 0.0 111.742 169.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.12 -24.58 0.79 Allowed Glycine 0 C--N 1.339 0.718 0 CA-C-N 120.13 1.332 . . . . 0.0 113.832 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.36 162.76 0.39 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -158.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.29 146.72 25.83 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.745 1.218 . . . . 0.0 108.129 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.5 156.37 6.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 123.518 0.511 . . . . 0.0 110.887 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -77.72 155.52 5.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 163.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.8 p -120.89 123.73 43.23 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.042 1.337 . . . . 0.0 107.64 169.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.2 m -154.59 108.04 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 171.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 t -61.38 120.69 7.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -72.24 143.3 48.85 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.319 0.58 . . . . 0.0 109.813 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.25 133.56 35.21 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.685 1.594 . . . . 0.0 106.904 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.71 0.48 89.18 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-O 118.65 -1.084 . . . . 0.0 113.606 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -82.23 -83.2 0.13 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.381 1.472 . . . . 0.0 107.762 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -82.34 78.29 9.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.994 0.917 . . . . 0.0 109.994 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -45.06 -61.05 2.52 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.566 1.146 . . . . 0.0 111.925 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.74 -32.9 28.99 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.258 1.972 . . . . 0.0 111.545 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -71.08 0.95 27.86 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-O 119.031 -0.871 . . . . 0.0 114.07 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -106.82 -48.38 3.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.196 1.399 . . . . 0.0 110.136 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.0 mt -56.55 -24.21 45.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.183 0.593 . . . . 0.0 112.265 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -57.13 -26.1 59.94 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.17 0.988 . . . . 0.0 112.387 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -75.38 -39.73 58.81 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -62.16 -43.71 98.23 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.346 0.658 . . . . 0.0 109.264 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -54.71 -16.33 2.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 pp -122.91 -4.38 8.58 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.718 1.207 . . . . 0.0 113.552 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -94.64 -12.18 27.88 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 117.844 -1.074 . . . . 0.0 112.103 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.0 m-85 -115.98 177.03 4.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.189 0.996 . . . . 0.0 108.899 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -128.94 -32.41 2.08 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.14 0.976 . . . . 0.0 111.666 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -146.68 60.85 6.28 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 124.329 1.052 . . . . 0.0 109.433 -171.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 54.6 Cg_endo -65.45 -31.74 50.97 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.706 2.271 . . . . 0.0 111.367 -169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -63.49 -4.81 3.07 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.723 1.609 . . . . 0.0 114.45 -176.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.52 4.02 1.16 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.471 -0.768 . . . . 0.0 112.82 165.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 1.3 m -72.1 112.06 7.86 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -78.99 99.0 6.66 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.56 134.83 34.39 Favored 'General case' 0 CA--C 1.518 -0.257 0 O-C-N 121.465 -0.772 . . . . 0.0 110.691 -170.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -111.14 105.63 14.41 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.81 146.33 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 O-C-N 121.48 -0.762 . . . . 0.0 109.861 173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.12 113.99 12.65 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.71 1.604 . . . . 0.0 109.17 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.58 174.23 5.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.434 1.893 . . . . 0.0 111.207 175.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 28' ' ' ARG . 62.6 mtpt -62.03 -48.37 80.57 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 126.013 1.725 . . . . 0.0 112.807 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -160.1 -36.51 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 121.403 1.911 . . . . 0.0 112.672 -163.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -159.1 -66.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.76 -110.71 0.57 Allowed Glycine 0 C--N 1.337 0.62 0 C-N-CA 126.122 1.82 . . . . 0.0 110.469 168.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -159.48 23.63 0.19 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.406 1.082 . . . . 0.0 111.268 -174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 p -54.6 -39.42 67.85 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.149 -1.595 . . . . 0.0 112.007 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -69.25 -31.15 69.5 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.324 0.511 . . . . 0.0 111.611 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.22 -51.09 63.12 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.5 -32.71 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 O-C-N 121.195 -0.941 . . . . 0.0 109.782 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.1 -24.41 67.89 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.074 0.95 . . . . 0.0 111.861 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.59 7.44 39.99 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.813 1.188 . . . . 0.0 112.114 175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.9 -55.17 2.42 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.22 -0.925 . . . . 0.0 110.529 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.64 -40.11 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 O-C-N 121.629 -0.669 . . . . 0.0 111.427 -173.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -10.37 24.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.163 1.385 . . . . 0.0 113.267 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.38 1.09 15.87 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.381 2.272 . . . . 0.0 110.879 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -134.89 12.48 3.65 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.21 1.404 . . . . 0.0 112.49 -167.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.41 -3.63 3.99 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 118.584 -1.12 . . . . 0.0 113.817 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -107.75 177.0 4.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.711 1.256 . . . . 0.0 109.115 172.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -97.42 -57.1 2.33 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.478 1.111 . . . . 0.0 113.125 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.9 m -149.41 139.17 21.81 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.117 1.367 . . . . 0.0 108.552 -171.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.62 161.13 36.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.193 0.597 . . . . 0.0 110.875 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.66 155.93 43.13 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 126.755 2.022 . . . . 0.0 108.789 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.4 164.22 14.24 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.182 0.993 . . . . 0.0 109.902 166.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.19 118.33 58.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.19 148.41 51.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.261 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.32 8.55 2.81 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.121 2.168 . . . . 0.0 112.855 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.23 -109.61 0.81 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 124.91 1.243 . . . . 0.0 114.136 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.61 -56.02 1.4 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 108.249 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -86.68 29.86 0.77 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.891 1.676 . . . . 0.0 111.311 -174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.06 153.04 17.59 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 170.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.66 -13.18 28.5 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.746 2.964 . . . . 0.0 114.315 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -120.11 5.49 10.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 117.697 -1.144 . . . . 0.0 111.843 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 -157.49 9.91 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.562 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.9 t-105 -60.93 -53.4 57.76 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.238 1.015 . . . . 0.0 110.69 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.6 mt -66.13 154.69 38.98 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 170.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.4 t30 63.27 -5.62 0.23 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 128.537 2.735 . . . . 0.0 114.011 -174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -85.95 7.16 25.37 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.593 1.557 . . . . 0.0 111.366 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.24 28.57 9.95 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 125.246 1.418 . . . . 0.0 111.393 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 115' ' ' TRP . 40.6 mt -84.96 158.29 59.03 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 110.589 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.91 146.89 54.21 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -135.0 152.25 51.56 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.734 1.614 . . . . 0.0 107.778 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.3 mt -87.16 -29.74 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.203 1.401 . . . . 0.0 110.257 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 62.61 155.76 0.12 Allowed Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.922 2.489 . . . . 0.0 114.476 -170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -75.47 -177.23 3.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.21 2.606 . . . . 0.0 108.787 171.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -110.68 20.61 17.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.3 1.04 . . . . 0.0 111.621 -167.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.08 9.74 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.586 1.955 . . . . 0.0 109.537 170.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -131.68 1.32 4.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.189 0.996 . . . . 0.0 111.572 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -84.81 98.31 10.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.14 48.44 0.53 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.959 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.18 7.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.838 2.358 . . . . 0.0 113.879 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.7 p -142.56 12.99 1.93 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.69 1.596 . . . . 0.0 111.987 -171.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -50.27 74.62 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.824 0.738 . . . . 0.0 110.977 -171.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.391 -1.783 . . . . 0.0 110.739 -172.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 t -163.39 -178.27 5.8 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.005 0.907 . . . . 0.0 109.451 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 p -117.2 -6.9 11.31 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.798 2.439 . . . . 0.0 111.03 163.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.97 88.71 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -169.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -145.53 168.55 20.33 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.038 0.935 . . . . 0.0 108.818 166.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 p -55.8 161.97 1.97 Allowed 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.85 1.66 . . . . 0.0 112.713 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.11 159.8 17.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.2 m -60.94 162.23 7.24 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.519 0.728 . . . . 0.0 109.045 163.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.94 -54.4 47.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 117.495 -1.241 . . . . 0.0 114.238 -165.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -60.31 -18.94 53.05 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 116.377 -1.773 . . . . 0.0 113.086 176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -46.77 -49.0 20.44 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 121.056 1.753 . . . . 0.0 110.198 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.35 2.1 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 123.924 0.765 . . . . 0.0 111.843 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.528 ' CE1' HD11 ' A' ' 44' ' ' LEU . 54.1 t80 -54.14 -43.05 70.19 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.269 1.395 . . . . 0.0 112.311 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.3 m -53.48 -48.53 68.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 122.902 0.481 . . . . 0.0 109.74 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -63.88 -54.06 40.72 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 117.056 -1.45 . . . . 0.0 109.584 176.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' LEU . 7.0 mp -45.22 -45.83 11.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.414 1.461 . . . . 0.0 111.395 -177.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.04 6.67 78.32 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 114.459 0.544 . . . . 0.0 114.459 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.07 0.26 4.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.779 1.232 . . . . 0.0 109.627 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -135.24 96.2 3.44 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 126.551 1.941 . . . . 0.0 107.901 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -25.95 65.51 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.396 0.678 . . . . 0.0 110.854 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -81.94 -14.04 56.66 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.363 1.065 . . . . 0.0 111.025 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.99 164.17 26.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.768 0.713 . . . . 0.0 110.079 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -148.78 173.47 13.23 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.337 1.455 . . . . 0.0 110.293 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD11 ' HB2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -126.3 130.96 51.88 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.719 1.208 . . . . 0.0 108.475 173.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -113.36 96.61 5.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 171.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.39 99.32 2.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.5 pt -88.75 3.02 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -61.7 155.41 22.78 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.472 0.653 . . . . 0.0 110.009 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.84 152.8 6.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.575 1.15 . . . . 0.0 110.718 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 m -60.22 -37.33 79.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.196 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -37.08 76.31 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.458 1.103 . . . . 0.0 112.145 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.77 -29.14 69.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.742 -173.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -69.72 -17.56 63.47 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.416 -1.428 . . . . 0.0 111.707 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -84.4 -34.93 23.44 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.336 1.054 . . . . 0.0 110.752 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -114.11 -28.21 7.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.509 1.123 . . . . 0.0 112.247 -166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.52 -45.68 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.329 1.452 . . . . 0.0 108.857 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.84 -161.5 13.17 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -172.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.88 163.99 46.09 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.658 1.183 . . . . 0.0 110.342 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.01 122.5 9.11 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.683 2.922 . . . . 0.0 112.775 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -83.17 79.56 9.34 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.724 1.21 . . . . 0.0 110.687 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 pt -102.29 6.55 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.158 0.983 . . . . 0.0 113.077 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -53.6 -43.45 68.63 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.642 0.777 . . . . 0.0 110.56 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -13.82 59.05 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.21 0.909 . . . . 0.0 114.473 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.528 HD11 ' CE1' ' A' ' 13' ' ' TYR . 32.4 mt -83.24 -11.39 57.84 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.061 1.43 . . . . 0.0 110.672 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.68 -22.43 1.49 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-O 118.79 -1.005 . . . . 0.0 114.67 170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.34 164.64 1.74 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.57 1.548 . . . . 0.0 109.29 -171.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -83.57 162.86 20.71 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 123.727 0.811 . . . . 0.0 109.855 -178.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.95 157.98 30.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.13 0.572 . . . . 0.0 111.001 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.0 t -99.47 113.89 35.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 124.942 1.297 . . . . 0.0 107.848 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 p -83.82 118.87 24.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -152.68 105.39 2.97 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 165.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.1 p -57.35 128.72 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.504 0.593 . . . . 0.0 110.444 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CZ ' ' HA2' ' A' ' 55' ' ' GLY . 23.2 t80 -75.79 151.76 37.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.752 0.821 . . . . 0.0 109.462 173.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -131.89 -3.91 3.61 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA2' ' CZ ' ' A' ' 53' ' ' TYR . . . 78.75 -69.48 2.85 Favored Glycine 0 N--CA 1.464 0.551 0 CA-C-N 120.558 1.526 . . . . 0.0 111.391 175.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -43.22 -66.01 0.42 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.504 2.322 . . . . 0.0 110.396 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.63 63.93 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.44 1.496 . . . . 0.0 109.401 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -46.26 -56.48 10.72 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.623 -1.298 . . . . 0.0 111.196 161.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.2 -49.7 5.87 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.371 2.047 . . . . 0.0 111.205 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.8 36.75 0.88 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.616 1.579 . . . . 0.0 113.22 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -142.75 -56.26 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.136 1.775 . . . . 0.0 106.931 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.8 mt -52.13 -25.58 9.24 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.845 1.258 . . . . 0.0 112.22 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -28.99 68.85 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 112.572 178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp -78.36 -28.04 47.03 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 119.347 -0.358 . . . . 0.0 110.286 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 mp -73.92 -36.26 64.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.407 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -63.6 -1.67 1.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -140.01 15.77 2.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.598 1.559 . . . . 0.0 111.971 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -111.6 -14.09 13.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.232 1.413 . . . . 0.0 112.415 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.408 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 48.1 m-85 -119.76 168.28 11.23 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.554 1.07 . . . . 0.0 109.869 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . 0.348 0.0 OUTLIER -109.61 -42.61 4.26 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -135.57 71.88 64.75 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -66.58 -40.97 12.37 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.44 1.427 . . . . 0.0 110.311 -172.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -56.8 -18.27 12.21 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.265 1.826 . . . . 0.0 113.559 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -118.56 -19.19 8.86 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.039 . . . . 0.0 111.871 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.0 m -60.65 129.19 40.29 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.308 -0.87 . . . . 0.0 110.271 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -88.53 98.39 11.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 167.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.63 154.63 41.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.993 -1.067 . . . . 0.0 108.84 176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -130.04 105.63 8.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 mt -67.51 162.6 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 120.527 -1.358 . . . . 0.0 108.891 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HB2' HD11 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -144.52 102.48 3.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.998 1.319 . . . . 0.0 108.136 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.88 -178.9 7.28 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.847 1.659 . . . . 0.0 110.377 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -89.19 -72.03 0.57 Allowed 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 120.121 -1.612 . . . . 0.0 109.816 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -78.1 0.59 Allowed 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.334 1.021 . . . . 0.0 109.25 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -113.25 -70.74 0.79 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.52 -141.29 34.99 Favored Glycine 0 N--CA 1.437 -1.264 0 CA-C-O 122.256 0.92 . . . . 0.0 113.042 159.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -141.09 12.55 2.21 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.229 1.812 . . . . 0.0 111.341 -167.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.467 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.7 OUTLIER -35.68 -55.8 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.938 2.095 . . . . 0.0 112.547 173.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -70.65 -19.28 62.82 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.26 1.424 . . . . 0.0 111.568 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.97 -48.24 13.69 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.482 1.513 . . . . 0.0 108.847 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -60.83 -36.7 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.39 -8.71 34.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.954 1.302 . . . . 0.0 112.232 -176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -116.08 11.39 15.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.86 1.264 . . . . 0.0 112.017 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.9 tp -106.02 -57.29 2.07 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.507 -0.745 . . . . 0.0 109.669 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.7 m -55.79 -43.47 74.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.046 0.385 . . . . 0.0 110.927 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.8 -13.16 54.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.64 1.176 . . . . 0.0 113.323 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.28 -15.36 14.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.17 1.388 . . . . 0.0 110.321 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -111.24 17.58 20.13 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.178 1.791 . . . . 0.0 110.93 -170.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.98 2.87 9.19 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.309 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -103.48 171.62 7.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 119.162 1.481 . . . . 0.0 109.825 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -75.56 -78.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.847 0.749 . . . . 0.0 112.834 -175.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.4 m -142.24 144.61 33.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.831 2.053 . . . . 0.0 106.409 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -132.75 166.72 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.76 0.79 . . . . 0.0 110.898 -171.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -141.85 157.67 44.72 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 128.212 2.605 . . . . 0.0 110.159 -166.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' A' ' 87' ' ' SER . . . -128.96 153.95 47.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.831 1.252 . . . . 0.0 109.148 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -107.34 125.82 63.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.5 tttp -69.81 156.53 38.9 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.654 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 50.99 10.52 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.13 -119.36 6.91 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.4 1.0 . . . . 0.0 112.161 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.17 -47.69 4.45 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.119 1.368 . . . . 0.0 111.369 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.69 -18.33 24.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.063 1.345 . . . . 0.0 112.718 -163.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.69 165.93 40.16 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 118.934 0.788 . . . . 0.0 111.994 -173.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.7 -15.46 50.24 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.723 2.282 . . . . 0.0 113.491 -169.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -134.43 26.3 3.77 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.476 1.11 . . . . 0.0 111.917 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.88 -172.08 35.62 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.527 1.06 . . . . 0.0 110.573 173.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -48.2 -53.36 17.19 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.243 1.817 . . . . 0.0 112.287 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.25 -38.57 87.15 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.61 0.641 . . . . 0.0 109.969 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -80.7 1.87 28.36 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.321 1.048 . . . . 0.0 113.289 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.8 t -95.08 1.86 55.07 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.375 1.47 . . . . 0.0 112.372 -175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 57.43 2.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.952 0.901 . . . . 0.0 109.727 -171.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.408 HD22 ' CG ' ' A' ' 13' ' ' TYR . 65.3 mt -122.27 159.04 53.96 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 126.587 1.955 . . . . 0.0 109.45 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -69.95 166.97 26.06 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.648 2.232 . . . . 0.0 111.662 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -145.96 163.6 34.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.862 1.265 . . . . 0.0 110.199 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 47' ' ' LYS . 70.5 mt -93.62 -37.44 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 123.844 0.858 . . . . 0.0 109.665 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 60.6 159.75 0.11 Allowed Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.869 2.068 . . . . 0.0 113.343 -167.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -70.35 -173.54 0.82 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.299 2.0 . . . . 0.0 111.264 164.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . 0.263 0.1 OUTLIER -113.06 10.39 18.75 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.35 1.46 . . . . 0.0 112.472 -169.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -126.66 167.5 15.62 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 125.701 1.6 . . . . 0.0 108.51 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -140.55 128.64 22.17 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -175.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.77 160.89 36.82 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.46 -0.775 . . . . 0.0 110.366 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 34.71 65.8 0.36 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 127.506 2.479 . . . . 0.0 114.178 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.44 -0.66 6.96 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.63 2.887 . . . . 0.0 115.732 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.8 m -146.67 33.97 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.469 1.108 . . . . 0.0 109.681 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 36.3 m -118.93 4.76 11.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.227 1.011 . . . . 0.0 112.751 -166.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-N 119.672 1.123 . . . . 0.0 110.338 177.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.687 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -162.36 -168.68 1.92 Allowed 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 t -148.72 -171.84 3.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.785 1.234 . . . . 0.0 108.05 162.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.4 -51.62 0.7 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.852 1.215 . . . . 0.0 111.432 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.3 p -131.06 -3.02 3.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -168.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 m -82.12 94.58 7.26 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 120.942 -1.099 . . . . 0.0 112.369 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.09 -176.59 46.37 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.7 m -60.91 164.15 5.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.929 1.292 . . . . 0.0 110.534 173.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.87 36.03 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' HE3' HD21 ' A' ' 120' ' ' LEU . 3.6 mtpt -58.27 -30.4 66.56 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 117.706 -1.14 . . . . 0.0 110.889 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.4 -29.66 69.1 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 120.09 1.314 . . . . 0.0 111.712 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.76 -61.87 1.78 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.451 0.569 . . . . 0.0 109.545 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 44' ' ' LEU . 77.8 t80 -57.33 -43.29 83.23 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -51.26 -34.93 34.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.392 176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -100.87 -4.91 26.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.385 0.993 . . . . 0.0 113.103 -171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.4 -26.62 61.94 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 126.33 1.852 . . . . 0.0 110.548 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.54 36.37 3.04 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 126.018 1.77 . . . . 0.0 111.501 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.1 p -125.3 2.67 7.79 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.705 1.202 . . . . 0.0 112.224 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -129.04 -17.27 3.93 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t0 54.97 -37.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 1 C-N-CA 133.681 4.792 . . . . 0.0 115.822 -171.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -65.06 -26.83 68.41 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.58 1.152 . . . . 0.0 110.406 171.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.09 14.28 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.89 1.676 . . . . 0.0 111.961 -178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.02 171.24 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.438 1.095 . . . . 0.0 112.252 -168.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.27 119.7 16.92 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.373 1.069 . . . . 0.0 110.437 -175.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -111.42 96.0 5.85 Favored 'General case' 0 CA--C 1.513 -0.461 0 C-N-CA 125.202 1.401 . . . . 0.0 107.46 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -74.0 104.39 4.83 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.419 -1.264 . . . . 0.0 107.753 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.9 pt -88.97 4.27 5.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.463 -178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtm-85 -66.91 151.8 46.9 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.36 0.982 . . . . 0.0 109.921 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.87 142.93 3.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.808 1.643 . . . . 0.0 110.405 172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 m -61.28 -23.17 65.49 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.771 -0.581 . . . . 0.0 112.227 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.94 -16.91 63.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.53 -46.49 72.65 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 119.276 0.943 . . . . 0.0 110.066 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -62.58 0.1 0.54 Allowed 'General case' 0 C--O 1.239 0.515 0 C-N-CA 126.219 1.808 . . . . 0.0 113.239 175.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.5 mmm-85 -113.79 -27.25 7.85 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.267 1.827 . . . . 0.0 111.873 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -103.69 -76.26 0.59 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.765 0.826 . . . . 0.0 110.037 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.94 -55.21 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.5 1.12 . . . . 0.0 112.273 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 127.42 -141.21 12.44 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 120.9 -1.125 . . . . 0.0 111.079 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.8 156.05 65.98 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.836 171.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.37 143.48 63.96 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.31 2.674 . . . . 0.0 110.321 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -91.31 114.08 26.52 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -130.84 5.08 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.503 0.721 . . . . 0.0 110.861 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -39.1 85.43 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.923 -0.486 . . . . 0.0 110.628 -168.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.61 56.15 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 117.453 -1.749 . . . . 0.0 113.901 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 13' ' ' TYR . 69.1 mt -70.92 -24.95 62.56 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.333 2.066 . . . . 0.0 111.748 177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 157.4 -19.69 0.39 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-O 117.609 -1.662 . . . . 0.0 115.862 -177.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.0 160.41 1.07 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.093 1.447 . . . . 0.0 109.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.3 158.57 33.77 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.62 143.39 57.87 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 164.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.5 t -70.58 165.17 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 p -142.58 103.79 4.28 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 122.133 0.968 . . . . 0.0 109.643 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.7 m -149.86 102.38 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.06 127.82 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -69.54 134.21 48.58 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -132.64 92.09 3.01 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.67 15.87 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.862 -0.966 . . . . 0.0 113.309 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -41.0 -50.45 3.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.286 1.834 . . . . 0.0 112.264 166.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -143.83 86.44 1.87 Allowed 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -161.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -46.18 -58.27 6.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.15 -38.75 34.52 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.771 1.647 . . . . 0.0 110.588 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.69 16.33 0.41 Allowed Glycine 0 C--N 1.339 0.713 0 C-N-CA 126.132 1.825 . . . . 0.0 115.703 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -125.55 -51.47 1.61 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.181 1.392 . . . . 0.0 107.389 168.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 59.6 mt -51.21 -27.32 8.68 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.97 1.308 . . . . 0.0 112.193 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.446 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.81 -24.66 52.37 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.728 1.211 . . . . 0.0 112.847 177.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -84.33 -27.83 27.49 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.989 0.813 . . . . 0.0 111.112 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.99 -38.46 66.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 118.679 -0.677 . . . . 0.0 109.663 -174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.11 1.25 2.12 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -169.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.29 2.64 6.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.641 1.976 . . . . 0.0 112.425 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -111.59 -9.37 14.17 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.314 1.445 . . . . 0.0 112.364 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -126.72 166.18 17.87 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.752 1.221 . . . . 0.0 110.576 -174.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -37.98 3.6 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.87 0.868 . . . . 0.0 112.423 -168.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -145.65 65.29 11.16 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 125.386 1.474 . . . . 0.0 107.795 -173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.38 -36.67 86.21 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.47 1.447 . . . . 0.0 110.199 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.46 -7.86 7.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.485 1.514 . . . . 0.0 113.982 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -124.24 -13.25 7.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.835 1.652 . . . . 0.0 111.938 172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -71.02 123.35 21.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.375 1.07 . . . . 0.0 110.488 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.6 m -73.19 111.44 8.31 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.3 145.85 30.69 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.381 168.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -118.36 109.33 16.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.9 mp -74.45 144.04 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.89 116.72 15.07 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.999 1.32 . . . . 0.0 107.824 176.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.18 178.97 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.248 1.419 . . . . 0.0 111.349 178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -62.56 -43.91 97.63 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 120.425 -1.422 . . . . 0.0 111.523 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -159.34 -42.13 0.05 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 120.35 1.432 . . . . 0.0 112.136 -163.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -160.35 -59.09 0.06 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.223 1.409 . . . . 0.0 108.1 -173.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.82 -105.85 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 125.926 1.726 . . . . 0.0 110.948 169.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -148.63 24.38 0.98 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 109.685 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.1 p -52.67 -40.4 62.84 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 119.817 1.19 . . . . 0.0 112.262 -168.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -64.89 -43.48 92.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.107 0.963 . . . . 0.0 111.278 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -53.95 -49.76 67.99 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.316 1.046 . . . . 0.0 109.249 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.36 -29.23 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 O-C-N 121.864 -0.522 . . . . 0.0 110.323 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.6 -24.97 67.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.915 1.286 . . . . 0.0 112.267 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.84 4.64 40.5 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.477 -0.764 . . . . 0.0 112.163 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.1 tp -104.05 -51.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.765 0.826 . . . . 0.0 111.512 -172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.9 m -59.65 -35.23 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.154 0.888 . . . . 0.0 111.642 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.03 -33.98 67.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.584 1.154 . . . . 0.0 111.453 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.5 mp -87.37 -4.49 59.04 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 120.805 -1.185 . . . . 0.0 111.049 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -119.82 15.65 12.62 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.035 1.334 . . . . 0.0 112.093 -172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.25 -11.97 5.81 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-O 118.616 -1.102 . . . . 0.0 113.26 170.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -90.69 169.21 11.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 118.912 1.356 . . . . 0.0 112.054 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.663 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -70.46 -68.8 0.4 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.975 174.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -150.76 162.82 39.99 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.71 2.004 . . . . 0.0 108.071 -167.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.39 171.0 17.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 112.747 169.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -137.81 156.11 48.29 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.749 2.019 . . . . 0.0 109.778 -171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -116.03 160.35 20.42 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.315 1.446 . . . . 0.0 109.671 168.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.35 127.67 71.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -65.09 153.48 40.68 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 62.89 9.4 3.67 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.912 1.285 . . . . 0.0 111.443 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 37.56 -126.21 1.32 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 127.767 2.603 . . . . 0.0 112.513 -177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.56 6.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.488 1.115 . . . . 0.0 111.046 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -92.82 -6.62 48.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.219 1.808 . . . . 0.0 113.429 -160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.95 172.47 55.28 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.185 1.374 . . . . 0.0 112.97 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -66.05 -15.66 49.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.251 2.634 . . . . 0.0 114.479 -168.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 29.9 mtt180 -141.71 30.13 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.15 1.78 . . . . 0.0 109.579 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.86 -171.75 9.23 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HA ' HD12 ' A' ' 120' ' ' LEU . 12.8 t-105 -50.46 -59.52 3.93 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.888 1.675 . . . . 0.0 110.464 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.3 mt -56.65 -48.62 77.16 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.672 1.189 . . . . 0.0 109.606 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -65.29 1.71 1.01 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.051 1.74 . . . . 0.0 114.234 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.3 m -126.09 25.08 6.8 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.085 1.311 . . . . 0.0 113.45 -171.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.49 9.36 7.24 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.831 1.252 . . . . 0.0 112.664 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 115' ' ' TRP . 31.1 mt -71.02 156.53 91.9 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.844 0.858 . . . . 0.0 110.422 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.18 153.06 75.56 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.196 3.264 . . . . 0.0 112.612 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.401 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 25.7 t-105 -140.68 168.57 19.47 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 48.8 mt -113.63 -43.01 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.993 1.317 . . . . 0.0 110.693 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.488 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.284 0.0 OUTLIER 65.19 167.73 0.11 Allowed Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.952 1.701 . . . . 0.0 112.449 -176.494 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 74.4 Cg_endo -66.16 -161.34 0.05 OUTLIER 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.03 2.487 . . . . 0.0 111.392 166.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -104.48 19.05 21.01 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.299 -1.501 . . . . 0.0 112.257 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -144.19 94.57 2.59 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.367 0.667 . . . . 0.0 109.475 173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.49 105.9 0.34 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.859 1.664 . . . . 0.0 108.243 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.8 m -98.98 -165.67 1.26 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.031 1.332 . . . . 0.0 109.648 -174.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.39 81.41 0.09 OUTLIER Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.818 -0.99 . . . . 0.0 111.08 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -81.14 86.53 1.61 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 124.642 3.561 . . . . 0.0 109.867 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.8 m 46.43 40.34 7.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.91 0.884 . . . . 0.0 111.711 -172.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.7 p -71.96 157.61 37.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.367 -0.833 . . . . 0.0 110.784 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 106.721 -2.552 . . . . 0.0 106.721 -177.557 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.642 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.3 m -59.33 157.96 10.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.892 1.277 . . . . 0.0 111.761 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -126.15 1.62 7.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.839 1.655 . . . . 0.0 112.866 -174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.63 -168.32 46.45 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.953 1.263 . . . . 0.0 114.42 167.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.8 -46.74 1.04 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.739 1.615 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 1.6 p -60.68 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 126.838 2.055 . . . . 0.0 110.898 172.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.5 171.93 12.67 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 126.954 2.216 . . . . 0.0 108.62 -171.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 t -59.46 167.26 1.99 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 122.584 1.183 . . . . 0.0 110.902 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.83 -58.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.234 168.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -64.9 -38.58 91.43 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.007 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -43.74 -50.09 7.76 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.42 -56.71 11.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.878 0.471 . . . . 0.0 110.613 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' CG ' HD22 ' A' ' 120' ' ' LEU . 74.1 t80 -55.42 -37.82 68.16 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 123.499 0.72 . . . . 0.0 112.557 178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.0 m -52.08 -55.22 22.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -60.82 -38.07 84.15 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.107 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 44' ' ' LEU . 9.2 mp -54.94 -28.29 50.0 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.54 1.518 . . . . 0.0 112.722 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.05 6.4 66.58 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-O 117.713 -1.604 . . . . 0.0 114.715 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -110.55 -16.41 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.31 1.555 . . . . 0.0 110.909 172.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -142.42 100.45 3.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.391 1.076 . . . . 0.0 108.251 -155.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.01 -22.22 36.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.066 0.947 . . . . 0.0 112.35 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -86.02 -11.04 53.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.634 1.574 . . . . 0.0 111.947 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.53 151.72 39.44 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -140.66 174.34 10.61 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 120.663 -1.273 . . . . 0.0 112.359 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.85 120.0 14.62 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.657 0.783 . . . . 0.0 110.658 -175.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -112.99 101.25 9.29 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -84.77 93.57 8.5 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 126.098 1.759 . . . . 0.0 106.687 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -87.75 1.05 6.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 123.927 0.891 . . . . 0.0 111.889 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.5 mtm180 -62.57 152.86 33.74 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.405 0.548 . . . . 0.0 109.68 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.39 159.85 30.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.037 0.446 . . . . 0.0 111.452 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.3 m -59.08 -31.54 68.98 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.829 -0.545 . . . . 0.0 111.365 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.55 -22.01 61.81 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.93 -24.81 43.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.875 0.761 . . . . 0.0 110.889 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -65.87 -19.83 66.02 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.825 -1.172 . . . . 0.0 111.184 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -90.81 -32.17 16.2 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.126 0.57 . . . . 0.0 111.683 -177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -119.54 -7.99 10.05 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.882 1.273 . . . . 0.0 113.336 -163.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -124.86 -38.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.358 1.463 . . . . 0.0 110.242 165.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.34 14.76 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 120.223 -1.548 . . . . 0.0 110.303 -174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.07 153.78 79.84 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 118.367 1.084 . . . . 0.0 111.67 -176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.82 141.28 33.43 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 124.229 3.286 . . . . 0.0 112.167 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -99.32 79.65 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.883 0.849 . . . . 0.0 111.029 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -87.27 -0.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -63.15 -37.19 86.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.581 1.082 . . . . 0.0 111.883 -167.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.31 -9.35 35.9 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.228 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.544 HD13 ' HB3' ' A' ' 16' ' ' LEU . 22.8 mt -87.29 -12.87 45.29 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.749 1.775 . . . . 0.0 110.586 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.98 -32.12 1.43 Allowed Glycine 0 C--N 1.341 0.819 0 CA-C-N 119.839 1.199 . . . . 0.0 114.768 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.58 164.92 5.54 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 119.85 1.825 . . . . 0.0 108.412 -176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 23.8 tptp -81.23 166.6 20.43 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.147 0.499 . . . . 0.0 109.935 177.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.35 149.9 47.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.86 165.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.9 t -79.41 131.96 33.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 158.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.0 p -101.44 131.8 47.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 m -158.94 112.87 2.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.7 121.62 10.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 42.3 t80 -66.72 145.68 55.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -134.7 116.6 15.09 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 126.034 1.734 . . . . 0.0 108.685 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.64 -14.02 81.58 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.86 167.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -59.55 -41.62 90.5 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.21 1.505 . . . . 0.0 109.653 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -134.99 73.37 1.48 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.952 1.301 . . . . 0.0 109.831 -166.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -46.41 -62.8 1.64 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.625 1.17 . . . . 0.0 112.326 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -65.02 -32.5 53.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.311 2.007 . . . . 0.0 111.813 174.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.22 -6.2 38.47 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.567 1.079 . . . . 0.0 113.683 178.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 13.7 t80 -103.62 -47.23 4.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.582 1.553 . . . . 0.0 109.901 173.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.2 mt -57.64 -17.49 14.97 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.778 0.831 . . . . 0.0 112.714 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -14.48 55.09 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.368 1.067 . . . . 0.0 112.57 178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -84.96 -50.88 7.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.481 0.712 . . . . 0.0 109.199 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.3 mp -61.63 -39.18 90.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.213 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -63.16 -0.48 0.78 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 -175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.25 11.37 6.94 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.372 1.469 . . . . 0.0 112.996 171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -117.56 -7.08 11.13 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.293 1.437 . . . . 0.0 114.369 -167.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -127.63 146.04 50.68 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.532 0.733 . . . . 0.0 109.051 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -86.93 -28.96 22.45 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -148.26 69.45 10.62 Favored Pre-proline 0 N--CA 1.448 -0.536 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.54 -31.79 40.76 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 120.679 0.919 . . . . 0.0 110.313 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 20.0 pt-20 -61.18 -28.73 69.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.095 -1.431 . . . . 0.0 112.287 -175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 -119.33 -1.4 10.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.681 1.128 . . . . 0.0 112.698 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 m -68.67 148.54 50.27 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.497 1.044 . . . . 0.0 110.837 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.2 m -110.92 97.17 6.63 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.23 150.6 38.57 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.784 -1.197 . . . . 0.0 110.153 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -134.15 108.26 8.19 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.399 1.48 . . . . 0.0 108.189 173.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mt -79.56 148.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 120.808 -1.183 . . . . 0.0 111.491 -176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.46 108.64 10.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.605 1.562 . . . . 0.0 109.118 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -94.25 175.89 6.52 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.929 1.692 . . . . 0.0 111.551 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -64.43 -52.05 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.216 2.606 . . . . 0.0 110.485 170.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -140.4 -55.25 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.23 -66.9 0.48 Allowed 'General case' 0 C--O 1.237 0.428 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -173.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.45 -111.0 3.49 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.69 29.18 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.921 1.688 . . . . 0.0 108.182 173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.4 p -47.86 -52.4 19.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.278 1.031 . . . . 0.0 111.214 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -66.89 -19.9 65.82 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.457 1.503 . . . . 0.0 112.954 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.47 -50.99 12.66 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.93 1.292 . . . . 0.0 108.5 173.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.54 -29.28 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 121.614 -0.679 . . . . 0.0 109.789 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -58.64 -41.15 85.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.186 0.994 . . . . 0.0 109.831 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -94.49 18.28 11.59 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.963 0.905 . . . . 0.0 111.279 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.24 -52.89 2.72 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 23.6 m -61.18 -47.35 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.413 1.006 . . . . 0.0 112.71 -174.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.67 84.28 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.55 2.13 1.98 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.558 1.943 . . . . 0.0 112.816 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -128.12 18.8 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.25 2.22 . . . . 0.0 110.987 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.65 25.55 11.76 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.159 -0.963 . . . . 0.0 114.092 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -94.36 175.16 6.79 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 152.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 12.4 tppt? -67.66 -81.78 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.021 0.828 . . . . 0.0 111.489 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 m -147.31 154.92 41.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.843 2.057 . . . . 0.0 107.03 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 91' ' ' ALA . . . -150.45 156.26 41.11 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.908 0.861 . . . . 0.0 111.569 -170.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -133.49 172.15 13.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.988 2.115 . . . . 0.0 109.951 -168.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -135.32 177.07 8.1 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.271 1.428 . . . . 0.0 108.044 169.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -121.93 125.81 73.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -63.39 156.57 25.52 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.897 0.317 . . . . 0.0 110.631 170.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 61.39 -1.8 0.27 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.669 1.988 . . . . 0.0 112.874 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.77 -135.12 42.84 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 120.597 -1.314 . . . . 0.0 111.656 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -89.62 -53.51 4.49 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.282 1.033 . . . . 0.0 110.326 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -95.69 -5.53 42.02 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 124.315 1.009 . . . . 0.0 111.819 -164.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.07 170.94 24.4 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 121.034 -1.041 . . . . 0.0 111.999 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.8 -24.39 46.99 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.3 2.0 . . . . 0.0 113.238 -162.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 113' ' ' ARG . 0.1 OUTLIER -138.05 38.4 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.859 0.863 . . . . 0.0 108.759 166.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.92 -167.06 14.68 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 169.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -43.36 -57.58 2.97 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.927 1.691 . . . . 0.0 112.374 -177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.3 mt -65.74 -16.4 63.74 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.797 0.839 . . . . 0.0 112.558 -173.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -122.46 31.5 6.1 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.635 1.974 . . . . 0.0 109.801 -177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.7 t -134.72 17.9 3.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.46 1.504 . . . . 0.0 110.712 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t 57.47 30.92 19.43 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.126 -173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.498 HD22 ' CG ' ' A' ' 13' ' ' TYR . 44.4 mt -91.22 145.87 32.4 Favored Pre-proline 0 N--CA 1.45 -0.44 0 O-C-N 121.668 -0.645 . . . . 0.0 109.493 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.36 150.84 25.71 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.714 2.276 . . . . 0.0 112.764 -164.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.41 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 4.4 t-105 -127.39 145.9 50.65 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.943 0.897 . . . . 0.0 108.837 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.489 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 11.2 mt -75.53 -52.35 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 163.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.317 0.0 OUTLIER 79.63 161.93 0.13 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 128.078 2.551 . . . . 0.0 112.127 -176.963 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.8 Cg_endo -68.77 -172.43 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.437 3.425 . . . . 0.0 113.164 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.79 15.73 11.8 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.439 1.896 . . . . 0.0 112.371 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -149.22 158.68 44.37 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 128.996 2.918 . . . . 0.0 106.826 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.0 p -67.37 -42.38 83.53 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.9 m 60.83 -3.27 0.15 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.499 2.407 . . . . 0.0 117.499 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 89.38 0.6 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.006 1.288 . . . . 0.0 110.633 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.56 -10.76 29.05 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.375 2.717 . . . . 0.0 114.575 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 p -146.2 7.57 1.03 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.572 1.149 . . . . 0.0 112.177 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.2 m -63.67 127.4 31.2 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 108.211 -1.956 . . . . 0.0 108.211 -174.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.843 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -74.33 73.29 1.84 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.759 2.024 . . . . 0.0 111.509 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -122.96 -95.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.098 1.759 . . . . 0.0 106.864 164.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.05 40.73 0.46 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.306 0.957 . . . . 0.0 111.479 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -128.55 146.33 50.87 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.235 1.014 . . . . 0.0 109.982 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 68.6 m -61.47 168.74 2.62 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.223 1.409 . . . . 0.0 113.252 -175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.88 176.82 30.07 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 126.531 2.015 . . . . 0.0 108.849 169.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.1 m -53.3 159.82 1.27 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.741 1.616 . . . . 0.0 113.444 -171.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -50.68 -58.91 4.73 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -55.54 -21.05 15.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 116.758 -1.591 . . . . 0.0 112.297 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.5 -45.05 73.21 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 120.562 1.528 . . . . 0.0 110.202 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.73 -55.4 5.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.918 1.287 . . . . 0.0 111.239 -175.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CE1' HD11 ' A' ' 44' ' ' LEU . 86.5 t80 -54.18 -42.28 69.5 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.102 -0.999 . . . . 0.0 111.769 177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.3 m -53.8 -43.84 69.67 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HA ' HG22 ' A' ' 18' ' ' THR . 41.1 mmtt -65.16 -51.44 61.15 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 117.626 -1.178 . . . . 0.0 110.429 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB3' HD13 ' A' ' 44' ' ' LEU . 11.0 mp -51.17 -35.09 34.41 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.473 1.488 . . . . 0.0 111.705 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.42 3.79 82.07 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.757 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -124.81 -7.27 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.066 2.146 . . . . 0.0 109.836 -179.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -137.25 103.48 5.11 Favored 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 126.04 1.736 . . . . 0.0 107.574 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -58.8 -33.27 70.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -75.13 -28.11 60.04 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.754 0.822 . . . . 0.0 110.663 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.17 150.96 32.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.549 0.74 . . . . 0.0 110.72 -167.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -140.22 174.85 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.88 1.272 . . . . 0.0 110.656 -174.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.41 126.99 27.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.56 0.744 . . . . 0.0 110.27 -176.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.91 92.16 3.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.071 1.349 . . . . 0.0 109.27 178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -75.69 97.51 3.84 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.2 pt -83.56 2.99 3.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.427 1.491 . . . . 0.0 111.987 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -66.68 155.42 38.03 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.959 0.8 . . . . 0.0 109.321 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.16 152.87 19.43 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 ' HA ' ' CD2' ' A' ' 33' ' ' PHE . 4.3 m -64.6 -23.98 67.44 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.332 -0.855 . . . . 0.0 111.501 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.36 62.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.326 1.85 . . . . 0.0 113.092 168.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -28.36 65.15 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 121.355 -0.841 . . . . 0.0 110.747 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 30' ' ' THR . 12.2 m-85 -67.89 -15.18 63.5 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.599 -1.313 . . . . 0.0 112.457 170.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -93.7 -26.65 16.93 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.515 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -114.97 -28.46 7.01 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.1 t -111.25 -34.13 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 125.91 1.684 . . . . 0.0 110.24 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.16 -171.62 29.9 Favored Glycine 0 CA--C 1.529 0.933 0 O-C-N 119.703 -1.873 . . . . 0.0 110.397 -172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -123.43 157.57 61.41 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.538 1.135 . . . . 0.0 110.598 -175.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.78 129.69 21.56 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.667 2.245 . . . . 0.0 111.454 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -89.97 69.71 7.43 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.967 1.307 . . . . 0.0 108.788 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 pt -82.22 4.33 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 122.059 -0.401 . . . . 0.0 111.568 164.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -59.41 -37.76 78.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.571 0.749 . . . . 0.0 110.344 -171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.78 17.88 5.32 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.009 -0.884 . . . . 0.0 113.859 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 16' ' ' LEU . 50.4 mt -106.32 -17.47 14.28 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.77 1.785 . . . . 0.0 109.756 166.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.78 -16.42 1.4 Allowed Glycine 0 C--N 1.338 0.692 0 CA-C-N 119.518 1.054 . . . . 0.0 114.582 -176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 165.06 0.56 Allowed 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 118.98 1.39 . . . . 0.0 110.702 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' HD12 ' A' ' 123' ' ' ILE . 3.2 mmmp? -67.72 169.53 9.39 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.319 1.447 . . . . 0.0 113.302 163.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 155.75 28.19 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 110.968 -2.833 . . . . 0.0 109.786 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.74 151.22 5.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -123.06 115.42 21.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -148.71 109.04 4.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.31 121.21 4.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -71.22 136.86 48.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -135.29 110.55 8.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.23 -12.84 66.5 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 118.591 0.632 . . . . 0.0 113.619 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -52.84 -36.02 58.22 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.047 2.539 . . . . 0.0 112.735 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -149.22 88.19 1.57 Allowed 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.572 0.749 . . . . 0.0 109.575 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -50.83 -58.79 9.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.066 0.947 . . . . 0.0 113.076 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.32 -37.96 16.49 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.357 2.038 . . . . 0.0 110.169 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -67.49 11.63 0.8 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 125.478 1.513 . . . . 0.0 114.248 172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.07 -48.96 2.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.256 1.823 . . . . 0.0 108.78 167.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.73 -19.43 11.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.855 1.262 . . . . 0.0 112.818 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.499 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.97 -13.86 3.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.764 2.025 . . . . 0.0 113.089 173.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -87.63 -49.85 6.89 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 118.822 0.737 . . . . 0.0 110.3 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.13 -34.66 76.78 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.376 0.67 . . . . 0.0 111.64 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -60.81 -8.25 2.92 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.412 1.485 . . . . 0.0 114.578 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -136.04 -22.41 1.38 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.875 0.87 . . . . 0.0 111.579 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -68.64 -18.81 64.36 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 116.721 -1.609 . . . . 0.0 112.412 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -123.62 136.74 54.68 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 121.366 1.894 . . . . 0.0 110.359 -170.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -75.47 -40.77 56.97 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -136.28 65.79 57.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -166.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -62.15 -37.53 62.48 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.289 1.326 . . . . 0.0 110.76 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.4 pt-20 -62.71 -12.92 26.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.155 1.782 . . . . 0.0 115.059 -174.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.09 -1.05 5.84 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.655 1.57 . . . . 0.0 111.563 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -79.37 124.38 28.37 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.447 -0.783 . . . . 0.0 109.401 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.8 m -81.91 104.76 12.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 164.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.77 142.92 33.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.878 175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -120.03 104.03 9.79 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 79' ' ' ILE . 3.9 mp -64.32 159.31 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 120.941 -1.099 . . . . 0.0 109.137 172.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.58 112.96 7.21 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.461 1.504 . . . . 0.0 107.557 171.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.72 -179.84 4.73 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.691 1.196 . . . . 0.0 109.404 171.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -51.71 7.29 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 119.578 -1.951 . . . . 0.0 109.738 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -128.77 -81.6 0.58 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.44 1.713 . . . . 0.0 110.192 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -114.2 -54.73 2.56 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.046 0.938 . . . . 0.0 109.015 -165.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 39.37 -121.39 1.38 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 126.318 1.913 . . . . 0.0 111.977 175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.54 28.27 1.08 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.9 p -38.36 -54.67 1.43 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.372 1.869 . . . . 0.0 112.965 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -63.64 -35.65 81.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.29 1.436 . . . . 0.0 112.818 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.53 -52.27 65.89 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.68 -35.06 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.248 1.019 . . . . 0.0 109.788 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.86 -14.53 53.97 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.574 1.15 . . . . 0.0 112.697 177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -127.31 32.85 4.97 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.762 1.225 . . . . 0.0 110.742 172.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.4 tp -112.21 -53.59 2.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 166.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.12 -45.27 92.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 118.12 0.418 . . . . 0.0 111.427 -172.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -23.22 67.32 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.461 0.704 . . . . 0.0 112.175 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.89 -10.76 30.23 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.754 1.622 . . . . 0.0 110.393 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -112.04 10.91 20.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.528 1.931 . . . . 0.0 110.967 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.06 6.06 14.32 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 119.748 1.158 . . . . 0.0 115.259 169.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -85.77 174.55 9.26 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.533 1.667 . . . . 0.0 110.151 165.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 2.6 tppt? -68.66 -92.86 0.01 OUTLIER 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.052 0.541 . . . . 0.0 110.579 171.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 m -139.19 149.47 44.44 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.323 1.849 . . . . 0.0 106.587 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -133.87 173.64 11.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 120.347 1.43 . . . . 0.0 111.527 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -143.98 154.67 43.53 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.908 1.683 . . . . 0.0 109.25 -171.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -114.19 153.31 29.82 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.789 1.236 . . . . 0.0 109.314 165.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -105.29 127.64 59.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 168.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.7 tptp -75.24 159.21 31.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.905 175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 55.52 14.11 1.11 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.933 1.693 . . . . 0.0 112.791 -173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.63 -120.66 3.74 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 126.499 2.0 . . . . 0.0 112.154 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -95.4 -48.38 5.89 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.129 0.972 . . . . 0.0 110.772 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -89.51 -17.89 27.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -159.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.35 168.34 45.64 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 119.33 0.968 . . . . 0.0 112.484 -169.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.02 -13.21 38.8 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.635 2.89 . . . . 0.0 112.477 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -129.64 15.59 5.93 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.141 1.777 . . . . 0.0 111.045 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.88 -164.63 12.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 124.813 1.197 . . . . 0.0 110.509 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -60.72 -49.88 75.73 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.092 0.957 . . . . 0.0 111.34 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.12 171.72 9.17 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-O 124.469 2.08 . . . . 0.0 106.15 172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 30.27 47.59 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 129.396 3.079 . . . . 0.0 112.732 -168.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 69.4 m -146.56 7.59 0.98 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.026 1.73 . . . . 0.0 113.321 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.6 t 96.65 0.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 128.805 2.842 . . . . 0.0 112.807 171.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.415 HD22 ' CG ' ' A' ' 13' ' ' TYR . 79.8 mt -84.21 157.44 62.42 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 119.266 0.939 . . . . 0.0 111.085 -172.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.79 158.69 52.55 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.315 2.01 . . . . 0.0 110.312 176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -152.46 148.7 27.73 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.954 1.301 . . . . 0.0 109.482 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.451 HD12 ' HE2' ' A' ' 47' ' ' LYS . 41.3 mt -76.63 -33.51 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 119.356 0.98 . . . . 0.0 109.889 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 68.75 161.64 0.14 Allowed Pre-proline 0 C--O 1.24 0.562 0 C-N-CA 127.873 2.469 . . . . 0.0 112.996 -168.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -73.44 -174.14 1.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.359 2.039 . . . . 0.0 109.99 167.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.68 23.61 10.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.249 1.02 . . . . 0.0 112.369 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -68.86 78.04 0.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 172.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 128' ' ' THR . 5.3 t -72.09 58.28 0.36 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.964 1.706 . . . . 0.0 108.987 168.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.3 p -155.47 161.33 40.97 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.004 -1.685 . . . . 0.0 111.497 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.61 171.07 12.91 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.59 2.043 . . . . 0.0 110.547 173.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -61.86 -25.76 78.55 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.461 2.108 . . . . 0.0 112.607 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -103.26 19.72 19.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.671 1.188 . . . . 0.0 111.81 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -53.52 -52.47 59.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.654 1.115 . . . . 0.0 109.831 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 CA-C-O 117.393 -1.781 . . . . 0.0 109.15 -154.724 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.972 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m -66.97 172.53 4.38 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.287 1.035 . . . . 0.0 112.291 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 t -145.96 150.5 36.17 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.098 1.359 . . . . 0.0 108.291 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.32 -87.96 2.0 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 126.34 1.924 . . . . 0.0 108.322 174.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -117.25 10.53 13.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.364 1.465 . . . . 0.0 114.664 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -106.68 178.44 4.56 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.727 1.149 . . . . 0.0 112.644 -169.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.14 -179.96 48.3 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.497 1.046 . . . . 0.0 110.51 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 m -57.55 164.61 1.9 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.16 1.784 . . . . 0.0 112.536 -174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.19 -50.75 72.43 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -62.93 -24.06 67.68 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.082 -1.011 . . . . 0.0 111.487 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -70.81 -3.66 20.09 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.399 1.08 . . . . 0.0 112.956 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.54 -55.64 2.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.407 1.003 . . . . 0.0 110.844 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.456 ' CD2' HD22 ' A' ' 120' ' ' LEU . 69.2 t80 -52.44 -42.94 64.58 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -176.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -49.52 -53.41 23.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.546 0.612 . . . . 0.0 110.798 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.6 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.3 mmpt? -52.81 -47.48 67.59 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.761 1.624 . . . . 0.0 111.085 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 44' ' ' LEU . 8.6 mp -48.77 -30.81 6.07 Favored 'General case' 0 N--CA 1.461 0.077 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.27 7.53 56.62 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.683 -1.065 . . . . 0.0 114.918 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -135.3 2.6 3.03 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.597 1.699 . . . . 0.0 110.871 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -135.55 93.24 2.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.99 2.516 . . . . 0.0 104.871 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -17.93 22.21 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.253 1.021 . . . . 0.0 112.227 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -78.29 -16.74 57.47 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 112.722 174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.46 158.52 31.23 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 120.952 -1.093 . . . . 0.0 111.832 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -148.07 173.79 12.58 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 125.908 1.683 . . . . 0.0 110.494 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.67 129.47 40.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.747 1.619 . . . . 0.0 108.971 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.625 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -116.37 98.7 6.72 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.553 1.141 . . . . 0.0 108.985 172.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.16 100.06 4.17 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 126.114 1.766 . . . . 0.0 108.457 176.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.3 pt -87.42 12.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.41 1.084 . . . . 0.0 112.923 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.459 HH11 ' HB3' ' A' ' 109' ' ' ALA . 54.1 mtm180 -74.64 160.58 30.65 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.02 29.26 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.705 0.802 . . . . 0.0 110.813 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.2 m -62.16 -30.96 71.42 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.995 -1.065 . . . . 0.0 111.221 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.36 78.04 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.998 1.319 . . . . 0.0 112.919 175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -42.22 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -71.13 -3.89 22.39 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.584 -1.323 . . . . 0.0 111.867 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.06 -45.25 8.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.93 1.292 . . . . 0.0 110.214 173.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -98.16 -26.18 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.803 0.841 . . . . 0.0 112.208 -169.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.38 -35.96 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 126.661 1.985 . . . . 0.0 110.005 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.6 178.37 43.11 Favored Glycine 0 C--N 1.337 0.621 0 O-C-N 120.828 -1.17 . . . . 0.0 110.479 -168.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.77 162.11 22.61 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 118.664 1.232 . . . . 0.0 111.463 -170.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.77 144.01 69.73 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 124.115 3.21 . . . . 0.0 111.275 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -96.16 90.12 5.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.537 -0.727 . . . . 0.0 109.448 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.3 pt -101.3 7.79 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.97 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -22.05 64.83 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.166 0.893 . . . . 0.0 111.905 -176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 -32.5 81.74 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.062 0.846 . . . . 0.0 111.33 168.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 16' ' ' LEU . 7.9 mt -78.2 21.14 0.36 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.64 1.976 . . . . 0.0 110.934 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.6 -15.17 49.73 Favored Glycine 0 C--N 1.336 0.539 0 O-C-N 120.852 -1.155 . . . . 0.0 115.041 160.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.18 164.04 11.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 119.203 1.501 . . . . 0.0 111.763 -173.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.82 158.36 32.25 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -75.07 151.56 38.66 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 162.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.457 HG11 ' HG2' ' A' ' 68' ' ' LYS . 83.9 t -103.53 113.65 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.478 1.511 . . . . 0.0 109.42 -177.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 p -75.75 128.28 34.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.323 -0.86 . . . . 0.0 110.968 177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.4 m -156.37 108.73 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.516 -1.365 . . . . 0.0 108.338 162.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.73 128.49 26.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-N 118.846 0.748 . . . . 0.0 109.907 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -83.65 138.25 33.42 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.539 0.336 . . . . 0.0 110.098 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -109.11 -69.71 0.85 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 164.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -8.99 11.63 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.17 1.366 . . . . 0.0 113.242 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -59.08 -75.42 0.05 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.119 1.368 . . . . 0.0 108.579 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -86.85 84.79 7.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.8 2.44 . . . . 0.0 108.593 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -49.23 -59.78 5.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 126.109 1.764 . . . . 0.0 111.459 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.32 -36.08 47.41 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 121.677 1.584 . . . . 0.0 111.321 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.47 26.87 0.47 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.771 2.129 . . . . 0.0 114.709 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -139.86 -54.42 0.54 Allowed 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.641 ' HA ' HD13 ' A' ' 65' ' ' LEU . 44.6 mt -51.42 -22.17 2.83 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 126.145 1.778 . . . . 0.0 112.805 173.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -25.65 60.98 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.619 177.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -78.75 -17.66 55.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.425 1.466 . . . . 0.0 111.986 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 62' ' ' LEU . 6.4 mp -84.81 -31.91 23.61 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 124.176 0.99 . . . . 0.0 110.711 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -63.91 -7.32 7.87 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -171.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -125.58 11.14 7.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.703 2.001 . . . . 0.0 112.311 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.457 ' HG2' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -106.47 -27.03 11.17 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 117.243 -1.36 . . . . 0.0 114.487 -174.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 34.7 m-85 -132.0 134.96 46.17 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -164.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -79.93 -26.98 39.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.892 0.477 . . . . 0.0 110.661 -173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -140.54 61.41 16.03 Favored Pre-proline 0 CA--C 1.519 -0.23 0 C-N-CA 123.266 0.627 . . . . 0.0 110.763 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.85 -35.16 28.1 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 120.817 1.012 . . . . 0.0 109.887 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -69.29 0.82 4.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.006 1.322 . . . . 0.0 113.682 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -131.93 -12.17 3.32 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.592 1.087 . . . . 0.0 113.57 167.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 16.2 m -72.75 126.96 31.15 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.193 1.397 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.9 m -89.01 111.49 22.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 120.737 1.608 . . . . 0.0 109.125 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 25' ' ' LEU . 1.1 mt -90.37 144.93 25.36 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.892 -1.13 . . . . 0.0 109.874 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -125.7 95.94 4.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.015 1.326 . . . . 0.0 107.745 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.17 139.37 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.354 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.42 105.94 8.44 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.806 1.643 . . . . 0.0 109.94 -174.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -89.01 171.94 9.49 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.939 1.296 . . . . 0.0 111.898 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -53.4 -58.88 5.54 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.577 1.951 . . . . 0.0 110.103 168.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -141.79 -33.92 0.48 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 119.913 1.233 . . . . 0.0 112.27 -163.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -172.65 -60.34 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -170.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.71 -100.03 0.03 OUTLIER Glycine 0 C--N 1.339 0.712 0 C-N-CA 128.398 2.904 . . . . 0.0 113.636 166.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -151.5 14.52 0.67 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.422 1.489 . . . . 0.0 111.178 -172.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.2 m -53.12 -40.32 64.1 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 120.854 1.661 . . . . 0.0 112.33 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -62.69 -46.97 85.69 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.275 0.63 . . . . 0.0 110.338 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -44.26 71.31 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.572 1.149 . . . . 0.0 109.664 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.23 -29.95 19.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 121.835 -0.54 . . . . 0.0 112.027 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.19 91.05 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -88.74 34.42 0.77 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.258 -0.901 . . . . 0.0 111.429 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 51.9 tp -129.08 -58.11 1.15 Allowed 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 121.187 -0.946 . . . . 0.0 110.389 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.86 -42.42 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 118.471 0.578 . . . . 0.0 110.948 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.24 -11.48 41.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.127 0.971 . . . . 0.0 112.685 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -114.8 11.23 16.69 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.528 1.531 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -131.06 16.92 5.09 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.839 1.656 . . . . 0.0 111.585 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.09 8.04 18.17 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 118.873 -0.96 . . . . 0.0 114.253 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -99.49 168.47 9.96 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.306 1.553 . . . . 0.0 107.883 160.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.08 -64.68 1.14 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.447 -0.783 . . . . 0.0 110.184 -177.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.9 m -140.23 160.39 40.06 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.842 1.657 . . . . 0.0 108.4 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.2 169.49 19.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.521 0.676 . . . . 0.0 110.491 172.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -138.91 162.55 34.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.751 2.42 . . . . 0.0 110.393 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.97 131.1 21.87 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.092 1.757 . . . . 0.0 109.746 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.05 132.29 35.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 C-N-CA 124.064 0.946 . . . . 0.0 108.812 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.9 tptm -73.43 151.95 40.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.823 171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 60.55 7.7 1.45 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.818 1.647 . . . . 0.0 112.624 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 40.75 -113.41 0.43 Allowed Glycine 0 C--N 1.34 0.783 0 C-N-CA 126.383 1.945 . . . . 0.0 111.123 -173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -117.65 -37.25 3.49 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 112.556 -175.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.33 -17.33 29.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.492 1.917 . . . . 0.0 111.807 -173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.28 166.58 47.95 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.369 0.509 . . . . 0.0 111.895 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -66.36 -15.86 49.49 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.484 2.123 . . . . 0.0 114.45 -167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -135.91 23.33 3.32 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.653 1.181 . . . . 0.0 109.915 167.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.15 -174.0 13.48 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 173.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.9 t-105 -44.23 -57.45 3.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.95 1.7 . . . . 0.0 112.877 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 88.3 mt -54.51 -53.74 50.35 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 122.27 1.033 . . . . 0.0 108.671 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -73.51 14.39 0.35 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.901 2.08 . . . . 0.0 113.772 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 t -123.37 19.39 9.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.273 1.429 . . . . 0.0 110.903 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.3 t 63.77 30.73 14.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.176 0.99 . . . . 0.0 111.814 173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD22 ' CD2' ' A' ' 13' ' ' TYR . 38.7 mt -93.86 162.03 28.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.969 0.908 . . . . 0.0 111.054 -175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.45 150.23 51.56 Favored 'Trans proline' 0 C--O 1.242 0.705 0 C-N-CA 123.031 2.487 . . . . 0.0 112.415 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 18.7 t-105 -136.67 152.74 50.73 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.239 1.015 . . . . 0.0 110.474 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.9 mt -87.08 -58.02 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 CA-C-O 116.172 -1.87 . . . . 0.0 107.492 171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER 78.36 157.99 0.14 Allowed Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.962 2.505 . . . . 0.0 111.49 -176.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.52 -77.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.159 2.573 . . . . 0.0 109.381 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.91 164.29 30.07 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.72 2.008 . . . . 0.0 108.092 170.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -80.17 21.17 0.6 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.443 1.097 . . . . 0.0 112.5 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 40.1 m -60.25 131.81 51.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.744 1.218 . . . . 0.0 108.901 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.3 p -64.52 105.4 0.94 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.88 1.272 . . . . 0.0 109.887 173.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -141.44 76.47 0.31 Allowed Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.641 1.591 . . . . 0.0 109.847 -175.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.89 -19.26 20.95 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.748 2.966 . . . . 0.0 113.903 -171.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 14.9 m -119.07 -63.77 1.36 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 87.11 -11.59 0.55 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.165 2.986 . . . . 0.0 112.723 -178.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 162.542 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.489 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 m -142.0 140.95 32.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 158.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.44 -16.28 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.215 1.006 . . . . 0.0 113.005 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.97 -145.82 8.55 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.764 1.166 . . . . 0.0 112.67 176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.8 m -107.9 6.7 27.54 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.95 1.3 . . . . 0.0 111.637 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 p -72.28 -172.9 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.547 1.539 . . . . 0.0 110.606 167.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.81 -179.49 41.54 Favored Glycine 0 N--CA 1.449 -0.476 0 O-C-N 120.976 -1.078 . . . . 0.0 111.168 170.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -56.09 163.73 1.47 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 122.422 1.106 . . . . 0.0 109.547 165.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -58.54 -46.74 86.18 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.61 177.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HE3' HD21 ' A' ' 120' ' ' LEU . 23.3 mtpt -73.57 -17.94 61.13 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.841 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -62.79 -26.29 68.65 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 120.164 1.347 . . . . 0.0 111.114 174.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.35 -59.7 2.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CD2' HD22 ' A' ' 120' ' ' LEU . 73.3 t80 -58.54 -46.18 87.36 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.628 -1.295 . . . . 0.0 114.246 -173.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.5 m -59.19 -14.4 10.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.787 1.176 . . . . 0.0 113.413 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -115.03 7.26 15.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.913 1.685 . . . . 0.0 112.687 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 tp -96.24 -22.39 17.28 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 126.217 1.807 . . . . 0.0 111.831 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.32 33.96 2.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.906 1.241 . . . . 0.0 112.728 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.81 -32.98 10.43 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.835 2.054 . . . . 0.0 108.904 168.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -115.59 136.72 52.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 129.981 3.312 . . . . 0.0 107.739 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.61 -26.14 66.1 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.795 0.725 . . . . 0.0 110.872 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -86.35 -6.73 58.88 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.278 0.631 . . . . 0.0 111.08 -172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.9 142.7 44.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.185 -0.947 . . . . 0.0 108.475 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -141.36 174.75 10.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.066 -1.021 . . . . 0.0 112.895 -169.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.81 126.07 33.43 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.807 1.243 . . . . 0.0 110.777 -175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -122.48 98.5 5.95 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.796 1.238 . . . . 0.0 109.219 175.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -79.35 102.95 8.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.3 pt -88.71 5.29 4.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.071 0.948 . . . . 0.0 111.872 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -67.33 158.04 32.52 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 119.487 1.04 . . . . 0.0 109.939 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.0 153.87 35.92 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.454 -173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.8 m -66.57 -21.3 66.15 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.553 -0.717 . . . . 0.0 111.781 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.06 60.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 112.463 169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -74.71 -25.92 59.47 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.184 0.994 . . . . 0.0 111.565 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -67.48 -9.09 38.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.103 -0.998 . . . . 0.0 112.171 167.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -105.46 -30.69 9.41 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.628 1.171 . . . . 0.0 110.735 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.6 -33.3 9.96 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.5 t -107.02 -43.97 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 CA-C-N 120.081 1.309 . . . . 0.0 112.105 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 117.17 -154.21 16.86 Favored Glycine 0 CA--C 1.528 0.882 0 O-C-N 120.676 -1.265 . . . . 0.0 111.0 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.43 158.17 61.17 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.166 1.483 . . . . 0.0 111.83 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.57 128.3 12.53 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.62 3.547 . . . . 0.0 112.736 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -83.03 94.04 7.7 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 170.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.2 5.77 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 122.711 0.404 . . . . 0.0 110.7 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -31.81 73.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.352 -0.832 . . . . 0.0 112.302 -171.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.48 -10.8 50.63 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 118.907 0.776 . . . . 0.0 113.446 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.3 mt -86.57 -11.06 52.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.654 1.227 . . . . 0.0 111.218 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 145.2 -39.6 1.17 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.363 0.982 . . . . 0.0 112.91 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 161.56 30.85 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.144 0.972 . . . . 0.0 111.712 -156.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.22 162.85 22.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.85 173.1 7.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.516 0.674 . . . . 0.0 110.568 171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.46 150.16 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 161.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -126.3 118.33 24.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.15 0.98 . . . . 0.0 108.411 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 m -152.04 106.59 3.2 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.2 121.35 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -62.83 142.9 58.03 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 167.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -138.1 97.23 3.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.05 -13.03 46.6 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.985 0.802 . . . . 0.0 113.258 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.84 -38.8 65.01 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.798 1.239 . . . . 0.0 110.745 167.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -134.53 73.93 1.51 Allowed 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.692 0.758 . . . . 0.0 110.227 -170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -42.64 -62.05 1.42 Allowed Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.089 1.356 . . . . 0.0 112.962 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.2 -46.29 0.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.209 1.939 . . . . 0.0 110.056 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -73.87 12.11 5.37 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.88 -173.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -96.17 -32.35 12.53 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.032 1.733 . . . . 0.0 111.302 167.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 47.9 mt -67.04 -7.39 22.39 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.46 -0.775 . . . . 0.0 112.056 -174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -58.44 -24.46 60.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.449 1.5 . . . . 0.0 111.673 -175.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -88.84 -17.71 29.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.817 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.76 -43.92 14.95 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.386 0.994 . . . . 0.0 109.576 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.2 m -60.05 -12.4 8.13 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.5 pt? -119.47 6.42 11.1 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.706 1.603 . . . . 0.0 113.518 175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -109.78 -9.97 14.8 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.514 1.526 . . . . 0.0 112.745 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -131.43 124.13 29.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 71' ' ' ASP . 1.8 ptmt -62.44 -38.35 89.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 172.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.7 t0 -139.23 64.3 32.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -159.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -63.34 -38.82 41.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 N-CA-C 109.173 -1.126 . . . . 0.0 109.173 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.66 -23.77 43.99 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.507 2.323 . . . . 0.0 114.679 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.43 1.89 7.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.784 1.234 . . . . 0.0 111.379 174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -70.94 148.95 47.19 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 119.983 1.265 . . . . 0.0 110.154 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 m -110.69 95.87 5.83 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.682 1.193 . . . . 0.0 107.937 167.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.22 149.48 37.21 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.95 -1.094 . . . . 0.0 110.367 -177.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -128.78 105.2 8.08 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -67.76 153.49 8.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.28 122.39 17.99 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 173.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.98 -178.14 3.3 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.085 1.354 . . . . 0.0 109.902 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.6 mtmm -67.42 -52.53 38.57 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 116.884 -1.531 . . . . 0.0 109.272 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.455 ' CZ ' ' HA2' ' A' ' 111' ' ' GLY . 1.5 t80 -154.66 -38.68 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.598 1.544 . . . . 0.0 112.779 -164.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -151.75 -74.84 0.14 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.53 -116.68 5.53 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.31 33.54 0.57 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.779 1.232 . . . . 0.0 108.361 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.9 p -49.74 -42.78 47.07 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 120.056 1.298 . . . . 0.0 110.943 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -73.35 -20.92 60.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.998 1.319 . . . . 0.0 111.828 -174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.81 -57.9 4.53 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.764 1.226 . . . . 0.0 108.223 171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.68 -29.08 46.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -27.56 69.22 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.955 1.702 . . . . 0.0 113.556 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -90.47 -37.37 13.97 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.403 1.001 . . . . 0.0 110.398 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.7 tp -65.88 -49.84 66.65 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.25 -165.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.7 m -57.2 -41.53 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 119.42 1.009 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -53.37 59.12 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.226 0.61 . . . . 0.0 109.383 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.7 mp -59.12 -15.27 13.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.798 1.239 . . . . 0.0 113.3 176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -113.51 17.8 18.09 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.243 1.817 . . . . 0.0 110.869 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.59 -1.06 18.22 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-O 118.471 -1.183 . . . . 0.0 114.495 164.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.19 172.36 11.97 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 119.066 1.433 . . . . 0.0 110.251 168.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.688 ' HA ' ' HE3' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -74.63 -68.68 0.52 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.283 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.1 m -152.76 152.3 31.49 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 126.615 1.966 . . . . 0.0 107.884 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.21 169.74 17.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.942 0.877 . . . . 0.0 111.321 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -132.27 159.76 38.18 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.513 1.925 . . . . 0.0 108.456 -169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -121.07 163.02 19.0 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.833 1.253 . . . . 0.0 108.867 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -116.03 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 172.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -71.41 150.79 44.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.28 0.632 . . . . 0.0 109.568 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 62.52 8.0 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.879 1.272 . . . . 0.0 112.981 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.82 -127.1 6.02 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.9 1.238 . . . . 0.0 111.532 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.83 -41.61 9.55 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.793 1.237 . . . . 0.0 111.415 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.86 -13.82 22.25 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.361 1.864 . . . . 0.0 113.422 -163.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 83' ' ' PHE . . . -69.49 166.79 48.22 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.617 -0.677 . . . . 0.0 112.031 -173.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.57 -16.24 51.16 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.965 3.11 . . . . 0.0 114.46 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -138.33 39.39 2.27 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.376 1.47 . . . . 0.0 109.443 167.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.28 -158.57 4.92 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -64.51 -45.02 89.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.872 1.269 . . . . 0.0 110.74 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.09 175.46 1.23 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 125.068 2.366 . . . . 0.0 106.383 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.4 p30 47.03 19.11 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 129.205 3.002 . . . . 0.0 114.648 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.5 m -133.17 14.87 4.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.729 2.412 . . . . 0.0 111.605 -170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 54.84 34.98 23.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.884 2.474 . . . . 0.0 113.582 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.49 HD22 ' CD2' ' A' ' 13' ' ' TYR . 67.8 mt -89.0 152.09 47.87 Favored Pre-proline 0 C--O 1.234 0.26 0 C-N-CA 123.083 0.553 . . . . 0.0 109.872 165.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -73.23 161.19 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.185 1.923 . . . . 0.0 111.034 -173.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.474 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 30.2 t-105 -150.29 146.47 26.79 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.671 -0.643 . . . . 0.0 110.014 176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.1 -38.04 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-O 116.961 -1.495 . . . . 0.0 109.834 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.295 3.2 pt-20 61.65 168.92 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.974 0 O-C-N 125.165 1.54 . . . . 0.0 111.884 -178.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 18.3 Cg_endo -70.65 -161.22 0.08 OUTLIER 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 122.815 2.343 . . . . 0.0 111.147 167.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -119.99 26.61 9.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.105 1.362 . . . . 0.0 111.49 166.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -136.31 146.25 46.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.036 1.334 . . . . 0.0 109.016 -170.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.2 m -132.89 71.78 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -157.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.59 100.24 2.08 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.141 0.976 . . . . 0.0 108.935 -156.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.36 71.39 1.29 Allowed Glycine 0 CA--C 1.529 0.926 0 CA-C-O 118.84 -0.978 . . . . 0.0 110.766 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -69.21 -40.96 5.47 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.831 2.354 . . . . 0.0 112.212 -165.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 m -79.79 -67.2 0.78 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.469 0.652 . . . . 0.0 109.46 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.7 m -88.2 -0.62 57.32 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -150.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 CA-C-O 118.344 -1.254 . . . . 0.0 112.392 -171.438 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.533 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.19 -9.49 36.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.91 0.855 . . . . 0.0 110.989 168.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 161.89 17.05 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.071 -1.018 . . . . 0.0 109.792 167.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.14 -169.62 21.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.376 0.988 . . . . 0.0 112.812 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.4 m -78.99 -11.25 60.0 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.842 2.057 . . . . 0.0 114.178 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 p -65.19 172.51 3.02 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.579 0.752 . . . . 0.0 110.715 172.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.96 174.18 46.87 Favored Glycine 0 C--N 1.336 0.533 0 O-C-N 120.64 -1.287 . . . . 0.0 111.156 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.0 m -58.55 158.92 7.02 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 109.989 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -58.66 4.49 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.001 0.92 . . . . 0.0 113.228 -175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HG2' HD21 ' A' ' 120' ' ' LEU . 41.0 mtpt -67.51 -16.63 64.3 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.036 -0.983 . . . . 0.0 112.493 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -54.49 -32.71 58.44 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 120.403 1.456 . . . . 0.0 110.251 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.79 -62.41 1.68 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.291 1.037 . . . . 0.0 110.958 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.536 ' CE2' HD11 ' A' ' 44' ' ' LEU . 41.3 t80 -50.41 -49.44 54.67 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.287 0.948 . . . . 0.0 113.232 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.9 m -50.09 -39.95 44.2 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.894 0.77 . . . . 0.0 112.142 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -66.99 -45.99 75.95 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 118.394 -0.812 . . . . 0.0 109.598 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 mp -51.44 -33.68 31.76 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.23 0.923 . . . . 0.0 111.359 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.45 1.33 84.05 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 118.28 -1.289 . . . . 0.0 114.53 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.03 -2.38 3.63 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.475 1.51 . . . . 0.0 110.632 -178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -130.31 102.12 6.06 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.747 1.619 . . . . 0.0 107.986 -168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.54 -6.51 20.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.052 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -108.99 -13.48 14.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.286 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' O ' ' HE3' ' A' ' 46' ' ' LYS . . . -69.0 154.86 41.34 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 121.202 1.819 . . . . 0.0 110.009 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -142.36 173.55 11.43 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.045 1.338 . . . . 0.0 111.007 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.42 125.25 38.19 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.963 1.305 . . . . 0.0 110.224 177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.36 98.05 6.69 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -73.98 101.01 3.71 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.3 pt -82.37 5.3 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.069 1.348 . . . . 0.0 112.638 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -69.94 162.47 27.98 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.283 1.04 . . . . 0.0 110.151 -174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.55 150.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.538 1.935 . . . . 0.0 110.626 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 m -63.23 -30.14 71.34 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.647 -1.283 . . . . 0.0 111.467 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.51 -18.95 64.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.384 -0.823 . . . . 0.0 112.571 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -37.05 84.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.429 1.013 . . . . 0.0 110.016 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.56 -6.14 10.08 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.801 1.24 . . . . 0.0 112.566 172.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -113.05 -29.34 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.26 1.824 . . . . 0.0 111.424 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.78 -18.52 13.91 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.343 1.057 . . . . 0.0 113.08 -174.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.09 -38.96 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 109.365 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 124' ' ' GLU . . . 95.51 -163.39 23.85 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -169.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.25 158.57 46.19 Favored Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 124.54 1.136 . . . . 0.0 111.238 -175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -68.06 145.05 66.01 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.285 1.99 . . . . 0.0 109.514 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -98.0 124.85 42.68 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 pt -138.32 10.74 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -22.04 65.61 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.838 -1.164 . . . . 0.0 112.709 -173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.66 -15.4 80.65 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 119.52 1.055 . . . . 0.0 111.988 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 13' ' ' TYR . 9.5 mt -90.97 12.28 20.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.383 1.873 . . . . 0.0 111.19 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.57 -17.83 15.74 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-O 118.71 -1.05 . . . . 0.0 114.189 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 22' ' ' ALA . 0.1 OUTLIER -172.39 166.51 5.77 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 124.583 1.153 . . . . 0.0 110.434 -164.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.75 156.77 16.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.881 1.272 . . . . 0.0 110.095 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.04 134.45 45.87 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.49 150.66 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 168.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 p -128.07 139.55 52.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 122.634 1.207 . . . . 0.0 110.772 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 59.6 m -157.84 154.61 28.3 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 166.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.7 124.34 44.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 121.474 1.943 . . . . 0.0 108.443 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -71.4 142.46 50.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -141.37 119.67 12.21 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 169.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.43 8.84 2.73 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.787 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -69.55 -76.04 0.1 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.668 1.587 . . . . 0.0 108.718 166.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -91.59 70.14 5.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.001 2.121 . . . . 0.0 108.121 -172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -45.73 -59.35 4.72 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 124.986 1.314 . . . . 0.0 114.08 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -69.51 -39.14 7.37 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.401 2.067 . . . . 0.0 111.551 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.04 38.79 0.66 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 127.087 2.28 . . . . 0.0 113.696 -175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.42 -52.32 0.44 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.448 1.899 . . . . 0.0 108.374 -171.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -61.13 -14.99 28.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.007 0.923 . . . . 0.0 112.095 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -12.44 2.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 126.12 1.768 . . . . 0.0 113.175 168.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 -44.52 7.56 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.065 0.848 . . . . 0.0 111.429 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.92 -38.85 92.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.499 -0.763 . . . . 0.0 110.566 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -62.82 -2.52 1.2 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 ' N ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -131.62 12.86 4.93 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.621 1.1 . . . . 0.0 113.255 172.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -108.71 -5.96 16.13 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.435 1.494 . . . . 0.0 114.967 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.61 172.35 8.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -109.01 -57.44 2.15 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.47 65.18 6.12 Favored Pre-proline 0 C--N 1.328 -0.335 0 C-N-CA 124.438 1.095 . . . . 0.0 110.007 -168.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 75' ' ' THR . 47.0 Cg_endo -66.31 -38.38 20.8 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.508 2.138 . . . . 0.0 110.858 -169.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HE2' ' A' ' 100' ' ' LYS . 1.8 pt-20 -56.58 -0.11 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.62 3.168 . . . . 0.0 114.155 171.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -140.59 0.36 1.63 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.045 1.293 . . . . 0.0 111.96 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 72' ' ' PRO . 3.2 m -93.7 112.42 24.29 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.378 1.071 . . . . 0.0 109.454 -172.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.4 m -76.72 104.98 7.51 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.86 145.94 32.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.876 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -123.19 111.2 16.2 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.95 144.99 11.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.74 125.11 29.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.204 1.802 . . . . 0.0 107.185 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.7 -177.69 3.25 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.494 1.518 . . . . 0.0 111.185 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -46.72 87.68 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 117.171 -1.395 . . . . 0.0 110.741 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -154.43 -44.58 0.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.947 1.248 . . . . 0.0 112.969 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -154.41 -58.28 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.817 -1.177 . . . . 0.0 107.995 -165.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.47 -109.46 0.17 Allowed Glycine 0 C--N 1.34 0.76 0 C-N-CA 127.811 2.624 . . . . 0.0 111.994 167.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -150.01 21.95 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.142 1.377 . . . . 0.0 110.944 -169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 m -56.25 -46.1 79.75 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.038 -1.039 . . . . 0.0 112.091 -172.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -60.93 -37.73 83.34 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.31 0.505 . . . . 0.0 111.153 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -51.95 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.154 1.382 . . . . 0.0 108.607 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.92 -30.91 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.125 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.31 -18.08 65.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 174.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.405 ' O ' HD13 ' A' ' 96' ' ' LEU . 11.6 pt-20 -117.33 26.83 9.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.167 0.987 . . . . 0.0 110.497 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.0 tp -109.4 -52.45 2.77 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 120.889 -1.132 . . . . 0.0 108.461 169.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.8 m -62.57 -42.4 95.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 O-C-N 121.891 -0.506 . . . . 0.0 111.126 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.87 -4.19 15.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.729 1.212 . . . . 0.0 112.939 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 92' ' ' GLU . 8.8 mp -111.17 -15.42 13.67 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.751 1.62 . . . . 0.0 110.416 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -102.65 -14.35 16.74 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.219 1.007 . . . . 0.0 112.606 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.62 -0.69 0.21 Allowed Glycine 0 CA--C 1.525 0.696 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.414 171.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -85.3 169.74 13.46 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.442 1.621 . . . . 0.0 108.51 165.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' A' ' 73' ' ' GLU . 8.1 tppt? -82.61 -58.65 2.82 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.699 0.799 . . . . 0.0 109.964 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 m -145.82 158.57 43.85 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.839 2.056 . . . . 0.0 107.997 -177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.44 173.99 12.53 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.32 -0.863 . . . . 0.0 110.971 170.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -140.48 167.28 22.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.086 2.155 . . . . 0.0 109.999 -168.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.5 167.47 19.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.182 1.793 . . . . 0.0 108.689 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.02 125.18 72.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.661 1.184 . . . . 0.0 108.805 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -69.45 149.07 48.71 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 63.33 10.97 5.09 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.856 1.662 . . . . 0.0 112.664 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.19 -132.85 10.7 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 127.478 2.466 . . . . 0.0 112.368 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.66 -55.58 3.91 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.191 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -69.91 -28.08 65.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 124.234 0.959 . . . . 0.0 113.026 -160.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.06 165.19 46.08 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-N 118.838 0.745 . . . . 0.0 113.672 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.49 -12.05 26.03 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.442 2.762 . . . . 0.0 113.107 177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 48.3 mtp85 -131.04 15.33 5.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.474 1.91 . . . . 0.0 111.039 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -77.09 -161.65 13.82 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -55.76 -48.58 75.04 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.575 0.75 . . . . 0.0 109.061 173.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.49 166.88 22.41 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 124.275 1.988 . . . . 0.0 106.971 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.7 t30 56.31 3.62 0.11 Allowed 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 128.441 2.696 . . . . 0.0 113.937 -170.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 51.1 m -113.29 19.48 17.0 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 120.277 -1.514 . . . . 0.0 113.739 -169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.2 t 59.04 39.68 23.07 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.873 1.269 . . . . 0.0 111.822 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.499 HD21 ' HG2' ' A' ' 10' ' ' LYS . 42.4 mt -105.93 151.75 40.09 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 169.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.49 158.11 36.42 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.938 2.425 . . . . 0.0 111.53 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 45.6 t-105 -141.46 161.25 38.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.838 0.855 . . . . 0.0 110.542 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.5 mt -100.63 -39.9 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 116.338 -1.791 . . . . 0.0 110.586 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.267 4.4 pt-20 64.38 161.04 0.12 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.83 2.052 . . . . 0.0 112.71 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 40.9 Cg_endo -67.04 -72.95 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.876 2.384 . . . . 0.0 110.097 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -148.81 152.02 35.8 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.861 2.864 . . . . 0.0 104.839 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -65.02 138.18 58.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.527 0.603 . . . . 0.0 110.85 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -120.24 -168.53 1.64 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.404 1.482 . . . . 0.0 108.616 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -140.59 179.27 6.78 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.525 1.53 . . . . 0.0 107.128 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.15 61.11 0.39 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-O 118.139 -1.367 . . . . 0.0 112.685 -171.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -70.92 9.34 0.81 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.589 2.859 . . . . 0.0 113.178 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 10.2 m -142.05 23.33 2.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.914 1.286 . . . . 0.0 110.027 170.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.4 p -73.21 121.57 20.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.039 -1.624 . . . . 0.0 109.039 170.442 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.3 m -120.46 164.18 16.8 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.994 1.318 . . . . 0.0 109.987 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.8 m -132.22 142.65 49.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.173 2.189 . . . . 0.0 105.446 164.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.82 -81.51 1.14 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -169.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.8 m -68.63 169.06 11.81 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.96 0.88 . . . . 0.0 112.43 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.41 37.71 16.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.127 2.171 . . . . 0.0 115.545 161.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.82 177.05 28.06 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 122.057 0.81 . . . . 0.0 112.805 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -55.97 162.86 1.69 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.39 1.476 . . . . 0.0 110.685 175.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.42 -51.31 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -56.02 -28.07 55.75 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-O 117.238 -1.363 . . . . 0.0 112.056 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -57.65 -54.15 50.1 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 120.419 1.463 . . . . 0.0 110.886 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.11 -51.45 69.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.362 0.665 . . . . 0.0 110.29 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CD2' HD22 ' A' ' 120' ' ' LEU . 85.2 t80 -59.8 -37.28 78.67 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 m -55.7 -53.16 60.03 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -60.7 -50.78 72.11 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.587 -0.72 . . . . 0.0 110.152 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -30.59 -52.18 0.16 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.413 2.685 . . . . 0.0 113.944 177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.91 4.19 45.62 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.481 -1.177 . . . . 0.0 115.683 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -107.96 -16.1 14.37 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.024 1.912 . . . . 0.0 110.19 167.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -123.93 71.78 1.13 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.84 -21.96 22.57 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.085 1.312 . . . . 0.0 114.366 -166.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -66.01 -15.25 62.86 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.687 1.195 . . . . 0.0 111.091 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.1 156.98 36.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.66 1.584 . . . . 0.0 110.396 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -149.37 172.36 15.05 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.518 0.727 . . . . 0.0 112.058 -165.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 121.34 26.66 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.497 0.719 . . . . 0.0 110.88 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' HA ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.24 97.3 6.8 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 122.688 1.232 . . . . 0.0 108.272 173.183 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -79.37 106.87 11.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.869 -1.514 . . . . 0.0 107.148 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.6 pt -95.55 7.96 6.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.78 0.832 . . . . 0.0 111.549 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.912 HH11 ' HB3' ' A' ' 109' ' ' ALA . 8.9 mtp180 -67.03 158.23 31.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.999 0.904 . . . . 0.0 108.976 176.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' ASP . . . -58.62 150.49 23.02 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.034 1.734 . . . . 0.0 111.807 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 m -64.44 -34.71 78.83 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.277 -0.889 . . . . 0.0 111.447 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.55 -15.25 55.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.457 -0.497 . . . . 0.0 112.094 176.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 16.9 t70 -63.81 -32.53 74.07 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.205 -0.934 . . . . 0.0 108.724 174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -66.01 -6.23 12.13 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -116.22 -21.35 9.4 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.664 1.185 . . . . 0.0 111.407 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -104.94 -31.93 9.01 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.809 1.243 . . . . 0.0 112.343 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -104.96 -76.34 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 125.863 1.665 . . . . 0.0 107.084 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.07 -162.91 29.34 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 -178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.1 m -138.44 157.8 71.72 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 118.98 1.39 . . . . 0.0 110.774 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.35 127.94 13.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 125.233 3.956 . . . . 0.0 113.284 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -92.63 99.98 12.59 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 124.922 1.289 . . . . 0.0 108.409 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.448 ' HB ' HD23 ' A' ' 44' ' ' LEU . 2.1 pt -113.51 13.65 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.772 0.829 . . . . 0.0 110.611 172.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -63.63 -34.37 77.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.422 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.35 -6.66 11.28 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 117.895 -1.503 . . . . 0.0 114.735 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -93.37 -32.43 14.27 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.441 1.621 . . . . 0.0 110.604 170.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.63 -23.35 0.2 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 115.402 0.921 . . . . 0.0 115.402 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.12 154.33 8.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.467 1.133 . . . . 0.0 109.494 -163.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.5 169.2 18.38 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.34 175.4 4.71 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.408 0.623 . . . . 0.0 110.874 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.2 t -117.33 109.58 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.34 105.85 11.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.489 1.116 . . . . 0.0 110.526 176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.8 m -139.49 97.15 3.21 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 166.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -53.91 126.6 10.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -85.36 150.71 24.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.793 0.437 . . . . 0.0 110.39 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.39 -99.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.17 1.788 . . . . 0.0 109.061 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.48 -23.17 2.69 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 125.177 1.37 . . . . 0.0 113.344 174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -56.42 -53.77 53.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 122.907 1.337 . . . . 0.0 109.194 164.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -100.43 61.83 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.427 2.291 . . . . 0.0 108.478 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -46.03 -64.41 0.95 Allowed Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 123.623 0.769 . . . . 0.0 112.595 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.35 -40.49 24.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.152 1.902 . . . . 0.0 110.573 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -71.64 3.59 17.67 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-O 117.305 -1.83 . . . . 0.0 115.135 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -101.74 -34.59 9.39 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.527 1.931 . . . . 0.0 110.041 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.5 -8.19 8.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.933 1.293 . . . . 0.0 112.78 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.45 -21.84 64.51 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 125.843 1.657 . . . . 0.0 112.452 -175.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -86.84 -23.35 25.33 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 117.915 -1.041 . . . . 0.0 112.611 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.4 -45.13 23.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.518 1.054 . . . . 0.0 110.15 -169.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.99 -10.27 20.65 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -167.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.6 pt? -119.32 8.95 11.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.301 1.44 . . . . 0.0 112.23 176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -108.56 -6.3 16.12 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.879 1.672 . . . . 0.0 113.366 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.511 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 41.9 m-85 -140.13 134.15 30.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.613 1.965 . . . . 0.0 106.318 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' HB3' ' A' ' 71' ' ' ASP . 3.5 ttpp -69.86 -55.82 8.74 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 123.511 0.507 . . . . 0.0 109.768 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' HB3' ' HE3' ' A' ' 70' ' ' LYS . 25.0 p-10 -113.79 71.42 1.86 Allowed Pre-proline 0 N--CA 1.429 -1.515 0 C-N-CA 130.936 3.694 . . . . 0.0 110.379 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -64.22 -27.31 64.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.973 1.782 . . . . 0.0 110.964 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -68.8 -12.75 61.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.102 0.961 . . . . 0.0 113.42 -172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -134.48 -0.06 2.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.276 1.03 . . . . 0.0 112.467 171.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -67.83 123.34 20.3 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.241 -0.912 . . . . 0.0 109.976 176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -85.4 101.0 12.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.35 147.66 27.78 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 120.151 -1.593 . . . . 0.0 110.325 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -128.01 105.88 8.7 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.95 148.95 9.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 123.769 0.828 . . . . 0.0 109.46 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.45 111.61 10.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 107.965 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -94.12 172.13 8.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.03 0.932 . . . . 0.0 109.808 170.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -56.84 -50.19 73.16 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 117.019 -1.467 . . . . 0.0 108.51 170.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.45 -42.39 0.17 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 119.617 1.099 . . . . 0.0 113.524 -160.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -160.43 -69.28 0.07 Allowed 'General case' 0 C--O 1.241 0.624 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.41 -101.06 0.29 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 127.256 2.36 . . . . 0.0 111.891 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.03 15.47 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.548 1.939 . . . . 0.0 109.593 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.8 m -52.99 -44.76 67.47 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.645 1.111 . . . . 0.0 111.862 -168.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -67.95 -32.5 72.97 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.183 0.993 . . . . 0.0 111.081 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.1 tp -63.94 -48.45 76.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.587 -1.321 . . . . 0.0 109.63 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.27 -30.46 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 118.438 -0.791 . . . . 0.0 109.913 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.13 -26.16 68.41 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.205 1.402 . . . . 0.0 113.659 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -88.58 -45.57 9.78 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.773 0.715 . . . . 0.0 110.449 171.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.7 tp -55.7 -47.6 76.55 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -163.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.7 m -62.41 -40.96 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 119.172 -0.442 . . . . 0.0 112.122 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.18 -46.59 88.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.16 -4.33 4.9 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.74 1.216 . . . . 0.0 112.611 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -116.57 21.73 13.26 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.098 2.159 . . . . 0.0 110.391 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 6.18 60.83 Favored Glycine 0 CA--C 1.528 0.9 0 O-C-N 121.259 -0.9 . . . . 0.0 114.715 166.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -77.78 178.76 7.12 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.887 1.344 . . . . 0.0 108.817 156.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -78.71 -75.25 0.24 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 m -158.75 128.47 5.73 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.531 1.933 . . . . 0.0 106.811 -170.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -126.74 167.61 15.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.513 0.673 . . . . 0.0 111.194 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -139.71 163.86 31.49 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.997 1.719 . . . . 0.0 110.495 -161.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.65 164.18 22.63 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 125.217 1.407 . . . . 0.0 109.043 172.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -113.39 135.27 53.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -66.42 139.95 58.02 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 171.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 71.9 3.48 4.69 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.17 1.788 . . . . 0.0 113.542 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.17 -136.65 25.36 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.912 ' HB3' HH11 ' A' ' 28' ' ' ARG . . . -94.5 -28.17 15.59 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.942 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.64 -14.78 19.7 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.156 1.343 . . . . 0.0 114.25 -170.273 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -71.7 170.96 48.11 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 120.66 -1.275 . . . . 0.0 113.06 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.28 -20.71 69.28 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.977 2.451 . . . . 0.0 114.138 -171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -132.52 29.48 4.23 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.49 1.116 . . . . 0.0 111.298 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.76 -178.42 40.74 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 170.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -46.88 -53.61 11.76 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.272 1.829 . . . . 0.0 111.452 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.78 -49.28 78.26 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.398 1.079 . . . . 0.0 109.575 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -73.62 -6.28 45.72 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.25 1.42 . . . . 0.0 113.542 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -110.75 21.06 16.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.317 1.047 . . . . 0.0 111.328 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 67.4 p 39.96 45.08 1.53 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.249 2.619 . . . . 0.0 112.484 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 13' ' ' TYR . 45.1 mt -83.55 158.15 63.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 124.395 1.078 . . . . 0.0 108.543 166.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -66.45 163.39 32.6 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.427 2.085 . . . . 0.0 111.516 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.42 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 12.2 t-105 -145.0 159.05 43.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.76 0.824 . . . . 0.0 109.568 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.9 mt -93.15 -53.9 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.54 0 CA-C-O 117.753 -1.118 . . . . 0.0 108.361 172.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.292 0.0 OUTLIER 65.52 165.33 0.12 Allowed Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 124.897 1.373 . . . . 0.0 112.611 -174.839 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.5 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 61.8 Cg_endo -70.74 -170.88 0.49 Allowed 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.662 3.575 . . . . 0.0 111.555 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 169.33 13.21 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.249 -0.907 . . . . 0.0 108.829 165.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -69.4 100.26 1.34 Allowed 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.851 0.86 . . . . 0.0 111.742 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.7 -163.24 1.22 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.802 2.441 . . . . 0.0 104.964 163.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.61 151.13 37.6 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 120.528 -1.358 . . . . 0.0 108.134 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.59 164.98 26.92 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 164.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.78 109.93 2.43 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.321 2.681 . . . . 0.0 108.931 -175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 p 50.88 0.3 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.73 2.812 . . . . 0.0 117.178 -177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 p -67.87 -6.45 21.76 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 120.543 1.519 . . . . 0.0 113.299 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 N-CA-C 104.129 -3.588 . . . . 0.0 104.129 176.626 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.58 -167.63 0.47 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.9 1.28 . . . . 0.0 109.73 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.37 138.05 41.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.137 0.975 . . . . 0.0 108.7 165.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.37 -90.98 0.16 Allowed Glycine 0 C--N 1.33 0.208 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.5 m -59.01 -30.18 67.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.656 1.182 . . . . 0.0 112.98 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.3 m -126.41 172.43 10.18 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 119.248 0.931 . . . . 0.0 110.043 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.14 175.04 28.55 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 125.235 1.398 . . . . 0.0 109.882 166.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 m -62.01 160.64 12.07 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.599 0.76 . . . . 0.0 110.306 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.27 -52.49 44.47 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -67.11 -21.97 65.82 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 115.935 -1.983 . . . . 0.0 113.277 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -50.22 -46.59 54.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 121.542 1.974 . . . . 0.0 109.488 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.75 -55.07 9.43 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.08 0.952 . . . . 0.0 112.485 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.542 ' CD2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -59.28 -40.4 85.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.736 -1.227 . . . . 0.0 112.881 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -52.82 -45.09 67.13 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 122.784 0.434 . . . . 0.0 110.4 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -65.36 -46.63 79.42 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.695 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 mp -52.78 -33.38 48.48 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.018 0.827 . . . . 0.0 112.034 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.54 0.1 88.21 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.242 -0.755 . . . . 0.0 114.652 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -123.13 -13.53 7.72 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.967 1.383 . . . . 0.0 111.904 174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -106.52 97.76 7.52 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.668 1.987 . . . . 0.0 107.99 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.23 -19.77 36.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.159 0.984 . . . . 0.0 110.963 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -106.41 1.72 25.88 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.323 1.449 . . . . 0.0 111.758 -178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.36 163.63 27.3 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.153 -1.592 . . . . 0.0 109.829 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -141.84 175.9 9.35 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.493 1.117 . . . . 0.0 110.129 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.26 127.25 31.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.81 1.244 . . . . 0.0 108.801 177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.45 96.57 5.71 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.112 1.365 . . . . 0.0 107.457 178.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -80.73 96.29 6.89 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.888 1.275 . . . . 0.0 107.715 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 pt -81.35 1.9 3.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.334 1.053 . . . . 0.0 111.871 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 82' ' ' LYS . 38.5 mtp180 -63.98 156.61 27.37 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 120.295 1.407 . . . . 0.0 109.769 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.44 155.52 37.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.757 0.789 . . . . 0.0 109.963 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 m -60.47 -24.37 65.22 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.227 -178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.52 -20.52 39.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.19 -27.47 68.71 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.147 0.885 . . . . 0.0 109.014 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -71.45 1.49 6.31 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -124.97 -50.82 1.69 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.856 2.063 . . . . 0.0 109.239 -167.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -70.27 -43.17 71.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.415 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.406 HG21 HH22 ' A' ' 28' ' ' ARG . 10.7 t -108.18 -55.3 5.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 C-N-CA 124.056 0.942 . . . . 0.0 111.934 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.68 -174.07 17.6 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.2 m -127.5 158.53 69.53 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.29 1.036 . . . . 0.0 110.722 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.65 134.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.589 2.86 . . . . 0.0 111.674 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -94.95 105.18 17.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 pt -111.56 7.83 8.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 122.867 0.467 . . . . 0.0 111.308 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -68.13 -28.43 67.3 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 120.997 -1.064 . . . . 0.0 110.179 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.77 -14.1 42.57 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.015 -0.881 . . . . 0.0 113.906 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.55 -53.31 4.48 Favored 'General case' 0 C--N 1.337 0.063 0 CA-C-N 119.344 1.572 . . . . 0.0 107.381 167.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 -42.62 0.02 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.205 0.442 . . . . 0.0 114.205 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 169.7 23.01 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.625 -1.515 . . . . 0.0 110.778 -167.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' HD11 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -82.87 161.59 21.86 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.399 -0.813 . . . . 0.0 110.066 -179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 165.88 15.5 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.158 0.583 . . . . 0.0 110.099 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.58 110.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.1 m -74.86 109.93 8.73 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.5 m -143.45 103.82 4.15 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 120.866 -1.146 . . . . 0.0 108.482 167.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 52' ' ' VAL . 2.2 t -56.32 117.89 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -72.74 149.0 44.1 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -143.65 165.26 28.12 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.535 1.534 . . . . 0.0 108.232 166.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.43 15.51 42.25 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -82.16 -48.03 11.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.937 2.495 . . . . 0.0 109.75 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.3 70.68 1.4 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.037 1.335 . . . . 0.0 109.787 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm -38.93 -67.44 0.27 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.414 2.286 . . . . 0.0 113.723 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -62.81 -29.87 77.21 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.227 1.951 . . . . 0.0 111.444 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.86 3.81 48.67 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 127.1 2.286 . . . . 0.0 114.968 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -102.81 -44.71 5.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.971 1.386 . . . . 0.0 109.398 169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.3 mt -58.8 -19.07 37.72 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.127 0.971 . . . . 0.0 112.486 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -28.96 56.78 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 124.966 1.306 . . . . 0.0 112.392 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -74.14 -40.55 62.54 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.209 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.5 -28.74 70.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.246 0.619 . . . . 0.0 110.776 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 t -47.38 -40.77 18.35 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.696 1.198 . . . . 0.0 113.001 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.38 -24.96 7.67 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.841 0.856 . . . . 0.0 111.268 -170.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -67.83 -16.59 64.17 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.972 0.909 . . . . 0.0 111.857 174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -120.74 142.52 49.46 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 pttp -104.07 -24.13 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 124.407 1.067 . . . . 0.0 113.364 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -141.03 61.58 14.72 Favored Pre-proline 0 N--CA 1.451 -0.423 0 O-C-N 123.794 0.684 . . . . 0.0 109.659 -170.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -65.78 -34.21 41.05 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.999 1.799 . . . . 0.0 110.499 -167.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.3 -19.81 64.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.066 1.346 . . . . 0.0 113.274 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -111.6 -14.07 13.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.856 1.207 . . . . 0.0 111.363 171.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.0 m -68.08 121.8 16.9 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 123.507 0.723 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.9 m -92.65 107.22 19.05 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 170.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 153.24 22.61 Favored 'General case' 0 C--O 1.226 -0.148 0 O-C-N 121.019 -1.051 . . . . 0.0 111.116 -175.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -130.88 114.6 15.48 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.76 162.25 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.81 127.99 17.66 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 163.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -116.22 170.43 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.475 1.91 . . . . 0.0 109.254 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HG2' ' HE ' ' A' ' 28' ' ' ARG . 42.1 mtpt -59.88 -53.88 52.72 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -151.73 -38.36 0.12 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 120.084 1.311 . . . . 0.0 112.561 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -153.15 -59.48 0.14 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.095 1.358 . . . . 0.0 108.388 -173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.09 -106.5 0.49 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 126.34 1.924 . . . . 0.0 111.084 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -153.68 31.83 0.46 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.325 2.25 . . . . 0.0 108.542 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.2 m -46.81 -53.48 11.87 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.026 -1.046 . . . . 0.0 112.753 -170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -69.12 -19.29 64.03 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.621 0.768 . . . . 0.0 111.22 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.24 -56.07 5.58 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 108.045 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.3 t -63.54 -31.02 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.94 -25.12 60.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.292 1.437 . . . . 0.0 113.048 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 96' ' ' LEU . 5.5 pt-20 -117.75 14.79 14.4 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.185 0.902 . . . . 0.0 112.147 -173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 14.5 tp -107.64 -52.17 2.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.472 1.509 . . . . 0.0 108.956 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.0 m -60.06 -38.33 76.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -49.71 71.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 0.0 109.177 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 96' ' ' LEU . 7.0 mp -71.89 1.09 7.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.232 2.213 . . . . 0.0 112.139 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -129.58 35.54 4.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.113 2.165 . . . . 0.0 107.812 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 99.31 14.92 34.14 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-O 118.96 -0.911 . . . . 0.0 114.903 162.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.16 174.99 5.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.719 1.259 . . . . 0.0 109.935 173.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -76.56 -72.16 0.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.695 -0.628 . . . . 0.0 111.781 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 m -158.71 136.41 10.29 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -170.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -128.48 169.85 13.85 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.695 0.759 . . . . 0.0 111.271 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -138.04 161.74 35.94 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.374 1.47 . . . . 0.0 111.307 -161.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.39 141.8 50.54 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.014 0.926 . . . . 0.0 111.649 173.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -91.45 130.57 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 126.664 1.985 . . . . 0.0 106.157 168.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -69.57 153.66 43.14 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.26 -0.77 1.69 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.547 1.539 . . . . 0.0 113.313 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.39 -138.52 22.86 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 124.589 1.09 . . . . 0.0 111.442 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.12 -54.34 3.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.609 0.764 . . . . 0.0 111.608 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.83 -16.67 61.13 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 111.996 -169.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.37 154.73 37.4 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.8 -9.73 22.23 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.478 2.119 . . . . 0.0 114.019 -172.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -141.08 20.97 2.28 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.62 1.568 . . . . 0.0 109.739 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -82.11 -146.54 5.82 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.383 1.468 . . . . 0.0 111.272 -171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.9 t-105 -67.17 -50.12 62.25 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.385 1.474 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 48.1 mt -64.33 167.76 6.44 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 169.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.2 p30 47.89 21.29 0.28 Allowed 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 111.421 -2.627 . . . . 0.0 115.324 -176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.96 12.0 11.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.721 2.008 . . . . 0.0 113.624 -171.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.6 t 82.8 3.11 1.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.488 2.715 . . . . 0.0 111.524 -175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.542 HD22 ' CD2' ' A' ' 13' ' ' TYR . 39.0 mt -86.2 149.85 50.8 Favored Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 119.461 1.028 . . . . 0.0 112.141 -169.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.86 162.42 39.72 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.894 3.062 . . . . 0.0 112.588 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -149.83 165.35 32.79 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.313 0.645 . . . . 0.0 112.073 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.429 HD11 ' HD2' ' A' ' 47' ' ' LYS . 68.5 mt -107.34 -32.97 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.062 1.745 . . . . 0.0 112.575 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.52 ' HB2' ' HD2' ' A' ' 125' ' ' PRO 0.285 7.3 pt-20 62.36 165.89 0.11 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.295 1.838 . . . . 0.0 112.503 177.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 124' ' ' GLU . 51.9 Cg_endo -69.54 -172.34 0.54 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.968 2.445 . . . . 0.0 110.755 167.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -69.87 159.53 33.5 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.212 -1.555 . . . . 0.0 107.516 160.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -64.26 109.51 1.91 Allowed 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.0 p -123.05 171.21 9.44 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.938 1.295 . . . . 0.0 110.449 -178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.9 p -76.05 74.94 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.973 1.709 . . . . 0.0 109.333 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 171.38 63.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 CA-C-O 118.218 -1.323 . . . . 0.0 111.531 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.04 -6.2 16.57 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.612 2.208 . . . . 0.0 113.203 174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -68.74 -16.32 63.77 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.712 -1.243 . . . . 0.0 112.261 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.2 t -96.81 -17.93 19.91 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.387 0.994 . . . . 0.0 113.398 -164.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -169.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.72 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 t -63.39 151.1 41.9 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.659 1.23 . . . . 0.0 108.944 173.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m -121.69 13.85 10.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.094 0.958 . . . . 0.0 110.213 167.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.06 131.37 10.3 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.2 m -135.77 -62.71 0.68 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.649 1.58 . . . . 0.0 107.159 174.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.18 141.12 11.79 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.052 2.941 . . . . 0.0 110.765 172.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.86 167.09 18.35 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 121.654 0.585 . . . . 0.0 112.257 -172.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.6 m -65.07 165.19 11.53 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.01 0.924 . . . . 0.0 112.302 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.29 -53.19 39.57 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -61.36 -23.12 65.55 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 116.063 -1.922 . . . . 0.0 111.441 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -57.08 -51.28 69.91 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 121.315 1.87 . . . . 0.0 109.019 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.46 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.632 0.773 . . . . 0.0 110.453 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' CD2' HD22 ' A' ' 120' ' ' LEU . 78.6 t80 -60.34 -43.5 96.39 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 m -54.28 -51.69 63.8 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 8.1 mmpt? -60.65 -47.24 87.12 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.811 0.445 . . . . 0.0 110.661 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -44.36 -41.73 6.31 Favored 'General case' 0 N--CA 1.432 -1.356 0 C-N-CA 127.328 2.251 . . . . 0.0 112.614 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.91 8.23 53.89 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-O 119.216 -0.769 . . . . 0.0 114.191 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -111.91 -11.31 13.9 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.79 1.295 . . . . 0.0 109.359 173.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -138.71 95.54 2.99 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.203 2.201 . . . . 0.0 105.685 -175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -67.19 -9.84 44.36 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 120.956 -1.09 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -85.82 -6.45 59.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.686 1.594 . . . . 0.0 111.981 169.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.11 157.5 37.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.941 -1.1 . . . . 0.0 108.683 167.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -141.87 170.79 15.05 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.77 0.828 . . . . 0.0 111.226 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.54 125.59 36.62 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.214 1.005 . . . . 0.0 108.422 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -115.18 94.18 4.62 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.48 104.85 4.6 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 pt -86.95 3.49 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.605 0.762 . . . . 0.0 112.878 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.1 mtm180 -67.3 157.58 33.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.059 0.845 . . . . 0.0 111.124 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.76 156.04 39.62 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 123.065 0.546 . . . . 0.0 112.237 -172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -55.65 -40.72 72.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.979 0.912 . . . . 0.0 111.192 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.82 -25.12 62.71 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 121.752 -0.592 . . . . 0.0 111.447 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.56 -29.35 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.327 0.651 . . . . 0.0 110.102 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -72.18 -19.62 61.72 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.817 -1.802 . . . . 0.0 112.561 171.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -86.51 -39.69 16.0 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 118.514 -0.755 . . . . 0.0 109.757 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -92.78 -29.14 16.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.69 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 t -114.28 -32.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 124.829 1.252 . . . . 0.0 113.24 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.36 -126.65 7.67 Favored Glycine 0 N--CA 1.473 1.162 0 O-C-N 119.829 -1.795 . . . . 0.0 115.993 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.96 157.81 12.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 121.158 -1.201 . . . . 0.0 110.787 168.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.21 140.34 48.81 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.683 2.256 . . . . 0.0 107.846 171.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -103.92 107.96 19.07 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.431 ' HB ' HD23 ' A' ' 44' ' ' LEU . 1.8 pt -111.11 10.9 8.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 122.312 0.245 . . . . 0.0 111.351 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -67.36 -24.26 65.69 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 120.844 -1.16 . . . . 0.0 110.724 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.45 -22.42 58.89 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.336 -1.258 . . . . 0.0 112.935 169.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.431 HD23 ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -84.22 -33.64 24.07 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.456 1.628 . . . . 0.0 110.997 170.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.91 -33.58 0.26 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 114.792 0.677 . . . . 0.0 114.792 176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.22 169.53 22.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.063 1.431 . . . . 0.0 110.978 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.42 168.29 19.68 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 169.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.76 173.98 12.07 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.316 1.447 . . . . 0.0 110.788 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.2 t -103.62 100.79 11.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.979 1.311 . . . . 0.0 108.336 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 p -78.04 114.89 17.34 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -152.49 104.18 2.89 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 120.571 -1.33 . . . . 0.0 107.47 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.82 125.09 8.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 23.3 t80 -69.76 136.69 51.21 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.28 138.56 41.88 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 163.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.44 -4.95 28.47 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.614 1.578 . . . . 0.0 111.197 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -54.79 -43.02 72.48 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.885 1.274 . . . . 0.0 109.768 170.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -128.78 89.42 2.88 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.536 1.935 . . . . 0.0 107.3 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -50.46 -60.12 5.94 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.467 1.107 . . . . 0.0 112.482 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.1 -19.54 69.13 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.646 2.231 . . . . 0.0 112.3 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.537 ' O ' ' HE3' ' A' ' 63' ' ' LYS . . . -87.04 5.82 84.46 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 126.219 1.866 . . . . 0.0 113.559 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 8.6 t80 -107.43 -39.59 5.61 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.435 1.617 . . . . 0.0 110.831 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.9 mt -60.91 -10.45 5.71 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -61.9 -11.84 15.02 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 125.997 1.719 . . . . 0.0 113.189 -178.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -96.58 -10.76 26.47 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 117.032 -1.461 . . . . 0.0 113.53 172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.46 -44.63 9.0 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 121.271 1.851 . . . . 0.0 110.968 -171.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -51.64 -31.17 24.32 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.2 pt? -108.03 4.58 25.25 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.026 1.33 . . . . 0.0 112.027 -173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -106.88 -35.78 6.84 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.816 1.646 . . . . 0.0 110.519 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -93.63 -171.55 2.64 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 -42.06 1.2 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.797 1.181 . . . . 0.0 110.268 166.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.15 78.43 70.78 Favored Pre-proline 0 N--CA 1.445 -0.723 0 C-N-CA 127.078 2.151 . . . . 0.0 105.437 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -66.78 -36.34 24.43 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 109.887 -0.851 . . . . 0.0 109.887 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -19.32 65.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -164.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -124.56 2.35 8.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.538 1.517 . . . . 0.0 113.658 166.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.1 m -70.23 124.26 23.7 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 119.199 0.909 . . . . 0.0 110.572 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.8 m -81.02 110.28 16.41 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 167.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mt -81.0 149.42 29.3 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.649 -0.657 . . . . 0.0 110.551 172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -124.28 105.12 9.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.2 137.7 22.64 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 O-C-N 121.17 -0.956 . . . . 0.0 108.87 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.28 106.53 9.93 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.912 1.285 . . . . 0.0 108.237 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.29 178.9 4.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.301 1.44 . . . . 0.0 111.08 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.9 mtmm -63.04 -53.26 56.55 Favored 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.86 1.664 . . . . 0.0 110.629 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -155.5 -42.46 0.08 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.926 1.239 . . . . 0.0 111.265 -169.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.75 -59.43 0.26 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.013 1.725 . . . . 0.0 106.545 -171.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.21 -112.38 0.83 Allowed Glycine 0 C--N 1.343 0.927 0 C-N-CA 125.782 1.658 . . . . 0.0 110.397 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -149.18 36.03 0.75 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.46 1.104 . . . . 0.0 108.743 170.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.6 p -51.27 -49.41 61.27 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.07 -1.019 . . . . 0.0 110.623 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -57.78 -43.45 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.345 1.458 . . . . 0.0 110.712 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -59.95 -53.33 59.12 Favored 'General case' 0 C--O 1.227 -0.097 0 C-N-CA 123.989 0.915 . . . . 0.0 109.322 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.6 -27.53 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 O-C-N 121.592 -0.693 . . . . 0.0 109.993 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.55 -19.07 65.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.697 1.199 . . . . 0.0 112.724 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -109.16 17.5 21.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.214 1.006 . . . . 0.0 111.043 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.2 tp -112.0 -58.65 2.1 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.153 -0.967 . . . . 0.0 110.52 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.1 m -56.01 -39.99 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.07 0.85 . . . . 0.0 111.183 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.48 -27.87 69.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 122.006 0.908 . . . . 0.0 112.535 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.3 mp -88.66 -5.6 58.03 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.686 -1.259 . . . . 0.0 110.404 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -117.61 5.54 12.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.448 1.899 . . . . 0.0 111.101 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.22 -23.6 2.06 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.773 1.178 . . . . 0.0 114.082 163.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.15 173.0 10.73 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.875 0.837 . . . . 0.0 110.413 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -82.67 -69.63 0.61 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.868 -1.145 . . . . 0.0 112.115 177.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -133.51 154.64 50.66 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -139.7 169.79 17.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 119.646 1.112 . . . . 0.0 109.498 164.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -132.96 157.8 44.26 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 126.348 1.859 . . . . 0.0 109.25 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.45 134.87 54.58 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.888 1.675 . . . . 0.0 108.67 171.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -87.68 116.77 30.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 169.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -59.94 154.93 17.66 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.032 0.933 . . . . 0.0 109.903 169.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 61.97 1.62 0.68 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.27 1.828 . . . . 0.0 112.701 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 43.88 -119.68 2.81 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.843 2.164 . . . . 0.0 112.81 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.96 -42.26 4.96 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 125.6 1.56 . . . . 0.0 111.131 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.32 3.26 53.11 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.656 1.983 . . . . 0.0 112.358 -166.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.0 176.06 54.17 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 120.843 -1.161 . . . . 0.0 113.206 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -70.91 -20.61 29.22 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.78 2.32 . . . . 0.0 112.48 -175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -140.85 20.81 2.32 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.862 1.265 . . . . 0.0 111.088 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.2 -166.5 4.76 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 173.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -47.67 -54.35 12.25 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 111.398 -171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -55.83 -60.98 2.69 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -76.22 25.66 0.13 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.163 1.385 . . . . 0.0 113.042 -177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.1 t -118.84 13.06 13.1 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.699 2.0 . . . . 0.0 111.035 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.1 m 72.95 27.58 2.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.861 1.664 . . . . 0.0 112.339 174.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 13' ' ' TYR . 59.7 mt -93.53 156.09 40.09 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 123.509 0.724 . . . . 0.0 111.744 -172.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -63.1 160.32 34.79 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.21 2.606 . . . . 0.0 111.859 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.416 ' HD1' ' HB3' ' A' ' 124' ' ' GLU . 9.6 t-105 -143.09 155.18 44.55 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.858 0.754 . . . . 0.0 110.642 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.49 -63.74 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.416 ' HB3' ' HD1' ' A' ' 122' ' ' TRP 0.252 0.0 OUTLIER 78.73 158.65 0.14 Allowed Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 128.281 2.633 . . . . 0.0 113.306 178.636 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.08 -170.06 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.417 2.745 . . . . 0.0 110.515 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -72.19 166.89 21.46 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.782 -1.199 . . . . 0.0 108.51 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -62.21 16.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 127.498 2.319 . . . . 0.0 115.22 173.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.54 92.19 3.73 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 69.3 m -139.9 -178.97 5.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.563 1.545 . . . . 0.0 110.326 -169.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 165.19 69.21 0.03 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.34 116.71 4.04 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.672 2.248 . . . . 0.0 109.237 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.2 t 59.95 29.34 18.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.983 0.913 . . . . 0.0 112.235 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -36.35 32.84 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.392 1.077 . . . . 0.0 113.744 -177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.086 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 177.371 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.414 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.5 t -135.69 178.11 7.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 159.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -134.29 165.34 25.35 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.662 0.785 . . . . 0.0 111.817 -160.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.82 -178.21 29.6 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -166.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.9 p -81.05 74.15 8.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.904 0.882 . . . . 0.0 109.911 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -146.29 170.64 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.877 0.871 . . . . 0.0 109.123 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.36 172.83 37.68 Favored Glycine 0 C--N 1.333 0.38 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -74.62 175.63 7.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.006 0.922 . . . . 0.0 111.135 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -55.54 -69.08 0.15 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -20.59 34.52 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.712 -1.243 . . . . 0.0 111.393 172.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.31 2.02 10.23 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.126 1.371 . . . . 0.0 114.353 176.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.87 -43.76 3.74 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.708 1.14 . . . . 0.0 111.717 158.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.94 -38.73 70.71 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.542 -0.724 . . . . 0.0 112.624 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.3 m -60.93 -39.16 88.35 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.769 -0.582 . . . . 0.0 110.532 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -80.85 -5.66 57.59 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.048 -1.033 . . . . 0.0 113.254 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.1 mt -74.0 -56.41 4.97 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 157.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.01 19.42 1.71 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 115.57 0.988 . . . . 0.0 115.57 -164.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.4 p -132.66 -1.65 3.42 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.643 1.577 . . . . 0.0 111.926 -175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -145.34 161.69 39.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.263 1.425 . . . . 0.0 109.599 -168.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.67 -23.72 12.01 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.114 0.966 . . . . 0.0 110.905 171.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -77.87 -14.67 59.48 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.75 -0.594 . . . . 0.0 111.059 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.69 16.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.079 -1.013 . . . . 0.0 109.919 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 3.4 mm-40 -153.55 174.1 14.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.981 1.313 . . . . 0.0 111.327 172.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 129.2 34.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.63 1.172 . . . . 0.0 109.71 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.2 OUTLIER -118.69 90.98 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.315 1.446 . . . . 0.0 109.873 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.432 ' OD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -68.73 98.78 0.94 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.367 1.867 . . . . 0.0 108.922 173.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.4 pt -92.2 7.1 5.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 125.616 1.566 . . . . 0.0 112.989 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -64.5 162.75 14.73 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 121.373 -0.829 . . . . 0.0 109.44 172.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.74 151.27 17.91 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 122.973 0.509 . . . . 0.0 111.207 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.9 m -55.7 -38.58 69.88 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.084 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 -17.94 50.04 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.582 0.628 . . . . 0.0 112.662 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -30.17 66.96 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 173.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -72.87 -0.26 13.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -120.15 -42.25 2.59 Favored 'General case' 0 C--O 1.216 -0.661 0 C-N-CA 125.774 1.629 . . . . 0.0 108.703 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -92.08 -23.94 19.3 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.56 -41.71 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.501 1.12 . . . . 0.0 109.856 175.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.25 -166.36 14.49 Favored Glycine 0 C--N 1.337 0.599 0 O-C-N 120.616 -1.302 . . . . 0.0 110.6 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.53 154.14 79.5 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.182 -169.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.75 124.85 11.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 1 C-N-CA 126.68 4.92 . . . . 0.0 112.814 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -88.39 115.85 26.19 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.114 0.566 . . . . 0.0 110.471 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 pt -143.0 4.24 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.848 0.859 . . . . 0.0 112.705 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.52 -30.59 71.62 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.607 -0.683 . . . . 0.0 112.301 -167.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.19 -10.18 78.5 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.5 mt -77.12 -21.49 54.15 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.682 1.741 . . . . 0.0 110.615 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.36 -55.3 0.2 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 123.605 0.622 . . . . 0.0 112.101 -169.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE3' ' HA ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -172.77 164.09 5.18 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 121.647 -0.913 . . . . 0.0 108.715 -157.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' HE2' ' CD1' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -86.87 149.1 25.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HB1' ' OD1' ' A' ' 26' ' ' ASP . . . -62.19 167.91 3.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.099 171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -117.28 101.78 12.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.423 1.489 . . . . 0.0 109.071 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.8 p -67.95 112.87 5.21 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.8 m -148.56 98.92 2.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 p -54.57 124.88 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . 39.4 t80 -75.62 149.39 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.005 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -143.47 132.89 23.4 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 170.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.58 -9.75 80.81 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-O 119.409 -0.662 . . . . 0.0 112.922 177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -64.61 -43.08 94.9 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.539 1.169 . . . . 0.0 109.551 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -131.16 70.87 1.46 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.257 1.823 . . . . 0.0 107.553 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HE2' ' OH ' ' A' ' 53' ' ' TYR . 21.8 mmtp -37.9 -57.47 1.63 Allowed Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.838 1.255 . . . . 0.0 111.087 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.41 -49.76 6.95 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.81 2.34 . . . . 0.0 112.56 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' HE2' ' A' ' 63' ' ' LYS . . . -62.79 -1.7 3.94 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.268 1.413 . . . . 0.0 114.486 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 53' ' ' TYR . 0.5 OUTLIER -107.11 -50.17 3.14 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.03 1.332 . . . . 0.0 110.628 168.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 53.9 mt -54.43 -23.97 18.13 Favored 'General case' 0 C--N 1.338 0.077 0 C-N-CA 123.866 0.866 . . . . 0.0 112.192 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -56.79 -32.14 65.35 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 123.785 0.834 . . . . 0.0 112.035 -179.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -71.74 -31.42 66.67 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.898 1.226 . . . . 0.0 108.881 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.58 -5.39 33.07 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 124.105 0.962 . . . . 0.0 110.865 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.32 7.07 46.72 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.571 1.948 . . . . 0.0 112.753 172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.31 10.37 2.99 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.884 -1.135 . . . . 0.0 113.889 174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.78 -5.36 5.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 126.086 1.754 . . . . 0.0 115.161 -171.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.559 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 19.9 m-85 -124.37 170.37 10.89 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tmmm? -113.05 -40.93 3.83 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 122.012 -0.43 . . . . 0.0 110.631 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -133.15 63.5 66.57 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 123.925 0.89 . . . . 0.0 109.402 -164.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 59.3 Cg_endo -66.27 -34.03 37.13 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.293 1.995 . . . . 0.0 110.425 -168.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.78 -1.16 2.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.744 2.018 . . . . 0.0 113.978 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -135.73 -8.7 2.14 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.074 -1.016 . . . . 0.0 113.046 167.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -77.07 115.35 16.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.283 0.947 . . . . 0.0 112.223 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -78.6 100.24 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.327 -0.858 . . . . 0.0 110.642 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 156.16 27.14 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 121.494 -0.754 . . . . 0.0 111.83 -176.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -133.25 100.8 4.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.997 1.719 . . . . 0.0 107.294 172.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.8 mp -65.03 144.47 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 O-C-N 120.829 -1.169 . . . . 0.0 108.936 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 115.32 12.7 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.44 1.496 . . . . 0.0 107.794 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.34 -162.75 0.88 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 109.827 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -99.41 -54.36 2.97 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 119.815 -1.803 . . . . 0.0 110.937 -175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.18 -52.56 1.4 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 124.253 0.97 . . . . 0.0 112.977 -170.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -154.69 -45.03 0.09 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.938 2.095 . . . . 0.0 107.054 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 49.63 -95.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.886 0 C-N-CA 127.859 2.647 . . . . 0.0 110.664 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -163.43 26.16 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 129.164 2.986 . . . . 0.0 107.692 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 p -55.82 -47.38 77.3 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.176 -1.578 . . . . 0.0 111.095 -174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -64.23 -29.74 70.82 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 122.759 0.424 . . . . 0.0 111.102 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.64 -54.18 15.17 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.193 -0.942 . . . . 0.0 110.44 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.07 -27.27 42.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 119.01 -0.519 . . . . 0.0 109.876 -176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.84 -9.54 21.59 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 118.17 -0.919 . . . . 0.0 113.439 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -134.26 45.96 2.55 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 120.466 1.485 . . . . 0.0 110.021 174.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.8 tp -128.98 -53.87 1.21 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.576 1.151 . . . . 0.0 110.176 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.3 m -61.37 -39.24 82.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.735 0.814 . . . . 0.0 112.488 -176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.17 -5.83 11.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.882 1.273 . . . . 0.0 113.365 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.64 21.75 10.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.886 1.674 . . . . 0.0 109.168 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -143.05 -43.98 0.3 Allowed 'General case' 0 C--O 1.231 0.108 0 C-N-CA 125.311 1.444 . . . . 0.0 110.931 -171.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.92 3.85 0.04 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.999 176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 72' ' ' PRO . 23.6 m-85 -118.48 171.87 7.86 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.741 1.27 . . . . 0.0 108.727 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -62.08 1.55 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.799 2.04 . . . . 0.0 110.649 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.8 m -145.74 146.18 31.13 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.994 0.918 . . . . 0.0 108.86 -174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -136.56 171.54 14.34 Favored 'General case' 0 C--N 1.334 -0.095 0 C-N-CA 124.689 1.196 . . . . 0.0 109.883 172.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -138.45 166.94 23.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.213 2.205 . . . . 0.0 111.009 -175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -127.91 164.67 21.76 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.452 1.501 . . . . 0.0 110.334 169.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.1 OUTLIER -120.87 129.66 75.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 127.514 2.326 . . . . 0.0 105.041 171.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 tptt -66.81 153.33 43.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 66.4 6.04 4.09 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 113.123 171.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 39.72 -122.02 1.63 Allowed Glycine 0 C--N 1.338 0.651 0 C-N-CA 127.103 2.287 . . . . 0.0 113.272 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.4 9.44 6.09 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.892 1.277 . . . . 0.0 112.915 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -130.12 -15.16 3.79 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.116 0.966 . . . . 0.0 112.047 171.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.34 158.12 39.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.462 1.028 . . . . 0.0 110.776 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.7 -12.24 27.67 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.871 3.047 . . . . 0.0 114.327 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.3 10.96 7.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.334 1.454 . . . . 0.0 111.539 176.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.47 -167.88 26.42 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.951 0.786 . . . . 0.0 111.944 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -47.92 -61.48 1.94 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 128.268 2.627 . . . . 0.0 111.899 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.7 -44.3 90.3 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -76.24 25.23 0.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.516 1.526 . . . . 0.0 111.844 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.0 t -135.99 23.0 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.061 2.144 . . . . 0.0 110.26 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 60.0 p 65.72 6.33 3.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.399 2.279 . . . . 0.0 113.984 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.0 mt -75.5 154.26 85.73 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 118.259 0.481 . . . . 0.0 112.043 -165.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.1 156.41 47.11 Favored 'Trans proline' 0 C--O 1.242 0.692 0 C-N-CA 123.491 2.794 . . . . 0.0 112.913 -174.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -141.85 148.86 39.48 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.145 0.978 . . . . 0.0 111.793 -174.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' CD1' ' HE2' ' A' ' 47' ' ' LYS . 68.6 mt -89.03 -35.86 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 126.603 1.961 . . . . 0.0 110.17 -176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 63.64 163.62 0.12 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.663 1.585 . . . . 0.0 114.095 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -70.98 -175.49 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.579 2.186 . . . . 0.0 112.867 163.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -133.99 133.1 40.91 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.008 1.723 . . . . 0.0 107.072 165.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt 42.94 31.64 0.34 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.153 2.181 . . . . 0.0 114.052 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.2 p -145.64 44.77 1.29 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.524 1.53 . . . . 0.0 110.811 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m -48.64 -46.88 40.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.12 0.968 . . . . 0.0 112.426 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.34 -161.95 18.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.228 -1.318 . . . . 0.0 111.134 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.78 75.39 1.23 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 125.06 3.84 . . . . 0.0 112.168 -171.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.9 m 53.93 17.96 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.141 1.776 . . . . 0.0 112.712 -174.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.5 1.92 . . . . 0.0 112.344 176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 105.463 -3.055 . . . . 0.0 105.463 169.053 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.515 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 m -74.9 123.71 25.58 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.6 t -155.17 -5.18 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 117.826 -1.083 . . . . 0.0 113.457 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 177.99 178.6 47.6 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 121.269 1.85 . . . . 0.0 110.96 -173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 m -110.26 60.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -165.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.3 p -68.7 -171.73 0.31 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.332 1.063 . . . . 0.0 110.728 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.62 178.92 39.63 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 165.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.65 169.7 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.707 0.803 . . . . 0.0 110.847 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' HD12 ' A' ' 105' ' ' ILE . . . -54.82 -64.81 0.72 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG2' HD21 ' A' ' 120' ' ' LEU . 25.5 mtpt -63.68 -20.75 65.95 Favored 'General case' 0 C--O 1.224 -0.255 0 O-C-N 121.259 -0.9 . . . . 0.0 110.792 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -9.05 12.3 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.655 1.116 . . . . 0.0 112.371 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.07 -49.74 4.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 120.574 1.534 . . . . 0.0 112.345 159.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -59.52 -43.51 93.41 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -55.56 -25.49 38.19 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 118.127 -0.939 . . . . 0.0 113.509 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -104.65 -4.28 22.69 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.268 1.827 . . . . 0.0 112.397 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.3 tp -81.85 -23.44 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.048 1.339 . . . . 0.0 110.184 -174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.6 5.63 8.58 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 124.267 0.937 . . . . 0.0 113.072 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -72.88 -17.99 61.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 118.462 1.131 . . . . 0.0 110.38 167.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.29 104.79 4.14 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 -156.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -61.27 -13.03 15.83 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.352 1.061 . . . . 0.0 112.629 -176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -77.64 -29.01 51.5 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.002 1.321 . . . . 0.0 112.141 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.53 160.15 22.96 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.223 0.919 . . . . 0.0 110.724 -171.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -149.34 177.14 9.94 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.613 1.165 . . . . 0.0 111.7 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.21 131.17 40.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.806 1.643 . . . . 0.0 109.396 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD23 ' HZ ' ' A' ' 69' ' ' PHE . 0.3 OUTLIER -118.49 95.7 4.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.82 1.248 . . . . 0.0 108.49 177.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.67 97.32 2.65 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 124.864 1.266 . . . . 0.0 109.112 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -79.87 4.59 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.461 HH22 ' HA ' ' A' ' 38' ' ' SER . 50.8 mtm-85 -65.92 154.37 39.48 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.819 0.847 . . . . 0.0 111.537 -176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.84 139.23 4.32 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.862 1.665 . . . . 0.0 110.905 169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 m -63.23 -28.84 70.31 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.979 0.419 . . . . 0.0 111.598 -176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.57 -32.04 73.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.605 0.762 . . . . 0.0 112.178 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -51.66 -44.53 63.07 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.627 1.171 . . . . 0.0 109.634 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -60.66 -17.48 47.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.086 1.354 . . . . 0.0 114.274 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -97.48 -20.76 17.54 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.211 1.404 . . . . 0.0 111.697 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -126.73 -43.09 1.73 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.102 1.361 . . . . 0.0 113.249 -167.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 t -89.05 -35.53 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.626 1.171 . . . . 0.0 109.002 166.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.46 -169.76 22.75 Favored Glycine 0 C--N 1.336 0.528 0 O-C-N 120.879 -1.138 . . . . 0.0 110.276 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.461 ' HA ' HH22 ' A' ' 28' ' ' ARG . 4.7 m -123.27 154.14 65.32 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.222 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -60.28 151.8 71.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 123.925 3.083 . . . . 0.0 110.744 169.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -110.96 92.53 4.08 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.763 0.425 . . . . 0.0 109.856 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.06 9.33 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.59 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -59.04 -31.36 68.78 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 119.102 0.864 . . . . 0.0 112.69 -172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.41 -29.95 74.83 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.323 173.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.84 7.4 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.789 1.294 . . . . 0.0 111.091 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.96 -13.13 9.17 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-O 118.567 -1.129 . . . . 0.0 113.726 159.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.72 161.31 7.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 125.283 1.433 . . . . 0.0 108.996 -174.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 155.15 23.39 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 169.06 7.23 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.605 0.762 . . . . 0.0 111.291 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.3 t -113.7 108.63 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.555 1.542 . . . . 0.0 109.977 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 p -72.23 118.82 15.59 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.1 m -145.48 106.59 4.17 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.272 -1.518 . . . . 0.0 107.723 156.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -62.57 127.38 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . 14.2 t80 -78.75 151.75 31.88 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.136 0.493 . . . . 0.0 110.075 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -141.19 111.09 6.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 163.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.39 -17.38 59.56 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 118.581 0.628 . . . . 0.0 112.996 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.36 -35.49 65.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.585 1.554 . . . . 0.0 112.111 167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -132.89 71.92 1.48 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.292 1.406 . . . . 0.0 110.502 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -45.6 -59.19 4.83 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.235 1.414 . . . . 0.0 113.905 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.43 -45.74 3.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.271 1.981 . . . . 0.0 111.455 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -77.29 38.77 1.62 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.897 1.237 . . . . 0.0 112.044 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 53' ' ' TYR . 35.8 t80 -137.67 -54.74 0.67 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.632 1.573 . . . . 0.0 108.71 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -57.85 -21.79 44.5 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.402 1.081 . . . . 0.0 112.282 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -18.24 9.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.731 1.612 . . . . 0.0 112.618 178.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -83.6 -28.47 28.48 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 119.107 0.867 . . . . 0.0 111.652 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.74 -37.18 62.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.728 0.695 . . . . 0.0 109.536 -174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 m -58.1 -13.1 4.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.527 1.931 . . . . 0.0 115.316 -170.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -134.64 14.89 3.69 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.317 1.847 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -115.09 -12.0 11.99 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.248 1.819 . . . . 0.0 111.815 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.565 ' HZ ' HD23 ' A' ' 25' ' ' LEU . 18.3 m-85 -131.75 125.67 32.55 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -42.86 71.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.482 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -135.73 72.71 62.41 Favored Pre-proline 0 N--CA 1.444 -0.728 0 O-C-N 124.688 1.242 . . . . 0.0 109.089 -163.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.49 -25.13 30.17 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.736 1.624 . . . . 0.0 113.013 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -59.53 -30.22 68.44 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.816 1.189 . . . . 0.0 112.262 -167.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.2 -15.08 7.35 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.796 2.038 . . . . 0.0 112.395 -173.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -61.19 124.89 21.86 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.632 1.106 . . . . 0.0 108.086 172.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m -81.69 126.1 31.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.057 1.343 . . . . 0.0 107.837 166.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.9 166.42 11.3 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.236 -1.54 . . . . 0.0 110.649 177.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -139.02 111.29 7.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.785 1.634 . . . . 0.0 107.057 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.89 143.82 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 119.757 1.162 . . . . 0.0 111.215 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.64 106.59 7.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.703 1.601 . . . . 0.0 110.284 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.0 171.26 10.44 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.143 0.977 . . . . 0.0 112.204 172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -47.93 -51.55 22.99 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.041 -1.662 . . . . 0.0 110.236 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -155.95 -39.02 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.171 0.896 . . . . 0.0 112.115 -165.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.49 -68.13 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -167.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.45 -100.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 128.121 2.772 . . . . 0.0 111.874 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.47 18.12 1.05 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.024 0.93 . . . . 0.0 111.235 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 m -52.77 -46.8 67.7 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.776 1.171 . . . . 0.0 111.669 -162.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -71.5 -16.37 62.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.075 1.35 . . . . 0.0 113.53 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.44 -50.39 12.79 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.29 -31.81 52.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.76 -17.79 64.48 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.965 0.906 . . . . 0.0 111.675 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.71 25.07 11.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.683 1.593 . . . . 0.0 110.954 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 tp -123.45 -63.65 1.22 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.626 0.77 . . . . 0.0 110.123 -169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.7 m -56.41 -41.45 71.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 118.123 0.419 . . . . 0.0 110.942 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -12.51 8.9 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.557 1.143 . . . . 0.0 113.124 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 mp -120.4 14.35 11.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.859 1.664 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -132.56 10.68 4.4 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 124.531 1.132 . . . . 0.0 112.216 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.96 11.53 2.06 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.665 -1.075 . . . . 0.0 113.948 176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.58 170.2 11.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.119 1.46 . . . . 0.0 111.537 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -70.45 -76.92 0.09 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -174.198 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 m -160.81 130.64 5.01 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 128.199 2.6 . . . . 0.0 107.249 -162.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -131.01 160.48 34.45 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 123.177 1.465 . . . . 0.0 112.388 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.14 161.74 36.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 129.793 3.237 . . . . 0.0 108.609 -166.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.34 165.32 22.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 109.65 170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 9' ' ' ALA . 0.2 OUTLIER -113.4 134.49 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.071 1.348 . . . . 0.0 107.417 170.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -75.95 155.97 34.6 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 125.183 1.393 . . . . 0.0 110.338 173.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 60.67 8.2 1.67 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.813 1.645 . . . . 0.0 112.439 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 -131.65 7.41 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.151 2.31 . . . . 0.0 112.362 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.68 -55.04 3.87 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.242 1.417 . . . . 0.0 109.817 177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -86.9 -3.79 59.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -160.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.15 158.95 44.8 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.408 1.004 . . . . 0.0 111.405 177.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -62.85 -10.16 19.1 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 124.839 3.693 . . . . 0.0 113.102 173.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -137.74 15.85 2.9 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.606 2.362 . . . . 0.0 110.289 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.65 -156.38 5.95 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -54.77 -50.0 69.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 109.915 174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 72.5 mt -72.58 164.61 26.17 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-O 124.765 2.222 . . . . 0.0 106.491 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 48.5 t30 48.58 20.18 0.3 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 128.063 2.545 . . . . 0.0 112.98 -171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.4 m -122.08 19.41 10.79 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 119.795 -1.815 . . . . 0.0 111.724 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.72 3.03 3.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.535 1.934 . . . . 0.0 113.031 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 10' ' ' LYS . 76.0 mt -80.03 147.18 65.06 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 119.872 1.214 . . . . 0.0 111.247 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.6 146.56 79.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.396 2.064 . . . . 0.0 112.177 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.1 t-105 -132.57 147.27 52.35 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.844 1.258 . . . . 0.0 108.667 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 72.7 mt -80.8 -36.78 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.018 1.327 . . . . 0.0 109.08 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 63.92 161.56 0.12 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.485 1.914 . . . . 0.0 112.394 -164.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -75.64 -177.54 3.65 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.593 2.195 . . . . 0.0 110.219 166.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -104.07 20.66 17.85 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.108 1.363 . . . . 0.0 111.797 -174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.75 157.27 17.85 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 125.018 1.327 . . . . 0.0 110.402 -173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -121.0 17.1 11.71 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.487 1.915 . . . . 0.0 109.487 167.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.7 m -128.49 139.35 52.37 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.99 69.36 0.41 Allowed Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.181 -1.344 . . . . 0.0 112.809 -167.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.97 10.43 0.88 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 124.149 3.232 . . . . 0.0 112.863 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 p -150.96 50.96 0.85 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.358 2.263 . . . . 0.0 106.36 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -15.99 56.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.397 -0.814 . . . . 0.0 111.46 -175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 178.951 . . . . . . . . 0 0 . 1 stop_ save_